Christel Daniel
David Ouagne
PATHLEX
Generic-Infiltrating malignant neoplasm-Specimen weight
Specimen weight
Generic-Infiltrating malignant neoplasm-Lesion size, largest dimension
Lesion size, largest dimension
Histologic grade
Ancillary techniques
Histologic grade
Target site
Specimen collection procedure
Generic-Infiltrating malignant neoplasm
Generic-In situ neoplasm
Generic-Lesion
Generic-Specimen
Prostate-Infiltrating malignant neoplasm-Histologic type-Adenocarcinoma (acinar, not otherwise specified)
Adenocarcinoma (acinar, not otherwise specified)
Prostate-Infiltrating malignant neoplasm-Histologic type-Prostatic duct adenocarcinoma
Prostatic duct adenocarcinoma
Prostate-Infiltrating malignant neoplasm-Histologic type-Mucinous (colloid) adenocarcinoma
Mucinous (colloid) adenocarcinoma
Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Primary (Predominant) Pattern)-Grade 1
Grade 1
Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Primary (Predominant) Pattern)-Grade 2
Grade 2
Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Primary (Predominant) Pattern)-Grade 3
Grade 3
Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Primary (Predominant) Pattern)-Grade 4
Grade 4
Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Primary (Predominant) Pattern)-Grade 5
Grade 5
Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Secondary (Worst Remaining) Pattern)-Grade 1
Grade 1
Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Secondary (Worst Remaining) Pattern)-Grade 2
Grade 2
Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Secondary (Worst Remaining) Pattern)-Grade 3
Grade 3
Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Secondary (Worst Remaining) Pattern)-Grade 4
Grade 4
Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Secondary (Worst Remaining) Pattern)-Grade 5
Grade 5
Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Tertiary Pattern)-Grade 3
Grade 3
Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Tertiary Pattern)-Grade 4
Grade 4
Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Tertiary Pattern)-Grade 5
Grade 5
Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Total Gleason Score)-2
2
Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Total Gleason Score)-3
3
Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Total Gleason Score)-4
4
Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Total Gleason Score)-5
5
Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Total Gleason Score)-6
6
Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Total Gleason Score)-7
7
Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Total Gleason Score)-8
8
Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Total Gleason Score)-9
9
Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Total Gleason Score)-10
10
Prostate-Infiltrating malignant neoplasm-pT-pT2: Organ confined
pT2: Organ confined
Prostate-Infiltrating malignant neoplasm-pT-pT2a: Unilateral, involving one-half of 1 side or less
pT2a: Unilateral, involving one-half of 1 side or less
Prostate-Infiltrating malignant neoplasm-pT-pT2b: Unilateral, involving more than one-half of 1 side but not both sides
pT2b: Unilateral, involving more than one-half of 1 side but not both sides
Prostate-Infiltrating malignant neoplasm-pT-pT2c: Bilateral disease
pT2c: Bilateral disease
Prostate-Infiltrating malignant neoplasm-pT-pT3: Extraprostatic extension
pT3: Extraprostatic extension
Prostate-Infiltrating malignant neoplasm-pT-pT3a: Extraprostatic extension or microscopic invasion of bladder neck
pT3a: Extraprostatic extension or microscopic invasion of bladder neck
Prostate-Infiltrating malignant neoplasm-pT-pT3b: Seminal vesicle invasion
pT3b: Seminal vesicle invasion
Prostate-Infiltrating malignant neoplasm-pT-pT4: Invasion of rectum, levator muscles and/or pelvic wall (Note J)
pT4: Invasion of rectum, levator muscles and/or pelvic wall (Note J)
Prostate-Infiltrating malignant neoplasm-pN-pN0: No regional lymph node metastasis
pN0: No regional lymph node metastasis
Prostate-Infiltrating malignant neoplasm-pN-pN1: Metastasis in regional lymph node or nodes
pN1: Metastasis in regional lymph node or nodes
Testis-Specimen-Target site-Testis
Testis
Testis-Specimen-Specimen collection procedure-Radical Orchiectomy
Radical Orchiectomy
Testis-Infiltrating malignant neoplasm-Histologic type-Teratoma
Teratoma
Testis-Infiltrating malignant neoplasm-Histologic type-Intratubular germ cell neoplasia, unclassified only
Intratubular germ cell neoplasia, unclassified only
Testis-Infiltrating malignant neoplasm-Histologic type-Seminoma, classic type
Seminoma, classic type
Testis-Infiltrating malignant neoplasm-Histologic type-Mixed germ cell tumor
Mixed germ cell tumor
Testis-Infiltrating malignant neoplasm-Histologic type-Yolk sac tumor
Yolk sac tumor
Testis-Infiltrating malignant neoplasm-Histologic type-Testicular scar only
Testicular scar only
Testis-Infiltrating malignant neoplasm-Margin site-Spermatic Cord Margin
Spermatic Cord Margin
Testis-Infiltrating malignant neoplasm-pT-pT0: No evidence of primary tumor
pT0: No evidence of primary tumor
Testis-Infiltrating malignant neoplasm-pT-pTis: Intratubular germ cell neoplasia (carcinoma in situ)
pTis: Intratubular germ cell neoplasia (carcinoma in situ)
Testis-Infiltrating malignant neoplasm-pT-pT1: Tumor limited to the testis and epididymis without vascular/lymphatic invasion; tumor may invade tunica albuginea but not tunica vaginalis
pT1: Tumor limited to the testis and epididymis without vascular/lymphatic invasion; tumor may invade tunica albuginea but not tunica vaginalis
Testis-Infiltrating malignant neoplasm-pT-pT2: Tumor limited to the testis and epididymis with vascular/lymphatic invasion, or tumor extending through the tunica albuginea with involvement of the tunica vaginalis
pT2: Tumor limited to the testis and epididymis with vascular/lymphatic invasion, or tumor extending through the tunica albuginea with involvement of the tunica vaginalis
Testis-Infiltrating malignant neoplasm-pT-pT3: Tumor invades the spermatic cord with or without vascular/lymphatic invasion
pT3: Tumor invades the spermatic cord with or without vascular/lymphatic invasion
Testis-Infiltrating malignant neoplasm-pT-pTX: Cannot be assessed
pT0: No evidence of primary tumor
pTis: Intratubular germ cell neoplasia (carcinoma in situ)
pT1: Tumor limited to the testis and epididymis without vascular/lymphatic
invasion; tumor may invade tunica albuginea but not tunica vaginalis
pT2: Tumor limited to the testis and epididymis with vascular/lymphatic invasion, or
tumor extending through the tunica albuginea with involvement of the tunica
vaginalis
pT3: Tumor invades the spermatic cord with or without vascular/lymphatic invasion
pT4: Tumor invades the scrotum with or without vascular/lymphatic invasion
pTX: Cannot be assessed
pT0: No evidence of primary tumor
pTis: Intratubular germ cell neoplasia (carcinoma in situ)
pT1: Tumor limited to the testis and epididymis without vascular/lymphatic
invasion; tumor may invade tunica albuginea but not tunica vaginalis
pT2: Tumor limited to the testis and epididymis with vascular/lymphatic invasion, or
tumor extending through the tunica albuginea with involvement of the tunica
vaginalis
pT3: Tumor invades the spermatic cord with or without vascular/lymphatic invasion
pT4: Tumor invades the scrotum with or without vascular/lymphatic invasion
Testis-Infiltrating malignant neoplasm-pN-pN0: No regional lymph node metastasis
pN0: No regional lymph node metastasis
Testis-Infiltrating malignant neoplasm-pN-pN1: Metastasis with a lymph node mass 2 cm or less in greatest dimension, or 5 or fewer positive nodes, none more than 2 cm in greatest dimension
pN1: Metastasis with a lymph node mass 2 cm or less in greatest dimension, or 5 or fewer positive nodes, none more than 2 cm in greatest dimension
Testis-Infiltrating malignant neoplasm-pN-pN2: Metastasis with a lymph node mass greater than 2 cm but not more than 5 cm in greatest dimension; or more than 5 nodes positive, none greater than 5 cm; or evidence of extranodal extension of tumor
pN2: Metastasis with a lymph node mass greater than 2 cm but not more than 5 cm in greatest dimension; or more than 5 nodes positive, none greater than 5 cm; or evidence of extranodal extension of tumor
Testis-Infiltrating malignant neoplasm-pN-pN3: Metastasis with a lymph node mass greater than 5 cm in greatest dimension
pN3: Metastasis with a lymph node mass greater than 5 cm in greatest dimension
Kidney-Specimen-Specimen collection procedure-Partial nephrectomy
Partial nephrectomy
Kidney-Specimen-Specimen collection procedure-Radical nephrectomy
Radical nephrectomy
Kidney-Infiltrating malignant neoplasm-Lesion site-Upper pole
Upper pole
Kidney-Infiltrating malignant neoplasm-Lesion site-Middle
Middle
Kidney-Infiltrating malignant neoplasm-Lesion site-Lower pole
Lower pole
Kidney-Infiltrating malignant neoplasm-Lesion site-Kidney
Kidney
Kidney-Infiltrating malignant neoplasm-Histologic type-Clear cell renal cell carcinoma
Clear cell renal cell carcinoma
Kidney-Infiltrating malignant neoplasm-Histologic type-Chromophobe renal cell carcinoma
Chromophobe renal cell carcinoma
Kidney-Infiltrating malignant neoplasm-Histologic type-Carcinoma of the collecting ducts of Bellini
Carcinoma of the collecting ducts of Bellini
Kidney-Infiltrating malignant neoplasm-Histologic type-Renal medullary carcinoma
Renal medullary carcinoma
Kidney-Infiltrating malignant neoplasm-Histologic grade (Fuhrman Nuclear Grade)-G1: Nuclei round, uniform, approximately 10 mm; nucleoli inconspicuous or absent
G1: Nuclei round, uniform, approximately 10 mm; nucleoli inconspicuous or absent
Kidney-Infiltrating malignant neoplasm-Histologic grade (Fuhrman Nuclear Grade)-G2: Nuclei slightly irregular, approximately 15 mm; nucleoli evident
G2: Nuclei slightly irregular, approximately 15 mm; nucleoli evident
Kidney-Infiltrating malignant neoplasm-Histologic grade (Fuhrman Nuclear Grade)-G3: Nuclei very irregular, approximately 20 mm; nucleoli large and proeminent
G3: Nuclei very irregular, approximately 20 mm; nucleoli large and proeminent
Kidney-Infiltrating malignant neoplasm-Histologic grade (Fuhrman Nuclear Grade)-G4: Nuclei bizarre and multilobated, 20 mm or greater, nucleoli prominent, chromatin clumped
G4: Nuclei bizarre and multilobated, 20 mm or greater, nucleoli prominent, chromatin clumped
Kidney-Infiltrating malignant neoplasm-Margin site-Renal parenchymal margin (partial nephrectomy only)
Renal parenchymal margin (partial nephrectomy only)
Kidney-Infiltrating malignant neoplasm-Margin site-Renal vein margin
Renal vein margin
Kidney-Infiltrating malignant neoplasm-pT-pT0: No evidence of primary tumor
pT0: No evidence of primary tumor
Kidney-Infiltrating malignant neoplasm-pT-pT1: Tumor 7 cm or less in greatest dimension, limited to the kidney
pT1: Tumor 7 cm or less in greatest dimension, limited to the kidney
Kidney-Infiltrating malignant neoplasm-pT-pT1a: Tumor 4 cm or less in greatest dimension, limited to the kidney
pT1a: Tumor 4 cm or less in greatest dimension, limited to the kidney
Kidney-Infiltrating malignant neoplasm-pT-pT1b: Tumor more than 4 cm but not more than 7 cm in greatest dimension, limited to the kidney
pT1b: Tumor more than 4 cm but not more than 7 cm in greatest dimension, limited to the kidney
Kidney-Infiltrating malignant neoplasm-pT-pT2: Tumor more than 7 cm in greatest dimension, limited to the kidney
pT2: Tumor more than 7 cm in greatest dimension, limited to the kidney
Generic-Infiltrating malignant neoplasm-Lesion size, additional dimension
Lesion size, additional dimension
Kidney-Infiltrating malignant neoplasm-pT-pT2a: Tumor more than 7 cm but less than or equal to 10 cm in greatest dimension, limited to the kidney
pT2a: Tumor more than 7 cm but less than or equal to 10 cm in greatest dimension, limited to the kidney
Kidney-Infiltrating malignant neoplasm-pT-pT2b: Tumor more than 10 cm, limited to the kidney
pT2b: Tumor more than 10 cm, limited to the kidney
Kidney-Infiltrating malignant neoplasm-pT-pT3: Tumor extends into major veins or perinephric tissues but not into the ipsilateral adrenal gland and not beyond Gerota’s fascia
pT3: Tumor extends into major veins or perinephric tissues but not into the ipsilateral adrenal gland and not beyond Gerota’s fascia
Kidney-Infiltrating malignant neoplasm-pT-pT3a: Tumor grossly extends into the renal vein or its segmental (muscle containing) branches, or tumor invades perirenal and/or renal sinus fat but not beyond Gerota’s fascia
pT3a: Tumor grossly extends into the renal vein or its segmental (muscle containing) branches, or tumor invades perirenal and/or renal sinus fat but not beyond Gerota’s fascia
Kidney-Infiltrating malignant neoplasm-pT-pT3b: Tumor grossly extends into the vena cava below the diaphragm
pT3b: Tumor grossly extends into the vena cava below the diaphragm
Kidney-Infiltrating malignant neoplasm-pT-pT3c: Tumor grossly extends into vena cava above diaphragm or invades the wall of the vena cava
pT3c: Tumor grossly extends into vena cava above diaphragm or invades the wall of the vena cava
Kidney-Infiltrating malignant neoplasm-pT-pT4: Tumor invades beyond Gerota’s fascia (including contiguous extension into the ipsilateral adrenal gland)
pT4: Tumor invades beyond Gerota’s fascia (including contiguous extension into the ipsilateral adrenal gland)
Kidney-Infiltrating malignant neoplasm-pN-pN0: No regional lymph node metastasis
pN0: No regional lymph node metastasis
Kidney-Infiltrating malignant neoplasm-pN-pN1: Metastasis in regional lymph node(s)
pN1: Metastasis in regional lymph node(s)
Urinary bladder-Infiltrating malignant neoplasm-Histologic type-Urothelial (transitional cell) carcinoma
Urothelial (transitional cell) carcinoma
Urinary bladder-Infiltrating malignant neoplasm-Histologic type-Small cell carcinoma
Small cell carcinoma
Urinary bladder-Infiltrating malignant neoplasm-pT-pT0: No evidence of primary tumor
pT0: No evidence of primary tumor
Urinary bladder-Infiltrating malignant neoplasm-pT-pTa: Noninvasive papillary carcinoma
pTa: Noninvasive papillary carcinoma
Urinary bladder-Infiltrating malignant neoplasm-pT-pTis: Carcinoma in situ: “flat tumor”
pTis: Carcinoma in situ: “flat tumor”
Urinary bladder-Infiltrating malignant neoplasm-pT-pT1: Tumor invades subepithelial connective tissue (lamina propria)
pT1: Tumor invades subepithelial connective tissue (lamina propria)
Urinary bladder-Infiltrating malignant neoplasm-pT-pT2: Tumor invades muscularis propria (detrusor muscle)
pT2: Tumor invades muscularis propria (detrusor muscle)
Urinary bladder-Infiltrating malignant neoplasm-pT-pT2a: Tumor invades superficial muscularis propria (inner half)
pT2a: Tumor invades superficial muscularis propria (inner half)
Urinary bladder-Infiltrating malignant neoplasm-pT-pT2b: Tumor invades deep muscularis propria (outer half)
pT2b: Tumor invades deep muscularis propria (outer half)
Urinary bladder-Infiltrating malignant neoplasm-pT-pT3: Tumor invades perivesical tissue
pT3: Tumor invades perivesical tissue
Urinary bladder-Infiltrating malignant neoplasm-pT-pT3a: Microscopically
pT3a: Microscopically
Urinary bladder-Infiltrating malignant neoplasm-pT-pT3b: Macroscopically (extravesicular mass)
pT3b: Macroscopically (extravesicular mass)
Urinary bladder-Infiltrating malignant neoplasm-pT-pT4: Tumor invades any of the following: prostatic stroma, seminal vesicles, uterus,vagina, pelvic wall, abdominal wall
pT4: Tumor invades any of the following: prostatic stroma, seminal vesicles, uterus,vagina, pelvic wall, abdominal wall
Urinary bladder-Infiltrating malignant neoplasm-pT-pT4a: Tumor invades prostatic stroma or uterus or vagina
pT4a: Tumor invades prostatic stroma or uterus or vagina
Urinary bladder-Infiltrating malignant neoplasm-pT-pT4b: Tumor invades pelvic wall or abdominal wall
pT4b: Tumor invades pelvic wall or abdominal wall
Urinary bladder-Infiltrating malignant neoplasm-pN-pN1: Single regional lymph node metastasis in the true pelvis (hypogastric, obturator, external iliac or presacral lymph node)
pN1: Single regional lymph node metastasis in the true pelvis (hypogastric, obturator, external iliac or presacral lymph node)
Urinary bladder-Infiltrating malignant neoplasm-pN-pN2: Multiple regional lymph node metastasis in the true pelvis (hypogastric, obrutrator, external iliac or presacral lymph node metastasis)
pN2: Multiple regional lymph node metastasis in the true pelvis (hypogastric, obrutrator, external iliac or presacral lymph node metastasis)
Urinary bladder-Infiltrating malignant neoplasm-pN-pN3: Lymph node metastasis to the common iliac lymph nodes
pN3: Lymph node metastasis to the common iliac lymph nodes
Skin (melanoma)-Infiltrating malignant neoplasm-Lesion site-Body
Body
Skin (melanoma)-Specimen-Specimen collection procedure-Excision
Excision
Skin (melanoma)-Infiltrating malignant neoplasm-Histologic type-Superficial spreading melanoma
Superficial spreading melanoma
Skin (melanoma)-Infiltrating malignant neoplasm-Histologic type-Nodular melanoma
Nodular melanoma
Skin (melanoma)-Infiltrating malignant neoplasm-Histologic grade (Clark)-I (Melanoma in situ)
I (Melanoma in situ)
Skin (melanoma)-Infiltrating malignant neoplasm-Histologic grade (Clark)-II (Melanoma present in but does not fill and expand papillary dermis)
II (Melanoma present in but does not fill and expand papillary dermis)
Skin (melanoma)-Infiltrating malignant neoplasm-Histologic grade (Clark)-III (Melanoma fills and expands papillary dermis)
III (Melanoma fills and expands papillary dermis)
Skin (melanoma)-Infiltrating malignant neoplasm-Histologic grade (Clark)-IV (Melanoma invades reticular dermis)
IV (Melanoma invades reticular dermis)
Skin (melanoma)-Infiltrating malignant neoplasm-Histologic grade (Clark)-V (Melanoma invades subcutaneum)
V (Melanoma invades subcutaneum)
Skin (melanoma)-Infiltrating malignant neoplasm-Margin site-Deep margin
Deep margin
Skin (melanoma)-Infiltrating malignant neoplasm-Margin site-Peripheral margins
Peripheral margins
Skin (melanoma)-Infiltrating malignant neoplasm-pT-pT0: No evidence of primary tumor
pT0: No evidence of primary tumor
Skin (melanoma)-Infiltrating malignant neoplasm-pT-pTis: Melanoma in situ (ie, not an invasive tumor: anatomic level I)
pTis: Melanoma in situ (ie, not an invasive tumor: anatomic level I)
Skin (melanoma)-Infiltrating malignant neoplasm-pT-pT1: Melanoma 1.0 mm or less in thickness, with or without ulceration (see Note D)
pT1: Melanoma 1.0 mm or less in thickness, with or without ulceration (see Note D)
Skin (melanoma)-Infiltrating malignant neoplasm-pT-pT1a: Melanoma 1.0 mm or less in thickness, no ulceration, <1 mitoses/mm2
pT1a: Melanoma 1.0 mm or less in thickness, no ulceration, <1 mitoses/mm2
Skin (melanoma)-Infiltrating malignant neoplasm-pT-pT1b: Melanoma 1.0 mm or less in thickness with ulceration and/or 1 or more mitoses/mm2
pT1b: Melanoma 1.0 mm or less in thickness with ulceration and/or 1 or more mitoses/mm2
Skin (melanoma)-Infiltrating malignant neoplasm-pT-pT2: Melanoma 1.01 to 2 mm in thickness, with or without ulceration
pT2: Melanoma 1.01 to 2 mm in thickness, with or without ulceration
Skin (melanoma)-Infiltrating malignant neoplasm-pT-pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration
pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration
Skin (melanoma)-Infiltrating malignant neoplasm-pT-pT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration
pT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration
Skin (melanoma)-Infiltrating malignant neoplasm-pT-pT3: Melanoma 2.01 to 4.0 mm in thickness, with or without ulceration
pT3: Melanoma 2.01 to 4.0 mm in thickness, with or without ulceration
Skin (melanoma)-Infiltrating malignant neoplasm-pT-pT3a: Melanoma 2.01 to 4.0 mm in thickness, no ulceration
pT3a: Melanoma 2.01 to 4.0 mm in thickness, no ulceration
Skin (melanoma)-Infiltrating malignant neoplasm-pT-pT3b: Melanoma 2.01 to 4.0 mm in thickness, with ulceration
pT3b: Melanoma 2.01 to 4.0 mm in thickness, with ulceration
Skin (melanoma)-Infiltrating malignant neoplasm-pT-pT4: Melanoma greater than 4.0 mm in thickness, with or without ulceration
pT4: Melanoma greater than 4.0 mm in thickness, with or without ulceration
Skin (melanoma)-Infiltrating malignant neoplasm-pT-pT4a: Melanoma greater than 4.0 mm in thickness, no ulceration
pT4a: Melanoma greater than 4.0 mm in thickness, no ulceration
Skin (melanoma)-Infiltrating malignant neoplasm-pT-pT4b: Melanoma greater than 4.0 mm in thickness, with ulceration
pT4b: Melanoma greater than 4.0 mm in thickness, with ulceration
Skin (melanoma)-Infiltrating malignant neoplasm-pN-pN0: No regional lymph node metastasis
pN0: No regional lymph node metastasis
Skin (melanoma)-Infiltrating malignant neoplasm-pN-pN1: Metastasis in 1 regional lymph node
pN1: Metastasis in 1 regional lymph node
Skin (melanoma)-Infiltrating malignant neoplasm-pN-pN1a: Clinically occult (microscopic) metastasis
pN1a: Clinically occult (microscopic) metastasis
Skin (melanoma)-Infiltrating malignant neoplasm-pN-pN1b: Clinically apparent (macroscopic) metastasis
pN1b: Clinically apparent (macroscopic) metastasis
Skin (melanoma)-Infiltrating malignant neoplasm-pN-pN2: Metastasis in 2 to 3 regional nodes or intralymphatic regional metastasis without nodal metastasis
pN2: Metastasis in 2 to 3 regional nodes or intralymphatic regional metastasis without nodal metastasis
Skin (melanoma)-Infiltrating malignant neoplasm-pN-pN2a: Clinically occult (microscopic) metastasis
pN2a: Clinically occult (microscopic) metastasis
Skin (melanoma)-Infiltrating malignant neoplasm-pN-pN2b: Clinically apparent (macroscopic) metastasis
pN2b: Clinically apparent (macroscopic) metastasis
Skin (melanoma)-Infiltrating malignant neoplasm-pN-pN2c: Satellite or in-transit metastasis without nodal metastasis
pN2c: Satellite or in-transit metastasis without nodal metastasis
Skin (melanoma)-Infiltrating malignant neoplasm-pN-pN3: Metastasis in 4 or more regional lymph nodes, or matted metastatic nodes, or in-transit metastasis or satellites(s) with metastasis in regional node(s)
pN3: Metastasis in 4 or more regional lymph nodes, or matted metastatic nodes, or in-transit metastasis or satellites(s) with metastasis in regional node(s)
Thyroid-Infiltrating malignant neoplasm-Lesion site-Thyroid
Thyroid
Thyroid-Specimen-Specimen collection procedure-Thyroid lobectomy
Thyroid lobectomy
Thyroid-Specimen-Specimen collection procedure-Partial thyroidectomy (anything less than a lobectomy)
Partial thyroidectomy (anything less than a lobectomy)
Thyroid-Specimen-Specimen collection procedure-Hemithyroidectomy (lobe and part or all of isthmus)
Hemithyroidectomy (lobe and part or all of isthmus)
Thyroid-Specimen-Specimen collection procedure-Total thyroidectomy
Total thyroidectomy
Margins involvement
Cervix-Infiltrating malignant neoplasm-Margins involvement
Cervix-Margins involvement
Thyroid-Infiltrating malignant neoplasm-Histologic type-Papillary carcinoma
Papillary carcinoma
Thyroid-Infiltrating malignant neoplasm-Histologic type-Follicular carcinoma
Follicular carcinoma
Thyroid-Infiltrating malignant neoplasm-Histologic type-Poorly differentiated thyroid Carcinoma, including insular carcinoma
Poorly differentiated thyroid Carcinoma, including insular carcinoma
Thyroid-Infiltrating malignant neoplasm-Histologic type-Medullary carcinoma
Medullary carcinoma
Thyroid-Infiltrating malignant neoplasm-Histologic type-Undifferentiated (anaplastic) carcinoma
Undifferentiated (anaplastic) carcinoma
Thyroid-Infiltrating malignant neoplasm-pT-pT0: No evidence of primary tumor
pT0: No evidence of primary tumor
Margins involvement
Cervix-In situ neoplasm-Margins involvement
Cervix-Margins involvement
Thyroid-Infiltrating malignant neoplasm-pT-pT1: Tumor size 2 cm or less, limited to thyroid
pT1: Tumor size 2 cm or less, limited to thyroid
Thyroid-Infiltrating malignant neoplasm-pT-pT1a: Tumor 1 cm or less in greatest dimension limited to the thyroid.
pT1a: Tumor 1 cm or less in greatest dimension limited to the thyroid.
Thyroid-Infiltrating malignant neoplasm-pT-pT1b: Tumor more than 1 cm but not more than 2 cm in greatest dimension, limited to the thyroid
pT1b: Tumor more than 1 cm but not more than 2 cm in greatest dimension, limited to the thyroid
Thyroid-Infiltrating malignant neoplasm-pT-pT2: Tumor more than 2 cm, but not more than 4 cm, limited to thyroid
pT2: Tumor more than 2 cm, but not more than 4 cm, limited to thyroid
Thyroid-Infiltrating malignant neoplasm-pT-pT3: Tumor more than 4 cm limited to thyroid or any tumor with minimal extrathyroid extension (eg, extension to sternothyroid muscle or perithyroid soft tissues)
pT3: Tumor more than 4 cm limited to thyroid or any tumor with minimal extrathyroid extension (eg, extension to sternothyroid muscle or perithyroid soft tissues)
Thyroid-Infiltrating malignant neoplasm-pT-pT4a: Moderately advanced disease. Tumor of any size extending beyond the thyroid capsule to invade subcutaneous soft tissues, larynx, trachea, esophagus or recurrent laryngeal nerve
pT4a: Moderately advanced disease. Tumor of any size extending beyond the thyroid capsule to invade subcutaneous soft tissues, larynx, trachea, esophagus or recurrent laryngeal nerve
Thyroid-Infiltrating malignant neoplasm-pT-pT4b: Very advanced disease. Tumor invades prevertebral fascia or encases carotid artery or mediastinal vessels
pT4b: Very advanced disease. Tumor invades prevertebral fascia or encases carotid artery or mediastinal vessels
Thyroid-Infiltrating malignant neoplasm-pT-pT0: No evidence of primary tumor
pT0: No evidence of primary tumor
Thyroid-Infiltrating malignant neoplasm-pT-pT1: Tumor size 2 cm or less, limited to thyroid
pT1: Tumor size 2 cm or less, limited to thyroid
Thyroid-Infiltrating malignant neoplasm-pT-pT1a: Tumor 1 cm or less in greatest dimension limited to the thyroid.
pT1a: Tumor 1 cm or less in greatest dimension limited to the thyroid.
Cervix-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin
Distance of lesion from closest uninvolved margin
Thyroid-Infiltrating malignant neoplasm-pT-pT1b: Tumor more than 1 cm but not more than 2 cm in greatest dimension, limited to the thyroid
pT1b: Tumor more than 1 cm but not more than 2 cm in greatest dimension, limited to the thyroid
Thyroid-Infiltrating malignant neoplasm-pT-pT2: Tumor more than 2 cm, but not more than 4 cm, limited to thyroid
pT2: Tumor more than 2 cm, but not more than 4 cm, limited to thyroid
Thyroid-Infiltrating malignant neoplasm-pT-pT3: Tumor more than 4 cm limited to thyroid or any tumor with minimal extrathyroid extension (eg, extension to sternothyroid muscle or perithyroid soft tissues)
pT3: Tumor more than 4 cm limited to thyroid or any tumor with minimal extrathyroid extension (eg, extension to sternothyroid muscle or perithyroid soft tissues)
Thyroid-Infiltrating malignant neoplasm-pT-pT4a: Intrathyroidal anaplastic carcinoma—surgically resectable
pT4a: Intrathyroidal anaplastic carcinoma—surgically resectable
Thyroid-Infiltrating malignant neoplasm-pT-pT4b: Extrathyroidal anaplastic carcinoma—surgically unresectable
pT4b: Extrathyroidal anaplastic carcinoma—surgically unresectable
Thyroid-Infiltrating malignant neoplasm-pN-pN0: No regional lymph node metastasis
pN0: No regional lymph node metastasis
Thyroid-Infiltrating malignant neoplasm-pN-pN1a: Nodal metastases to Level VI (pretracheal, paratracheal and prelaryngeal/Delphian) lymph nodes
pN1a: Nodal metastases to Level VI (pretracheal, paratracheal and prelaryngeal/Delphian) lymph nodes
Thyroid-Infiltrating malignant neoplasm-pN-pN1b: Metastases to unilateral, bilateral or contralateral cervical (Levels I, II, III, IV,V) or retropharyngeal or superior mediastinal lymph nodes (Level VII).
pN1b: Metastases to unilateral, bilateral or contralateral cervical (Levels I, II, III, IV,V) or retropharyngeal or superior mediastinal lymph nodes (Level VII).
Cervix-In situ neoplasm-Distance of lesion from closest uninvolved margin
Distance of lesion from closest uninvolved margin
Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Squamous cell carcinoma, conventional
Squamous cell carcinoma, conventional
Lymph-vascular invasion
Cervix-Infiltrating malignant neoplasm-Lymph-vascular invasion
Cervix-Lymph-vascular invasion
Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Basaloid squamous cell carcinoma
Basaloid squamous cell carcinoma
Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Spindle cell squamous carcinoma
Spindle cell squamous carcinoma
Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Verrucous carcinoma
Verrucous carcinoma
Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Adenosquamous carcinoma
Adenosquamous carcinoma
Lymph node sampling
Cervix-Infiltrating malignant neoplasm-Lymph node sampling
Cervix-Lymph node sampling
Lip, oral cavity-Infiltrating malignant neoplasm-pT carcinoma-pT0: No evidence of primary tumor
pT0: No evidence of primary tumor
Lip, oral cavity-Infiltrating malignant neoplasm-pT carcinoma-pTis: Carcinoma in situ
pTis: Carcinoma in situ
Extent
Cervix-Infiltrating malignant neoplasm-Extent
Cervix-Extent
Lip, oral cavity-Infiltrating malignant neoplasm-pT carcinoma-pT1: Tumor 2 cm or less in greatest dimension
pT1: Tumor 2 cm or less in greatest dimension
Lip, oral cavity-Infiltrating malignant neoplasm-pT carcinoma-pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension
Lip, oral cavity-Infiltrating malignant neoplasm-pT carcinoma-pT3: Tumor more than 4 cm in greatest dimension - Oropharynx : or extension to lingual surface of epiglottis
pT3: Tumor more than 4 cm in greatest dimension - Oropharynx : or extension to lingual surface of epiglottis
Lip, oral cavity-Infiltrating malignant neoplasm-pT carcinoma-pT4a: Moderately advanced local disease. Lip: Tumor invades through cortical bone, inferior alveolar nerve, floor of mouth, or skin of face, ie, chin or nose - Oral cavity: Tumor invades adjacent structures only (eg, through cortical bone [mandible, maxilla], into deep [extrinsic] muscle of tongue [genioglossus, hyoglossus, palatoglossus, and styloglossus], maxillary sinus, skin of face) - Oropharynx : Tumor invades larynx, deep/extrinsic muscle of tongue, medial pterygoid muscles, hard palate, or mandible
pT4a: Moderately advanced local disease. Lip: Tumor invades through cortical bone, inferior alveolar nerve, floor of mouth, or skin of face, ie, chin or nose - Oral cavity: Tumor invades adjacent structures only (eg, through cortical bone [mandible, maxilla], into deep [extrinsic] muscle of tongue [genioglossus, hyoglossus, palatoglossus, and styloglossus], maxillary sinus, skin of face) - Oropharynx : Tumor invades larynx, deep/extrinsic muscle of tongue, medial pterygoid muscles, hard palate, or mandible
Lip, oral cavity-Infiltrating malignant neoplasm-pT carcinoma-pT4b: Very advanced local disease. Tumor invades masticator space, pterygoid plates, or skull base, and/or encases internal carotid artery - Oropharynx: Tumor invades lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, or skull base, or encases carotid artery
pT4b: Very advanced local disease. Tumor invades masticator space, pterygoid plates, or skull base, and/or encases internal carotid artery - Oropharynx: Tumor invades lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, or skull base, or encases carotid artery
Lip, oral cavity-Infiltrating malignant neoplasm-pN-pN0: No regional lymph node metastasis
pN0: No regional lymph node metastasis
Lip, oral cavity-Infiltrating malignant neoplasm-pN-pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension
pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension
Lip, oral cavity-Infiltrating malignant neoplasm-pN-pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension
pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension
Lip, oral cavity-Infiltrating malignant neoplasm-pN-pN2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension
pN2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension
Lip, oral cavity-Infiltrating malignant neoplasm-pN-pN2c: Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension
pN2c: Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension
Cervix-Lesion-Identification of pathogen agents
Identification of pathogen agents
Lip, oral cavity-Infiltrating malignant neoplasm-pN-pN3: Metastasis in a lymph node more than 6 cm in greatest dimension
pN3: Metastasis in a lymph node more than 6 cm in greatest dimension
Pharynx-Specimen-Target site-Nasopharynx
Nasopharynx
Pharynx-Specimen-Target site-Hypopharynx
Hypopharynx
Pharynx-Specimen-Specimen collection procedure-Laryngopharyngectomy
Laryngopharyngectomy
Lesion site
Cervix-Infiltrating malignant neoplasm-Lesion site
Cervix-Lesion site
Pharynx-Infiltrating malignant neoplasm-Lesion site-Hypopharynx: Piriform sinus
Hypopharynx: Piriform sinus
Pharynx-Infiltrating malignant neoplasm-Lesion site-Hypopharynx: Postcricoid
Hypopharynx: Postcricoid
Pharynx-Infiltrating malignant neoplasm-Lesion site-Hypopharynx: Pharyngeal wall (posterior and/or lateral)
Hypopharynx: Pharyngeal wall (posterior and/or lateral)
Lymph node site
Cervix-Infiltrating malignant neoplasm-Lymph node site
Cervix-Lymph node site
Number of lymph nodes involved
Cervix-Infiltrating malignant neoplasm-Number of lymph nodes involved
Cervix-Number of lymph nodes involved
Number of lymph nodes examined
Cervix-Infiltrating malignant neoplasm-Number of lymph nodes examined
Cervix-Number of lymph nodes examined
Salivary gland-Specimen-Target site-Total parotid gland (qualifier : right, left)
Total parotid gland (qualifier : right, left)
Salivary gland-Infiltrating malignant neoplasm-Lesion site-Submandibular gland
Submandibular gland
Salivary gland-Infiltrating malignant neoplasm-Lesion site-Sublingual gland
Sublingual gland
Salivary gland-Specimen-Specimen collection procedure-Superficial parotidectomy (qualifier: right, left)
Superficial parotidectomy (qualifier: right, left)
Salivary gland-Specimen-Specimen collection procedure-Total parotidectomy (qualifier: right, left)
Total parotidectomy (qualifier: right, left)
Salivary gland-Infiltrating malignant neoplasm-Histologic type-Adenoid cystic carcinoma
Adenoid cystic carcinoma
Salivary gland-Infiltrating malignant neoplasm-Histologic type-Adenocarcinoma, not otherwise specified (NOS)
Adenocarcinoma, not otherwise specified (NOS)
Salivary gland-Infiltrating malignant neoplasm-Histologic type-Basal cell adenocarcinoma
Basal cell adenocarcinoma
Salivary gland-Infiltrating malignant neoplasm-Histologic type-Carcinoma ex pleomorphic adenoma (malignant mixed tumor)
Carcinoma ex pleomorphic adenoma (malignant mixed tumor)
Salivary gland-Infiltrating malignant neoplasm-Histologic type-Carcinosarcoma (true malignant mixed tumor)
Carcinosarcoma (true malignant mixed tumor)
Salivary gland-Infiltrating malignant neoplasm-Histologic type-Mucoepidermoid carcinoma
Mucoepidermoid carcinoma
pN
Cervix-Infiltrating malignant neoplasm-pN
Cervix-Infiltrating malignant neoplasm-pN
Salivary gland-Infiltrating malignant neoplasm-Histologic type-Sebaceous adenocarcinoma
Sebaceous adenocarcinoma
Salivary gland-Infiltrating malignant neoplasm-Histologic type-Small cell (neuroendocrine) carcinoma
Small cell (neuroendocrine) carcinoma
Salivary gland-Infiltrating malignant neoplasm-Histologic type-Undifferentiated carcinoma, large cell type
Undifferentiated carcinoma, large cell type
Salivary gland-Infiltrating malignant neoplasm-pT-pTX: Cannot be assessed
pTX: Cannot be assessed
Salivary gland-Infiltrating malignant neoplasm-pT-pT0: No evidence of primary tumor
pT0: No evidence of primary tumor
Salivary gland-Infiltrating malignant neoplasm-pT-pT1: Tumor 2 cm or less in greatest dimension without extraparenchymal extension
pT1: Tumor 2 cm or less in greatest dimension without extraparenchymal extension
Salivary gland-Infiltrating malignant neoplasm-pT-pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension without extraparenchymal extension
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension without extraparenchymal extension
Salivary gland-Infiltrating malignant neoplasm-pT-pT3: Tumor more than 4 cm and/or tumor having extraparenchymal extension
pT3: Tumor more than 4 cm and/or tumor having extraparenchymal extension
Salivary gland-Infiltrating malignant neoplasm-pT-pT4a: Moderately advanced disease. Tumor invades skin, mandible, ear canal, and/or facial nerve.
pT4a: Moderately advanced disease. Tumor invades skin, mandible, ear canal, and/or facial nerve.
Salivary gland-Infiltrating malignant neoplasm-pT-pT4b: Very advanced local disease. Tumor invades skull base and/or pterygoid plates and/or encases carotid artery
pT4b: Very advanced local disease. Tumor invades skull base and/or pterygoid plates and/or encases carotid artery
Salivary gland-Infiltrating malignant neoplasm-pN-pN0: No regional lymph node metastasis
pN0: No regional lymph node metastasis
Salivary gland-Infiltrating malignant neoplasm-pN-pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension
pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension
Salivary gland-Infiltrating malignant neoplasm-pN-pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension
pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension
pT
Cervix-Infiltrating malignant neoplasm-pT
Cervix-Infiltrating malignant neoplasm-pT
Salivary gland-Infiltrating malignant neoplasm-pN-pN2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension
pN2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension
Salivary gland-Infiltrating malignant neoplasm-pN-pN2c: Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension
pN2c: Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension
Salivary gland-Infiltrating malignant neoplasm-pN-pN3: Metastasis in a lymph node, more than 6 cm in greatest dimension
pN3: Metastasis in a lymph node, more than 6 cm in greatest dimension
Larynx-Specimen-Specimen collection procedure-Partial laryngectomy (specify type)
Partial laryngectomy (specify type)
Larynx-Specimen-Specimen collection procedure-Total laryngectomy
Total laryngectomy
Lesion size, largest dimension
Cervix-Infiltrating malignant neoplasm-Lesion size, largest dimension
Cervix-Lesion size, largest dimension
Larynx-Infiltrating malignant neoplasm-Histologic type-Squamous cell carcinoma, conventional
Squamous cell carcinoma, conventional
Larynx-Infiltrating malignant neoplasm-Histologic type-Adenosquamous carcinoma
Adenosquamous carcinoma
Larynx-Infiltrating malignant neoplasm-Histologic type-Verrucous carcinoma
Verrucous carcinoma
Larynx-Infiltrating malignant neoplasm-Histologic type-Lymphoepithelial carcinoma (non-nasopharyngeal)
Lymphoepithelial carcinoma (non-nasopharyngeal)
Larynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands
Carcinoma of Minor Salivary Glands
Cervix-In situ neoplasm-Cytologic type
Cytologic type
Larynx-Infiltrating malignant neoplasm-pT supra glottis carcinoma-pT0: No evidence of primary tumor
pT0: No evidence of primary tumor
Larynx-Infiltrating malignant neoplasm-pT supra glottis carcinoma-pTis: Carcinoma in situ
pTis: Carcinoma in situ
Larynx-Infiltrating malignant neoplasm-pT supra glottis carcinoma-pT1: Tumor limited to one subsite of supraglottis with normal vocal cord mobility
pT1: Tumor limited to one subsite of supraglottis with normal vocal cord mobility
Larynx-Infiltrating malignant neoplasm-pT supra glottis carcinoma-pT2: Tumor invades mucosa of more than one adjacent subsite of supraglottis or glottis or region outside the supraglottis (eg, mucosa of base of tongue, vallecula, medial wall of pyriform sinus) without fixation of the larynx
pT2: Tumor invades mucosa of more than one adjacent subsite of supraglottis or glottis or region outside the supraglottis (eg, mucosa of base of tongue, vallecula, medial wall of pyriform sinus) without fixation of the larynx
Cervix-Infiltrating malignant neoplasm-Cytologic type
Cytologic type
Larynx-Infiltrating malignant neoplasm-pT supra glottis carcinoma-pT3: Tumor limited to larynx with vocal cord fixation and/or invades any of the following: postcricoid area, preepiglottic space, paraglottic space, and/or inner cortex of thyroid cartilage
pT3: Tumor limited to larynx with vocal cord fixation and/or invades any of the following: postcricoid area, preepiglottic space, paraglottic space, and/or inner cortex of thyroid cartilage
Larynx-Infiltrating malignant neoplasm-pT supra glottis carcinoma-pT4a: Moderately advanced local disease. Tumor invades through the thyroid cartilage and/or invades tissues beyond the larynx (eg, trachea, soft tissues of neck including deep extrinsic muscle of tongue, strap muscles, thyroid, or esophagus)
pT4a: Moderately advanced local disease. Tumor invades through the thyroid cartilage and/or invades tissues beyond the larynx (eg, trachea, soft tissues of neck including deep extrinsic muscle of tongue, strap muscles, thyroid, or esophagus)
Larynx-Infiltrating malignant neoplasm-pT supra glottis carcinoma-pT4b: Very advanced local disease. Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures
pT4b: Very advanced local disease. Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures
Larynx-Infiltrating malignant neoplasm-pT glottis carcinoma-pT0: No evidence of primary tumor
pT0: No evidence of primary tumor
Larynx-Infiltrating malignant neoplasm-pT glottis carcinoma-pTis: Carcinoma in situ
pTis: Carcinoma in situ
Larynx-Infiltrating malignant neoplasm-pT glottis carcinoma-pT1: Tumor limited to the vocal cord(s) (may involve anterior or posterior commissure) with normal mobility
pT1: Tumor limited to the vocal cord(s) (may involve anterior or posterior commissure) with normal mobility
Larynx-Infiltrating malignant neoplasm-pT glottis carcinoma-pT1a: Tumor limited to one vocal cord
pT1a: Tumor limited to one vocal cord
Larynx-Infiltrating malignant neoplasm-pT glottis carcinoma-pT1b: Tumor involves both vocal cords
pT1b: Tumor involves both vocal cords
Larynx-Infiltrating malignant neoplasm-pT glottis carcinoma-pT2: Tumor extends to supraglottis and/or subglottis and/or with impaired vocal cord mobility
pT2: Tumor extends to supraglottis and/or subglottis and/or with impaired vocal cord mobility
Larynx-Infiltrating malignant neoplasm-pT glottis carcinoma-pT3: Tumor limited to the larynx with vocal cord fixation and/or invades paraglottic space and/or minor thyroid cartilage erosion (eg, inner cortex) (Note H)
pT3: Tumor limited to the larynx with vocal cord fixation and/or invades paraglottic space and/or minor thyroid cartilage erosion (eg, inner cortex) (Note H)
Histologic type
Cervix-Lesion-Histologic type
Cervix-Histologic type
Larynx-Infiltrating malignant neoplasm-pT glottis carcinoma-pT4a: Moderately advanced local disease. Tumor invades through the outer cortex of the thyroid cartilage and/or invades tissues beyond the larynx (eg, trachea, soft tissues of neck including deep extrinsic muscle of the tongue, strap muscles, thyroid, or esophagus) (Note H)
pT4a: Moderately advanced local disease. Tumor invades through the outer cortex of the thyroid cartilage and/or invades tissues beyond the larynx (eg, trachea, soft tissues of neck including deep extrinsic muscle of the tongue, strap muscles, thyroid, or esophagus) (Note H)
Larynx-Infiltrating malignant neoplasm-pT glottis carcinoma-pT4b: Very advanced local disease. Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures
pT4b: Very advanced local disease. Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures
Larynx-Infiltrating malignant neoplasm-pT sub glottis carcinoma-pT0: No evidence of primary tumor
pT0: No evidence of primary tumor
Larynx-Infiltrating malignant neoplasm-pT sub glottis carcinoma-pTis: Carcinoma in situ
pTis: Carcinoma in situ
Larynx-Infiltrating malignant neoplasm-pT sub glottis carcinoma-pT1: Tumor limited to subglottis
pT1: Tumor limited to subglottis
Larynx-Infiltrating malignant neoplasm-pT sub glottis carcinoma-pT2: Tumor extends to vocal cord(s) with normal or impaired mobility
pT2: Tumor extends to vocal cord(s) with normal or impaired mobility
Larynx-Infiltrating malignant neoplasm-pT sub glottis carcinoma-pT3: Tumor limited to larynx with vocal cord fixation
pT3: Tumor limited to larynx with vocal cord fixation
Larynx-Infiltrating malignant neoplasm-pT sub glottis carcinoma-pT4a: Moderately advanced local disease. Tumor invades cricoid or thyroid cartilage and/or invades tissues beyond the larynx (eg, trachea, soft tissues of neck including deep extrinsic muscles of the tongue, strap muscles, thyroid, or esophagus)
pT4a: Moderately advanced local disease. Tumor invades cricoid or thyroid cartilage and/or invades tissues beyond the larynx (eg, trachea, soft tissues of neck including deep extrinsic muscles of the tongue, strap muscles, thyroid, or esophagus)
Larynx-Infiltrating malignant neoplasm-pT sub glottis carcinoma-pT4b: Very advanced local disease. Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures
pT4b: Very advanced local disease. Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures
Larynx-Infiltrating malignant neoplasm-pT mucosal malignant melanoma-pT0: No evidence of primary tumor
pT0: No evidence of primary tumor
Prostate-Infiltrating malignant neoplasm-Lesion size, largest dimension
Lesion size, largest dimension
Histologic type
Cervix-In situ neoplasm-Histologic type
Cervix-Histologic type
Larynx-Infiltrating malignant neoplasm-pT mucosal malignant melanoma-pTis: Carcinoma in situ
pTis: Carcinoma in situ
Larynx-Infiltrating malignant neoplasm-pT mucosal malignant melanoma-pT3: Mucosal disease
pT3: Mucosal disease
Larynx-Infiltrating malignant neoplasm-pT mucosal malignant melanoma-pT4a: Moderately advanced disease. Tumor involving deep soft tissue, cartilage, bone, or overlying skin
pT4a: Moderately advanced disease. Tumor involving deep soft tissue, cartilage, bone, or overlying skin
Larynx-Infiltrating malignant neoplasm-pT mucosal malignant melanoma-pT4b: Very advanced disease. Tumor involving brain, dura, skull base, lower cranial nerves (IX, X, XI, XII), masticator space, carotid artery, prevertebral space, or mediastinal structures
pT4b: Very advanced disease. Tumor involving brain, dura, skull base, lower cranial nerves (IX, X, XI, XII), masticator space, carotid artery, prevertebral space, or mediastinal structures
Larynx-Infiltrating malignant neoplasm-pN carcinoma-pN0: No regional lymph node metastasis
pN0: No regional lymph node metastasis
Larynx-Infiltrating malignant neoplasm-pN carcinoma-pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension
pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension
Larynx-Infiltrating malignant neoplasm-pN carcinoma-pN2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension
pN2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension
Larynx-Infiltrating malignant neoplasm-pN carcinoma-pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension
pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension
Larynx-Infiltrating malignant neoplasm-pN carcinoma-pN2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension
pN2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension
Larynx-Infiltrating malignant neoplasm-pN carcinoma-pN2c: Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension
pN2c: Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension
Histologic type
Cervix-Infiltrating malignant neoplasm-Histologic type
Cervix-Histologic type
Larynx-Infiltrating malignant neoplasm-pN carcinoma-pN3: Metastasis in a lymph node more than 6 cm in greatest dimension
pN3: Metastasis in a lymph node more than 6 cm in greatest dimension
Larynx-Infiltrating malignant neoplasm-pN mucosal malignant melanoma-pN0: No regional lymph node metastases
pN0: No regional lymph node metastases
Larynx-Infiltrating malignant neoplasm-pN mucosal malignant melanoma-pN1: Regional lymph node metastases present
pN1: Regional lymph node metastases present
Esophagus-Specimen-Specimen collection procedure-Endoscopic resection
Endoscopic resection
Urinary bladder-Specimen-Target site-Urinary bladder
Urinary bladder
Concept pT UICC TNM 7ème édition
Generic-Infiltrating malignant neoplasm-pT-Concept pT UICC TNM 7ème édition
pT-Concept pT UICC TNM 7ème édition
Concept pN UICC TNM 7ème édition
Generic-Infiltrating malignant neoplasm-pN-Concept pN UICC TNM 7ème édition
pN-Concept pN UICC TNM 7ème édition
Concept pM UICC TNM 7ème édition
Generic-Infiltrating malignant neoplasm-pM-Concept pM UICC TNM 7ème édition
pM-Concept pM UICC TNM 7ème édition
Cervix-Infiltrating malignant neoplasm-Cytologic type-Squamous cell carcinoma
Squamous cell carcinoma
Cervix-Infiltrating malignant neoplasm-Cytologic type-Adenocarcinoma
Adenocarcinoma
Cervix-In situ neoplasm-Cytologic type-Atypical squamous cells
Atypical squamous cells
Cervix-In situ neoplasm-Cytologic type-Atypical squamous cells of undetermined significance (ASC-US)
Atypical squamous cells of undetermined significance (ASC-US)
Cervix-In situ neoplasm-Cytologic type-Atypical squamous cells for which a high-grade lesion cannot be excluded (ASC-H)
Atypical squamous cells for which a high-grade lesion cannot be excluded (ASC-H)
Cervix-In situ neoplasm-Cytologic type-Low-grade squamous intraepithelial lesion encompassing HPV infection or mild dysplasia (CIN 1)
Low-grade squamous intraepithelial lesion encompassing HPV infection or mild dysplasia (CIN 1)
Cervix-In situ neoplasm-Cytologic type-High-grade squamous intraepithelial lesion encompassing moderate (CIN 2) and severe dysplasia (CIN 3/CIS); whether the lesion has features suggesting invasion is noted
High-grade squamous intraepithelial lesion encompassing moderate (CIN 2) and severe dysplasia (CIN 3/CIS); whether the lesion has features suggesting invasion is noted
Cervix-In situ neoplasm-Cytologic type-Atypical glandular cells
Atypical glandular cells
Cervix-In situ neoplasm-Cytologic type-Atypical endocervical cells
Atypical endocervical cells
Cervix-In situ neoplasm-Cytologic type-Atypical endometrial cells
Atypical endometrial cells
Cervix-In situ neoplasm-Cytologic type-Atypical glandular cells likely to be
cancerous
Atypical glandular cells likely to be
cancerous
Colon-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin
Distance of lesion from closest uninvolved margin
Cervix-In situ neoplasm-Cytologic type-Atypical endocervical cells likely to be
cancerou
Atypical endocervical cells likely to be
cancerou
Cervix-In situ neoplasm-Cytologic type-Adenocarcinoma endocervical in situ
Adenocarcinoma endocervical in situ
Cervix-Lesion-Histologic type-Inflammation
Inflammation
Colon-Infiltrating malignant neoplasm-Lymph-vascular invasion
Lymph-vascular invasion
Breast-Infiltrating malignant neoplasm-HER2/neu (immunoperoxidase study)-Positive (Score 3+)
Positive (Score 3+)
Breast-Infiltrating malignant neoplasm-HER2/neu (immunoperoxidase study)-Negative (Score 0)
Negative (Score 0)
Colon-Infiltrating malignant neoplasm-Extent
Extent
Colon-Infiltrating malignant neoplasm-Perineural invasion
Perineural invasion
Prostate-Infiltrating malignant neoplasm-Lesion size, largest dimension
Lesion size, largest dimension
Colon-Infiltrating malignant neoplasm-Lesion site
Lesion site
Colon-Infiltrating malignant neoplasm-Margin site
Margin site
Colon-Infiltrating malignant neoplasm-Number of lymph nodes involved
Number of lymph nodes involved
Colon-Infiltrating malignant neoplasm-Number of lymph nodes examined
Number of lymph nodes examined
Colon-Infiltrating malignant neoplasm-pN
pN
Colon-Infiltrating malignant neoplasm-pT
pT
Colon-Infiltrating malignant neoplasm-Lesion size, largest dimension
Lesion size, largest dimension
Colon-Infiltrating malignant neoplasm-Specimen size, largest dimension
Specimen size, largest dimension
Generic-Infiltrating malignant neoplasm-TNM Descriptors -Multiple primary tumors
Multiple primary tumors
Generic-Infiltrating malignant neoplasm-TNM Descriptors -Recurrent
Recurrent
Generic-Infiltrating malignant neoplasm-TNM Descriptors -Post-treatment
Post-treatment
Skin (melanoma)-Infiltrating malignant neoplasm-Lesion size, largest dimension
Lesion size, largest dimension
Colon-Infiltrating malignant neoplasm-Histologic type
Histologic type
Breast-Infiltrating malignant neoplasm-Estrogen receptor-No immunoreactive tumor cells present
No immunoreactive tumor cells present
Endometrium-Infiltrating malignant neoplasm-Margins involvement
Margins involvement
Pharynx-Infiltrating malignant neoplasm-pN hypopharynx carcinoma-pN0: No regional lymph node metastasis
pN0: No regional lymph node metastasis
Endometrium-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin
Distance of lesion from closest uninvolved margin
Pharynx-Infiltrating malignant neoplasm-pN hypopharynx carcinoma-pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension
pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension
Pharynx-Infiltrating malignant neoplasm-pN hypopharynx carcinoma-pN2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension
pN2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension
Pharynx-Infiltrating malignant neoplasm-pN hypopharynx carcinoma-pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension
pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension
Pharynx-Infiltrating malignant neoplasm-pN hypopharynx carcinoma-pN2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension
pN2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension
Pharynx-Infiltrating malignant neoplasm-pN hypopharynx carcinoma-pN2c: Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension
pN2c: Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension
Pharynx-Infiltrating malignant neoplasm-pN hypopharynx carcinoma-pN3: Metastasis in a lymph node more than 6 cm in greatest dimension
pN3: Metastasis in a lymph node more than 6 cm in greatest dimension
Pharynx-Infiltrating malignant neoplasm-pN nasopharynx carcinoma-pN0: No regional lymph node metastasis
pN0: No regional lymph node metastasis
Pharynx-Infiltrating malignant neoplasm-pN nasopharynx carcinoma-pN1: Unilateral metastasis in lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa
pN1: Unilateral metastasis in lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa
Pharynx-Infiltrating malignant neoplasm-pN nasopharynx carcinoma-pN2: Bilateral metastasis in lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa
pN2: Bilateral metastasis in lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa
Pharynx-Infiltrating malignant neoplasm-pN nasopharynx carcinoma-pN3: Metastasis in a lymph node greater than 6 cm and/or to supraclavicular fossa
pN3: Metastasis in a lymph node greater than 6 cm and/or to supraclavicular fossa
Endometrium-Infiltrating malignant neoplasm-Lymph-vascular invasion
Lymph-vascular invasion
Pharynx-Infiltrating malignant neoplasm-pN nasopharynx carcinoma-pN3a: Greater than 6 cm in dimension
pN3a: Greater than 6 cm in dimension
Pharynx-Infiltrating malignant neoplasm-pN nasopharynx carcinoma-pN3b: Extension to the supraclavicular fossa
pN3b: Extension to the supraclavicular fossa
Pharynx-Infiltrating malignant neoplasm-pN mucosal malignant melanoma-pN0: No regional lymph node metastases
pN0: No regional lymph node metastases
Pharynx-Infiltrating malignant neoplasm-pN mucosal malignant melanoma-pN1: Regional lymph node metastases present
pN1: Regional lymph node metastases present
Pharynx-Infiltrating malignant neoplasm-pT hypopharynx carcinoma-pT0: No evidence of primary tumor
pT0: No evidence of primary tumor
Pharynx-Infiltrating malignant neoplasm-pT hypopharynx carcinoma-pTis: Carcinoma in situ
pTis: Carcinoma in situ
Pharynx-Infiltrating malignant neoplasm-pT hypopharynx carcinoma-pT1: Tumor limited to one subsite of hypopharynx and/or 2 cm or less in greatest dimension
pT1: Tumor limited to one subsite of hypopharynx and/or 2 cm or less in greatest dimension
Pharynx-Infiltrating malignant neoplasm-pT hypopharynx carcinoma-pT2: Tumor invades more than one subsite of hypopharynx or an adjacent site, or measures more than 2 cm but not more than 4 cm in greatest dimension without fixation of hemilarynx
pT2: Tumor invades more than one subsite of hypopharynx or an adjacent site, or measures more than 2 cm but not more than 4 cm in greatest dimension without fixation of hemilarynx
Pharynx-Infiltrating malignant neoplasm-pT hypopharynx carcinoma-pT3: Tumor measures more than 4 cm in greatest dimension or with fixation of hemilarynx or extension to esophagus
pT3: Tumor measures more than 4 cm in greatest dimension or with fixation of hemilarynx or extension to esophagus
Pharynx-Infiltrating malignant neoplasm-pT hypopharynx carcinoma-pT4a: Moderately advanced local disease. Tumor invades thyroid/cricoid cartilage, hyoid bone, thyroid gland, or central compartment soft tissue#
pT4a: Moderately advanced local disease. Tumor invades thyroid/cricoid cartilage, hyoid bone, thyroid gland, or central compartment soft tissue#
Endometrium-Infiltrating malignant neoplasm-Lymph node sampling
Lymph node sampling
Pharynx-Infiltrating malignant neoplasm-pT hypopharynx carcinoma-pT4b: Very advanced local disease. Tumor invades prevertebral
pT4b: Very advanced local disease. Tumor invades prevertebral
Pharynx-Infiltrating malignant neoplasm-pT mucosal malignant melanoma-pT3: Mucosal disease
pT3: Mucosal disease
Pharynx-Infiltrating malignant neoplasm-pT mucosal malignant melanoma-pT4a: Moderately advanced disease. Tumor involving deep soft tissue, cartilage,bone, or overlying skin.
pT4a: Moderately advanced disease. Tumor involving deep soft tissue, cartilage,bone, or overlying skin.
Pharynx-Infiltrating malignant neoplasm-pT mucosal malignant melanoma-pT4b: Very advanced disease. Tumor involving brain, dura, skull base, lower cranial nerves (IX, X, XI, XII), masticator space, carotid artery, prevertebral space, or mediastinal structures.
pT4b: Very advanced disease. Tumor involving brain, dura, skull base, lower cranial nerves (IX, X, XI, XII), masticator space, carotid artery, prevertebral space, or mediastinal structures.
Pharynx-Infiltrating malignant neoplasm-pT nasopharynx carcinoma-pT0: No evidence of primary tumor
pT0: No evidence of primary tumor
Pharynx-Infiltrating malignant neoplasm-pT nasopharynx carcinoma-pTis: Carcinoma in situ
pTis: Carcinoma in situ
Pharynx-Infiltrating malignant neoplasm-pT nasopharynx carcinoma-pT1: Tumor confined to nasopharynx, or tumor extends to oropharynx and/or nasal cavity without parapharyngeal extension#
pT1: Tumor confined to nasopharynx, or tumor extends to oropharynx and/or nasal cavity without parapharyngeal extension#
Pharynx-Infiltrating malignant neoplasm-pT nasopharynx carcinoma-pT2: Tumor with parapharyngeal extension
pT2: Tumor with parapharyngeal extension
Pharynx-Infiltrating malignant neoplasm-pT nasopharynx carcinoma-pT3: Tumor invades bony structures of skull base and/or paranasal sinuses
pT3: Tumor invades bony structures of skull base and/or paranasal sinuses
Pharynx-Infiltrating malignant neoplasm-pT nasopharynx carcinoma-pT4: Tumor with intracranial extension and/or involvement of cranial nerves, hypopharynx, orbit, or with extension to the infratemporal fossa/masticator space
pT4: Tumor with intracranial extension and/or involvement of cranial nerves, hypopharynx, orbit, or with extension to the infratemporal fossa/masticator space
Endometrium-Infiltrating malignant neoplasm-Extent
Extent
Larynx-Infiltrating malignant neoplasm-Lesion site-Epiglottis
Epiglottis
Larynx-Infiltrating malignant neoplasm-Lesion site-Aryepiglottic folds
Aryepiglottic folds
Larynx-Infiltrating malignant neoplasm-Lesion site-Arytenoid(s)
Arytenoid(s)
Larynx-Infiltrating malignant neoplasm-Lesion site-False vocal cord
False vocal cord
Larynx-Infiltrating malignant neoplasm-Lesion site-Ventricle
Ventricle
Larynx-Infiltrating malignant neoplasm-Lesion site-True vocal cord
True vocal cord
Larynx-Infiltrating malignant neoplasm-Lesion site-Posterior commissure
Posterior commissure
Larynx-Infiltrating malignant neoplasm-Lesion site-Anterior commissure
Anterior commissure
Larynx-Infiltrating malignant neoplasm-Lesion site-Larynx, subglottis
Larynx, subglottis
Endometrium-Infiltrating malignant neoplasm-Histologic grade (FIGO)
Histologic grade (FIGO)
Endometrium-Infiltrating malignant neoplasm-Lesion site
Lesion site
Endometrium-Infiltrating malignant neoplasm-Lymph node site
Lymph node site
Endometrium-Infiltrating malignant neoplasm-Number of lymph nodes involved
Number of lymph nodes involved
Breast-Infiltrating malignant neoplasm-Extensive intraductal component
Extensive intraductal component
Endometrium-Infiltrating malignant neoplasm-Number of lymph nodes examined
Number of lymph nodes examined
Endometrium-Infiltrating malignant neoplasm-pN
pN
Endometrium-Infiltrating malignant neoplasm-pT
pT
Endometrium-Infiltrating malignant neoplasm-Lesion size, largest dimension
Lesion size, largest dimension
Endometrium-Infiltrating malignant neoplasm-Histologic type
Histologic type
Larynx-Infiltrating malignant neoplasm-Histologic type-Basaloid squamous cell carcinoma
Basaloid squamous cell carcinoma
Larynx-Infiltrating malignant neoplasm-Histologic type-Spindle cell squamous cell carcinoma
Spindle cell squamous cell carcinoma
Stomach-Infiltrating malignant neoplasm-Margins involvement
Margins involvement
Stomach-Infiltrating malignant neoplasm-Margins involvement
Margins involvement
Stomach-Infiltrating malignant neoplasm-Margins involvement
Margins involvement
Stomach-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin
Distance of lesion from closest uninvolved margin
Stomach-Infiltrating malignant neoplasm-Lymph-vascular invasion
Lymph-vascular invasion
Lip, oral cavity-Infiltrating malignant neoplasm-pT mucosal malignant melanoma-pT3: Mucosal disease
pT3: Mucosal disease
Lip, oral cavity-Infiltrating malignant neoplasm-pT mucosal malignant melanoma-pT4a: Moderately advanced disease. Tumor involving deep soft tissue, cartilage, or overlying skin
pT4a: Moderately advanced disease. Tumor involving deep soft tissue, cartilage, or overlying skin
Lip, oral cavity-Infiltrating malignant neoplasm-pT mucosal malignant melanoma-pT4b: Very advanced disease. Tumor involving brain, dura, skull base, lower cranial nerves (IX, X, XI, XII), masticator space, carotid artery, prevertebral space, or mediastinal structures
pT4b: Very advanced disease. Tumor involving brain, dura, skull base, lower cranial nerves (IX, X, XI, XII), masticator space, carotid artery, prevertebral space, or mediastinal structures
Colon-Infiltrating malignant neoplasm-Histologic grade (Two-Tier Grading System)
Histologic grade (Two-Tier Grading System)
Colon-Infiltrating malignant neoplasm-pM
pM
Colon-Infiltrating malignant neoplasm-Histologic Features Suggestive of Microsatellite Instability
Histologic Features Suggestive of Microsatellite Instability
Colon-Infiltrating malignant neoplasm-Macroscopic type
Macroscopic type
Stomach-Infiltrating malignant neoplasm-Extent
Extent
Colon-Lesion-Histologic type
Histologic type
Colon-Lesion-Macroscopic type
Macroscopic type
Endometrium-Infiltrating malignant neoplasm-Histologic grade (WHO)
Histologic grade (WHO)
Endometrium-Infiltrating malignant neoplasm-pM
pM
Endometrium-Lesion-Histologic type
Histologic type
Endometrium-Lesion-Lesion site
Lesion site
Stomach-Infiltrating malignant neoplasm-pM
pM
Stomach-Lesion-Histologic type
Histologic type
Stomach-Infiltrating malignant neoplasm-Perineural invasion
Perineural invasion
Stomach-Lesion-Lesion site
Lesion site
Liver-Infiltrating malignant neoplasm-pM
pM
Liver-Lesion-Histologic type
Histologic type
Liver-Lesion-Lesion site
Lesion site
Generic-Infiltrating malignant neoplasm-TNM Descriptors
TNM Descriptors
Generic-Infiltrating malignant neoplasm-Margin site
Margin site
Stomach-Infiltrating malignant neoplasm-Lesion site
Lesion site
Generic-In situ neoplasm-Histologic type
Histologic type
Generic-In situ neoplasm-Lesion site
Lesion site
Salivary gland-Infiltrating malignant neoplasm-Lesion site
Lesion site
Salivary gland-Infiltrating malignant neoplasm-Macroscopic type
Macroscopic type
Salivary gland-Lesion-Histologic type
Histologic type
Salivary gland-Lesion-Lesion site
Lesion site
Larynx-Infiltrating malignant neoplasm-pM
pM
Larynx-Infiltrating malignant neoplasm-Macroscopic type
Macroscopic type
Stomach-Infiltrating malignant neoplasm-Margin site
Margin site
Larynx-Lesion-Histologic type
Histologic type
Larynx-Lesion-Lesion site
Lesion site
Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site
Lesion site
Lip, oral cavity-Lesion-Histologic type
Histologic type
Lip, oral cavity-Lesion-Lesion site
Lesion site
Esophagus-Infiltrating malignant neoplasm-Histologic grade (WHO)
Histologic grade (WHO)
Esophagus-Infiltrating malignant neoplasm-pM
pM
Esophagus-Lesion-Histologic type
Histologic type
Stomach-Infiltrating malignant neoplasm-Number of lymph nodes involved
Number of lymph nodes involved
Esophagus-Lesion-Lesion site
Lesion site
Ovary-Infiltrating malignant neoplasm-Histologic grade (WHO)
Histologic grade (WHO)
Ovary-Infiltrating malignant neoplasm-Lesion site
Lesion site
Ovary-Infiltrating malignant neoplasm-pM
pM
Ovary-Lesion-Histologic type
Histologic type
Ovary-Lesion-Lesion site
Lesion site
Pancreas-Infiltrating malignant neoplasm-pM
pM
Pancreas-Lesion-Histologic type
Histologic type
Stomach-Infiltrating malignant neoplasm-Number of lymph nodes examined
Number of lymph nodes examined
Pancreas-Lesion-Lesion site
Lesion site
Skin (melanoma)-Infiltrating malignant neoplasm-Lymph node site
Lymph node site
Skin (melanoma)-Infiltrating malignant neoplasm-pM
pM
Skin (melanoma)-Lesion-Histologic type
Histologic type
Skin (melanoma)-Lesion-Lesion site
Lesion site
Pharynx-Infiltrating malignant neoplasm-EBV (Epstein Barr virus encoded RNA [EBER], other)
EBV (Epstein Barr virus encoded RNA [EBER], other)
Pharynx-Infiltrating malignant neoplasm-HPV (p16 immunoreactivity, in situ)
HPV (p16 immunoreactivity, in situ)
Pharynx-Infiltrating malignant neoplasm-pM
pM
Pharynx-Infiltrating malignant neoplasm-pT oropharynx carcinoma
pT oropharynx carcinoma
Pharynx-Lesion-Histologic type
Histologic type
Pharynx-Lesion-Lesion site
Lesion site
Lung-Infiltrating malignant neoplasm-Epidermal growth factor receptor (EGFR)
Epidermal growth factor receptor (EGFR)
Lung-Infiltrating malignant neoplasm-KRAS mutational analysis
KRAS mutational analysis
Lung-Infiltrating malignant neoplasm-Histologic grade (WHO)
Histologic grade (WHO)
Lung-Infiltrating malignant neoplasm-Lesion site
Lesion site
Lung-Infiltrating malignant neoplasm-pM
pM
Stomach-Infiltrating malignant neoplasm-pN
pN
Lung-Lesion-Histologic type
Histologic type
Lung-Lesion-Lesion site
Lesion site
Prostate-Infiltrating malignant neoplasm-Margin site
Margin site
Prostate-Infiltrating malignant neoplasm-pM
pM
Prostate-Lesion-Histologic type
Histologic type
Prostate-Lesion-Lesion site
Lesion site
Kidney-Infiltrating malignant neoplasm-pM
pM
Kidney-Lesion-Histologic type
Histologic type
Kidney-Lesion-Lesion site
Lesion site
Breast-In situ neoplasm-Necrosis of ductal carcinoma in situ (DCIS)
Necrosis of ductal carcinoma in situ (DCIS)
pM
Breast-Infiltrating malignant neoplasm-pM
Breast-Infiltrating malignant neoplasm-pM
Histologic type
Breast-Lesion-Histologic type
Breast-Histologic type
Lesion site
Breast-Lesion-Lesion site
Breast-Lesion site
Lesion site
Breast-In situ neoplasm-Lesion site
Breast-Lesion site
Testis-Infiltrating malignant neoplasm-pM
pM
Testis-Lesion-Histologic type
Histologic type
Stomach-Infiltrating malignant neoplasm-pT
pT
Testis-Lesion-Lesion site
Lesion site
Thyroid-Infiltrating malignant neoplasm-Histologic grade (WHO)
Histologic grade (WHO)
Thyroid-Infiltrating malignant neoplasm-pM
pM
Thyroid-Lesion-Histologic type
Histologic type
Thyroid-Lesion-Lesion site
Lesion site
Urinary bladder-Infiltrating malignant neoplasm-pM
pM
Urinary bladder-Infiltrating malignant neoplasm-Macroscopic type
Macroscopic type
Urinary bladder-Lesion-Histologic type
Histologic type
Stomach-Infiltrating malignant neoplasm-Lesion size, largest dimension
Lesion size, largest dimension
Urinary bladder-Lesion-Lesion site
Lesion site
Pharynx-Infiltrating malignant neoplasm-Epstein-Barr virus (Epstein Barr virus encoded RNA [EBER], other)-Present
Present
Pharynx-Infiltrating malignant neoplasm-Epstein-Barr virus (Epstein Barr virus encoded RNA [EBER], other)-Negative
Negative
Pharynx-Infiltrating malignant neoplasm-Human papillomavirus (p16 immunoreactivity, in situ)-Present
Present
Pharynx-Infiltrating malignant neoplasm-Human papillomavirus (p16 immunoreactivity, in situ)-Negative
Negative
Breast-Infiltrating malignant neoplasm-HER2/neu (FISH method)-Equivocal (HER2 gene copy 4.0 to 6.0 or ratio 1.8 to 2.2)
Equivocal (HER2 gene copy 4.0 to 6.0 or ratio 1.8 to 2.2)
Breast-Infiltrating malignant neoplasm-HER2/neu (immunoperoxidase study)-Negative (Score 1+)
Negative (Score 1+)
Breast-Infiltrating malignant neoplasm-HER2/neu (immunoperoxidase study)-Equivocal (Score 2+)
Equivocal (Score 2+)
Colon-Infiltrating malignant neoplasm-Microsatellite instability-Stable
Stable
Colon-Infiltrating malignant neoplasm-Microsatellite instability-Low
Low
Stomach-Infiltrating malignant neoplasm-Histologic type
Histologic type
Colon-Infiltrating malignant neoplasm-Microsatellite instability-High
High
Lung-Infiltrating malignant neoplasm-Epidermal growth factor receptor (EGFR)-Positive
Positive
Lung-Infiltrating malignant neoplasm-Epidermal growth factor receptor (EGFR)-Negative
Negative
Colon-Infiltrating malignant neoplasm-Mismatch Repair Proteins-MLH1 (Immunohistochemistry Study)-Intact nuclear positivity, tumor cells
Intact nuclear positivity, tumor cells
Colon-Infiltrating malignant neoplasm-Mismatch Repair Proteins-MLH1 (Immunohistochemistry Study)-Loss of nuclear positivity, tumor cells
Loss of nuclear positivity, tumor cells
Colon-Infiltrating malignant neoplasm-Mismatch Repair Proteins-MLH2 (Immunohistochemistry Study)-Intact nuclear positivity, tumor cells
Intact nuclear positivity, tumor cells
Colon-Infiltrating malignant neoplasm-Mismatch Repair Proteins-MLH2 (Immunohistochemistry Study)-Loss of nuclear positivity, tumor cells
Loss of nuclear positivity, tumor cells
Colon-Infiltrating malignant neoplasm-Mismatch Repair Proteins-MLH6 (Immunohistochemistry Study)-Intact nuclear positivity, tumor cells
Intact nuclear positivity, tumor cells
Colon-Infiltrating malignant neoplasm-Mismatch Repair Proteins-MLH6 (Immunohistochemistry Study)-Loss of nuclear positivity, tumor cells
Loss of nuclear positivity, tumor cells
Colon-Infiltrating malignant neoplasm-BRAF V600E mutational analysis-Mutant detected
Mutant detected
Liver-Infiltrating malignant neoplasm-Margins involvement
Margins involvement
Colon-Infiltrating malignant neoplasm-BRAF V600E mutational analysis-No mutant detected
No mutant detected
Colon-Infiltrating malignant neoplasm-KRAS mutational analysis-Intact nuclear positivity, tumor cells
Intact nuclear positivity, tumor cells
Colon-Infiltrating malignant neoplasm-KRAS mutational analysis-Loss of nuclear positivity, tumor cells
Loss of nuclear positivity, tumor cells
Lung-Infiltrating malignant neoplasm-KRAS mutational analysis-Mutant detected
Mutant detected
Lung-Infiltrating malignant neoplasm-KRAS mutational analysis-No mutant detected
No mutant detected
Colon-Infiltrating malignant neoplasm-Mismatch Repair Proteins-PMS2 (Immunohistochemistry Study)-Intact nuclear positivity, tumor cells
Intact nuclear positivity, tumor cells
Colon-Infiltrating malignant neoplasm-Mismatch Repair Proteins-PMS2 (Immunohistochemistry Study)-Loss of nuclear positivity, tumor cells
Loss of nuclear positivity, tumor cells
Colon-Infiltrating malignant neoplasm-Extent-No evidence of primary tumor
No evidence of primary tumor
Colon-Infiltrating malignant neoplasm-Extent-Intramucosal carcinoma, invasion of lamina propria
Intramucosal carcinoma, invasion of lamina propria
Colon-Infiltrating malignant neoplasm-Extent-Tumor invades submucosa
Tumor invades submucosa
Liver-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin
Distance of lesion from closest uninvolved margin
Colon-Infiltrating malignant neoplasm-Extent-Tumor invades muscularis propria
Tumor invades muscularis propria
Colon-Infiltrating malignant neoplasm-Extent-Tumor invades through the muscularis propria into the subserosal adipose tissue or the nonperitonealized pericolic or perirectal soft tissues but does not extend to the serosal surface
Tumor invades through the muscularis propria into the subserosal adipose tissue or the nonperitonealized pericolic or perirectal soft tissues but does not extend to the serosal surface
Colon-Infiltrating malignant neoplasm-Extent-Tumor penetrates to the surface of the visceral peritoneum (serosa)
Tumor penetrates to the surface of the visceral peritoneum (serosa)
Colon-Infiltrating malignant neoplasm-Extent-Tumor is adherent to other organs or structures (specify: _________________)
Tumor is adherent to other organs or structures (specify: _________________)
Colon-Infiltrating malignant neoplasm-Extent-Tumor directly invades adjacent structures (specify: __________________)
Tumor directly invades adjacent structures (specify: __________________)
Colon-Infiltrating malignant neoplasm-Extent-Tumor penetrates to the surface of the visceral peritoneum (serosa) and directly invades adjacent structures (specify: _____________________)
Tumor penetrates to the surface of the visceral peritoneum (serosa) and directly invades adjacent structures (specify: _____________________)
Endometrium-Infiltrating malignant neoplasm-Extent-<50% myometrial invasion
<50% myometrial invasion
Endometrium-Infiltrating malignant neoplasm-Extent->=50% myometrial invasion
>=50% myometrial invasion
Colon-Infiltrating malignant neoplasm-Histologic grade (Two-Tier Grading System)-Low-grade (well-differentiated to moderately differentiated)
Low-grade (well-differentiated to moderately differentiated)
Liver-Infiltrating malignant neoplasm-Lymph-vascular invasion
Lymph-vascular invasion
Colon-Infiltrating malignant neoplasm-Histologic grade (Two-Tier Grading System)-High-grade (poorly differentiated to undifferentiated)
High-grade (poorly differentiated to undifferentiated)
Cervix-Infiltrating malignant neoplasm-Histologic grade (WHO)-G1: Well differentiated
G1: Well differentiated
Cervix-Infiltrating malignant neoplasm-Histologic grade (WHO)-G2: Moderately differentiated
G2: Moderately differentiated
Cervix-Infiltrating malignant neoplasm-Histologic grade (WHO)-G3: Poorly differentiated
G3: Poorly differentiated
Endometrium-Infiltrating malignant neoplasm-Histologic grade (WHO)-G1: Well differentiated
G1: Well differentiated
Endometrium-Infiltrating malignant neoplasm-Histologic grade (WHO)-G2: Moderately differentiated
G2: Moderately differentiated
Endometrium-Infiltrating malignant neoplasm-Histologic grade (WHO)-G3: Poorly differentiated
G3: Poorly differentiated
Esophagus-Infiltrating malignant neoplasm-Histologic grade (WHO)-G1: Well differentiated
G1: Well differentiated
Esophagus-Infiltrating malignant neoplasm-Histologic grade (WHO)-G2: Moderately differentiated
G2: Moderately differentiated
Esophagus-Infiltrating malignant neoplasm-Histologic grade (WHO)-G3: Poorly differentiated
G3: Poorly differentiated
Liver-Infiltrating malignant neoplasm-Extent
Extent
Esophagus-Infiltrating malignant neoplasm-Histologic grade (WHO)-G4: Undifferentiated
G4: Undifferentiated
Ovary-Infiltrating malignant neoplasm-Histologic grade (WHO)-G1: Well differentiated
G1: Well differentiated
Ovary-Infiltrating malignant neoplasm-Histologic grade (WHO)-G2: Moderately differentiated
G2: Moderately differentiated
Ovary-Infiltrating malignant neoplasm-Histologic grade (WHO)-G3: Poorly differentiated
G3: Poorly differentiated
Lung-Infiltrating malignant neoplasm-Histologic grade (WHO)-G1: Well differentiated
G1: Well differentiated
Lung-Infiltrating malignant neoplasm-Histologic grade (WHO)-G2: Moderately differentiated
G2: Moderately differentiated
Lung-Infiltrating malignant neoplasm-Histologic grade (WHO)-G3: Poorly differentiated
G3: Poorly differentiated
Lung-Infiltrating malignant neoplasm-Histologic grade (WHO)-G4: Undifferentiated
G4: Undifferentiated
Thyroid-Infiltrating malignant neoplasm-Histologic grade (WHO)-G1: Well differentiated
G1: Well differentiated
Thyroid-Infiltrating malignant neoplasm-Histologic grade (WHO)-G2: Moderately differentiated
G2: Moderately differentiated
Liver-Infiltrating malignant neoplasm-Perineural invasion
Perineural invasion
Thyroid-Infiltrating malignant neoplasm-Histologic grade (WHO)-G3: Poorly differentiated
G3: Poorly differentiated
Thyroid-Infiltrating malignant neoplasm-Histologic grade (WHO)-G4: Undifferentiated
G4: Undifferentiated
Skin (melanoma)-Infiltrating malignant neoplasm-Lymph node site-Subcapsular
Subcapsular
Skin (melanoma)-Infiltrating malignant neoplasm-Lymph node site-Intramedullary
Intramedullary
Skin (melanoma)-Infiltrating malignant neoplasm-Lymph node site-Subcapsular and intramedullary
Subcapsular and intramedullary
Breast-Infiltrating malignant neoplasm-Lymph node site-Supraclavicular
Supraclavicular
Cervix-Infiltrating malignant neoplasm-Margin site-Endocervical Margin
Endocervical Margin
Cervix-Infiltrating malignant neoplasm-Margin site-Exocervical Margin
Exocervical Margin
Liver-Infiltrating malignant neoplasm-Lesion site
Lesion site
Cervix-Infiltrating malignant neoplasm-Margin site-Deep Margin
Deep Margin
Colon-Infiltrating malignant neoplasm-Margin site-Deep Margin (Stalk Margin)
Deep Margin (Stalk Margin)
Colon-Infiltrating malignant neoplasm-Margin site-Mucosal/Lateral Margin (for non-circumferential transanal disk excision)
Mucosal/Lateral Margin (for non-circumferential transanal disk excision)
Colon-Infiltrating malignant neoplasm-Margin site-Circumferential (Radial) or Mesenteric Margin
Circumferential (Radial) or Mesenteric Margin
Stomach-Infiltrating malignant neoplasm-Margin site-Omental (Radial) Margins
Omental (Radial) Margins
Stomach-Infiltrating malignant neoplasm-Margin site-Deep Margin (applies to endoscopic resections)
Deep Margin (applies to endoscopic resections)
Liver-Infiltrating malignant neoplasm-Margin site-Parenchymal margin
Parenchymal margin
Liver-Infiltrating malignant neoplasm-Margin site-Other margin
Other margin
Esophagus-Infiltrating malignant neoplasm-Margin site-Circumferential (Adventitial) Margin (esophagectomy or esophagogastrectomy specimens)
Circumferential (Adventitial) Margin (esophagectomy or esophagogastrectomy specimens)
Esophagus-Infiltrating malignant neoplasm-Margin site-Deep Margin (endoscopic resection specimens)
Deep Margin (endoscopic resection specimens)
Generic-Infiltrating malignant neoplasm-Specimen size, largest dimension
Specimen size, largest dimension
Liver-Infiltrating malignant neoplasm-Margin site
Margin site
Lung-Infiltrating malignant neoplasm-Margin site-Parietal Pleural Margin
Parietal Pleural Margin
Lung-Infiltrating malignant neoplasm-Margin site-Chest Wall Margin
Chest Wall Margin
Kidney-Infiltrating malignant neoplasm-Margin site-Renal capsular margin (partial nephrectomy only)
Renal capsular margin (partial nephrectomy only)
Kidney-Infiltrating malignant neoplasm-Margin site-Perinephric fat margin (partial nephrectomy only)
Perinephric fat margin (partial nephrectomy only)
Liver-Infiltrating malignant neoplasm-Number of lymph nodes involved
Number of lymph nodes involved
Kidney-Infiltrating malignant neoplasm-Margin site-Gerota’s fascial margin
Gerota’s fascial margin
Kidney-Infiltrating malignant neoplasm-Margin site-Ureteral margin
Ureteral margin
Cervix-Infiltrating malignant neoplasm-Lesion site-Right superior quadrant (12 to 3 o’clock)
Right superior quadrant (12 to 3 o’clock)
Cervix-Infiltrating malignant neoplasm-Lesion site-Right inferior quadrant (3 to 6 o’clock)
Right inferior quadrant (3 to 6 o’clock)
Cervix-Infiltrating malignant neoplasm-Lesion site-Left inferior quadrant (6 to 9 o’clock)
Left inferior quadrant (6 to 9 o’clock)
Cervix-Infiltrating malignant neoplasm-Lesion site-Left superior quadrant (9 to 12 o’clock)
Left superior quadrant (9 to 12 o’clock)
Colon-Infiltrating malignant neoplasm-Lesion site-Cecum
Cecum
Colon-Infiltrating malignant neoplasm-Lesion site-Rectosigmoid
Rectosigmoid
Colon-Infiltrating malignant neoplasm-Lesion site-Colon, not otherwise specified
Colon, not otherwise specified
Colon-Infiltrating malignant neoplasm-Lesion site-Terminal ileum
Terminal ileum
Liver-Infiltrating malignant neoplasm-Number of lymph nodes examined
Number of lymph nodes examined
Colon-Infiltrating malignant neoplasm-Lesion site-Appendix
Appendix
Colon-Infiltrating malignant neoplasm-Lesion site-Anus
Anus
Endometrium-Infiltrating malignant neoplasm-Lesion site-Anterior endometrium
Anterior endometrium
Endometrium-Infiltrating malignant neoplasm-Lesion site-Posterior endometrium
Posterior endometrium
Stomach-Infiltrating malignant neoplasm-Lesion site-Body: Anterior wall
Body: Anterior wall
Stomach-Infiltrating malignant neoplasm-Lesion site-Body: Posterior wall
Body: Posterior wall
Stomach-Infiltrating malignant neoplasm-Lesion site-Body: Lesser curvature
Body: Lesser curvature
Stomach-Infiltrating malignant neoplasm-Lesion site-Body: Greater curvature
Body: Greater curvature
Stomach-Infiltrating malignant neoplasm-Lesion site-Antrum: Anterior wall
Antrum: Anterior wall
Stomach-Infiltrating malignant neoplasm-Lesion site-Antrum: Posterior wall
Antrum: Posterior wall
Stomach-Infiltrating malignant neoplasm-Lesion site-Antrum: Lesser curvature
Antrum: Lesser curvature
Stomach-Infiltrating malignant neoplasm-Lesion site-Antrum: Greater curvature
Antrum: Greater curvature
Stomach-Infiltrating malignant neoplasm-Lesion site-Fundus: Anterior wall
Fundus: Anterior wall
Stomach-Infiltrating malignant neoplasm-Lesion site-Fundus: Posterior wall
Fundus: Posterior wall
Liver-Infiltrating malignant neoplasm-Lesion site-Gallbladder
Gallbladder
Salivary gland-Infiltrating malignant neoplasm-Lesion site-Parotid gland
Parotid gland
Salivary gland-Infiltrating malignant neoplasm-Lesion site-Superficial lobe
Superficial lobe
Salivary gland-Infiltrating malignant neoplasm-Lesion site-Deep lobe
Deep lobe
Salivary gland-Infiltrating malignant neoplasm-Lesion site-Entire parotid gland
Entire parotid gland
Liver-Infiltrating malignant neoplasm-pN
pN
Salivary gland-Infiltrating malignant neoplasm-pM-pM1: Distant metastasis - Specify site(s)
pM1: Distant metastasis - Specify site(s)
Larynx-Infiltrating malignant neoplasm-Lesion site-Larynx, supraglottis
Larynx, supraglottis
Larynx-Infiltrating malignant neoplasm-Lesion site-Lingual aspect
Lingual aspect
Larynx-Infiltrating malignant neoplasm-Lesion site-Laryngeal aspect
Laryngeal aspect
Larynx-Infiltrating malignant neoplasm-Lesion site-Larynx, glottis
Larynx, glottis
Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Vermilion border upper lip (qualifier : right, left, medial)
Vermilion border upper lip (qualifier : right, left, medial)
Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Vermilion border lower lip (qualifier : right, left, medial)
Vermilion border lower lip (qualifier : right, left, medial)
Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Mucosa of lower lip (qualifier : right, left, medial)
Mucosa of lower lip (qualifier : right, left, medial)
Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Commissure of lip (qualifier : right, left, medial)
Commissure of lip (qualifier : right, left, medial)
Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Lateral border of tongue (qualifier : right, left, medial)
Lateral border of tongue (qualifier : right, left, medial)
Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Ventral surface of tongue, not otherwise specified (NOS) (qualifier : right, left, medial)
Ventral surface of tongue, not otherwise specified (NOS) (qualifier : right, left, medial)
Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Dorsal surface of tongue, NOS (qualifier : right, left, medial)
Dorsal surface of tongue, NOS (qualifier : right, left, medial)
Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Anterior two-thirds of tongue, NOS (qualifier : right, left, medial)
Anterior two-thirds of tongue, NOS (qualifier : right, left, medial)
Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Upper gingiva (gum) (qualifier : right, left, medial)
Upper gingiva (gum) (qualifier : right, left, medial)
Liver-Infiltrating malignant neoplasm-pT
pT
Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Lower gingiva (gum) (qualifier : right, left, medial)
Lower gingiva (gum) (qualifier : right, left, medial)
Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Anterior floor of mouth (qualifier : right, left, medial)
Anterior floor of mouth (qualifier : right, left, medial)
Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Floor of mouth, NOS (qualifier : right, left, medial)
Floor of mouth, NOS (qualifier : right, left, medial)
Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Hard palate (qualifier : right, left, medial)
Hard palate (qualifier : right, left, medial)
Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Buccal mucosa (inner cheek) (qualifier : right, left, medial)
Buccal mucosa (inner cheek) (qualifier : right, left, medial)
Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Upper vestibule of mouth (qualifier : right, left, medial)
Upper vestibule of mouth (qualifier : right, left, medial)
Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Lower vestibule of mouth (qualifier : right, left, medial)
Lower vestibule of mouth (qualifier : right, left, medial)
Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Upper alveolar process (qualifier : right, left, medial)
Upper alveolar process (qualifier : right, left, medial)
Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Lower alveolar process (qualifier : right, left, medial)
Lower alveolar process (qualifier : right, left, medial)
Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Mandible (qualifier : right, left, medial)
Mandible (qualifier : right, left, medial)
Liver-Infiltrating malignant neoplasm-Lesion size, largest dimension
Lesion size, largest dimension
Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Maxilla (qualifier : right, left, medial)
Maxilla (qualifier : right, left, medial)
Lip, oral cavity-Infiltrating malignant neoplasm-pM-pM1: Distant metastasis - Specify site(s)
pM1: Distant metastasis - Specify site(s)
Esophagus-Infiltrating malignant neoplasm-Lesion site-Midesophagus: Upper thoracic esophagus
Midesophagus: Upper thoracic esophagus
Esophagus-Infiltrating malignant neoplasm-Lesion site-Midesophagus: Midthoracic esophagus
Midesophagus: Midthoracic esophagus
Esophagus-Infiltrating malignant neoplasm-Lesion site-Distal esophagus (lower thoracic esophagus)
Distal esophagus (lower thoracic esophagus)
Esophagus-Infiltrating malignant neoplasm-Lesion site-Proximal stomach and esophagogastric junction
Proximal stomach and esophagogastric junction
Pharynx-Infiltrating malignant neoplasm-Lesion site-Nasopharynx: Nasopharyngeal tonsils (adenoids)
Nasopharynx: Nasopharyngeal tonsils (adenoids)
Pharynx-Infiltrating malignant neoplasm-Lesion site-Oropharynx: Palatine tonsil
Oropharynx: Palatine tonsil
Pharynx-Infiltrating malignant neoplasm-Lesion site-Oropharynx: Base of tongue, including lingual tonsil
Oropharynx: Base of tongue, including lingual tonsil
Liver-Infiltrating malignant neoplasm-Histologic type
Histologic type
Pharynx-Infiltrating malignant neoplasm-Lesion site-Oropharynx: Soft palate
Oropharynx: Soft palate
Pharynx-Infiltrating malignant neoplasm-Lesion site-Oropharynx: Uvula
Oropharynx: Uvula
Pharynx-Infiltrating malignant neoplasm-Lesion site-Oropharynx: Pharyngeal wall (posterior)
Oropharynx: Pharyngeal wall (posterior)
Pharynx-Infiltrating malignant neoplasm-Lesion site-Oropharynx: Other
Oropharynx: Other
Lung-Infiltrating malignant neoplasm-Lesion site-Lung upper lobe
Lung upper lobe
Lung-Infiltrating malignant neoplasm-Lesion site-Lung middle lobe
Lung middle lobe
Lung-Infiltrating malignant neoplasm-Lesion site-Lung lower lobe
Lung lower lobe
Lung-Infiltrating malignant neoplasm-Lesion site-Bronchus (specify)
Bronchus (specify)
Prostate-Infiltrating malignant neoplasm-Lesion site-Prostate
Prostate
Generic-Infiltrating malignant neoplasm-Lymph node sampling
Lymph node sampling
Thyroid-Infiltrating malignant neoplasm-Lesion site-Lobe
Lobe
Cervix-Specimen-Target site-Fallopian tube (qualifier : right, left)
Fallopian tube (qualifier : right, left)
Cervix-Specimen-Target site-Vagina
Vagina
Cervix-Specimen-Target site-Urinary bladder
Urinary bladder
Generic-Infiltrating malignant neoplasm-Histologic type
Histologic type
Generic-Infiltrating malignant neoplasm-Histologic grade (Two-Tier Grading System)
Histologic grade (Two-Tier Grading System)
Colon-Specimen-Target site-Appendix
Appendix
Colon-Specimen-Target site-Anus
Anus
Endometrium-Specimen-Target site-Parametrium (qualifier : right, left)
Parametrium (qualifier : right, left)
Endometrium-Specimen-Target site-Vaginal cuff
Vaginal cuff
Endometrium-Specimen-Target site-Omentum
Omentum
Stomach-Specimen-Target site-Portion of stomach
Portion of stomach
Stomach-Specimen-Target site-Gastric body
Gastric body
Stomach-Specimen-Target site-Gastric antrum
Gastric antrum
Stomach-Specimen-Target site-Distal esophagus
Distal esophagus
Stomach-Specimen-Target site-Proximal duodenum
Proximal duodenum
Salivary gland-Specimen-Target site-Superficial lobe of parotid gland only (qualifier : right, left)
Superficial lobe of parotid gland only (qualifier : right, left)
Salivary gland-Specimen-Target site-Deep lobe of parotid gland only (qualifier : right, left)
Deep lobe of parotid gland only (qualifier : right, left)
Lip, oral cavity-Specimen-Target site-Dorsal surface of tongue, NOS (qualifier : right, left, medial)
Dorsal surface of tongue, NOS (qualifier : right, left, medial)
Lip, oral cavity-Specimen-Target site-Anterior two-thirds of tongue, NOS (qualifier : right, left, medial)
Anterior two-thirds of tongue, NOS (qualifier : right, left, medial)
Generic-Infiltrating malignant neoplasm-Macroscopic type
Macroscopic type
Lip, oral cavity-Specimen-Target site-Anterior floor of mouth (qualifier : right, left, medial)
Anterior floor of mouth (qualifier : right, left, medial)
Lip, oral cavity-Specimen-Target site-Buccal mucosa (inner cheek) (qualifier : right, left, medial)
Buccal mucosa (inner cheek) (qualifier : right, left, medial)
Lip, oral cavity-Specimen-Target site-Lower vestibule of mouth (qualifier : right, left, medial)
Lower vestibule of mouth (qualifier : right, left, medial)
Salivary gland-Infiltrating malignant neoplasm-Margins involvement
Margins involvement
Esophagus-Specimen-Target site-Proximal stomach
Proximal stomach
Ovary-Specimen-Target site-Cervix
Cervix
Ovary-Specimen-Target site-Peritoneum
Peritoneum
Pancreas-Specimen-Target site-Head of pancreas
Head of pancreas
Pancreas-Specimen-Target site-Body of pancreas
Body of pancreas
Pancreas-Specimen-Target site-Tail of pancreas
Tail of pancreas
Salivary gland-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin
Distance of lesion from closest uninvolved margin
Pancreas-Specimen-Target site-Duodenum
Duodenum
Pancreas-Specimen-Target site-Common bile duct
Common bile duct
Pancreas-Specimen-Target site-Spleen
Spleen
Pancreas-Specimen-Target site-Adjacent large vessels
Adjacent large vessels
Pancreas-Specimen-Target site-Portal vein
Portal vein
Pancreas-Specimen-Target site-Superior mesenteric vein
Superior mesenteric vein
Pharynx-Specimen-Target site-Oropharynx
Oropharynx
Salivary gland-Infiltrating malignant neoplasm-Lymph-vascular invasion
Lymph-vascular invasion
Lung-Specimen-Target site-Bronchus (specify)
Bronchus (specify)
Breast-Specimen-Target site-Partial breast
Partial breast
Breast-Infiltrating malignant neoplasm-Necrosis of ductal carcinoma in situ (DCIS)-Not identified
Not identified
Breast-Infiltrating malignant neoplasm-Necrosis of ductal carcinoma in situ (DCIS)-Present, focal (small foci or single cell necrosis)
Present, focal (small foci or single cell necrosis)
Salivary gland-Infiltrating malignant neoplasm-Extent
Extent
Breast-Infiltrating malignant neoplasm-Necrosis of ductal carcinoma in situ (DCIS)-Present, central (expansive “comedo” necrosis)
Present, central (expansive “comedo” necrosis)
Cervix-Infiltrating malignant neoplasm-pM-pM1 [IVB] - Distant metastasis site(s)
pM1 [IVB] - Distant metastasis site(s)
Colon-Infiltrating malignant neoplasm-pM-pM1: Distant metastasis
pM1: Distant metastasis
Colon-Infiltrating malignant neoplasm-pM-pM1a: Metastasis to single organ or site (eg, liver, lung, ovary, nonregional lymph node)
pM1a: Metastasis to single organ or site (eg, liver, lung, ovary, nonregional lymph node)
Colon-Infiltrating malignant neoplasm-pM-pM1b: Metastasis to more than one organ/site or to the peritoneum - Specify site(s)
pM1b: Metastasis to more than one organ/site or to the peritoneum - Specify site(s)
Endometrium-Infiltrating malignant neoplasm-pM-pM1 [IVB]: Distant metastasis (includes metastasis to inguinal lymph nodes, intraperitoneal disease, or lung, liver, or bone metastasis. It excludes metastasis to para-aortic lymph nodes, vagina, pelvic serosa, or adnexa) - Specify site(s)
pM1 [IVB]: Distant metastasis (includes metastasis to inguinal lymph nodes, intraperitoneal disease, or lung, liver, or bone metastasis. It excludes metastasis to para-aortic lymph nodes, vagina, pelvic serosa, or adnexa) - Specify site(s)
Stomach-Infiltrating malignant neoplasm-pM-pM1: Distant metastasis - Specify site(s)
pM1: Distant metastasis - Specify site(s)
Liver-Infiltrating malignant neoplasm-PM-pM1: Distant metastasis - Specify site(s)
pM1: Distant metastasis - Specify site(s)
Larynx-Infiltrating malignant neoplasm-pM-pM1: Distant metastasis - Specify site(s)
pM1: Distant metastasis - Specify site(s)
Esophagus-Infiltrating malignant neoplasm-pM-pM1: Distant metastasis. Specify site(s)
pM1: Distant metastasis. Specify site(s)
Salivary gland-Infiltrating malignant neoplasm-Perineural invasion
Perineural invasion
Ovary-Infiltrating malignant neoplasm-pM-pM1 [IV]: Distant metastases (includes extraperitoneal sites such as liver parenchyma, lung, skeletal metastases, and supraclavicular and axillary nodes)
pM1 [IV]: Distant metastases (includes extraperitoneal sites such as liver parenchyma, lung, skeletal metastases, and supraclavicular and axillary nodes)
Skin (melanoma)-Infiltrating malignant neoplasm-pM-pM1: Distant metastasis (documented in this specimen)
pM1: Distant metastasis (documented in this specimen)
Skin (melanoma)-Infiltrating malignant neoplasm-pM-pM1a: Metastasis in skin, subcutaneous tissues, or distant lymph nodes
pM1a: Metastasis in skin, subcutaneous tissues, or distant lymph nodes
Skin (melanoma)-Infiltrating malignant neoplasm-pM-pM1b: Metastasis to lung
pM1b: Metastasis to lung
Skin (melanoma)-Infiltrating malignant neoplasm-pM-pM1c: Metastasis to all other visceral sites or distant metastasis at any site associated with an elevated serum lactic dehydrogenase (LDH)
pM1c: Metastasis to all other visceral sites or distant metastasis at any site associated with an elevated serum lactic dehydrogenase (LDH)
Pharynx-Infiltrating malignant neoplasm-pM-pM1: Distant metastasis - Specify site(s)
pM1: Distant metastasis - Specify site(s)
Lung-Infiltrating malignant neoplasm-pM-pM1a: Separate tumor nodule(s) in contralateral lung; tumor with pleural nodules or malignant pleural (or pericardial) effusion (Note A)
pM1a: Separate tumor nodule(s) in contralateral lung; tumor with pleural nodules or malignant pleural (or pericardial) effusion (Note A)
Lung-Infiltrating malignant neoplasm-pM-pM1b: Distant metastases outside the lung/pleura
pM1b: Distant metastases outside the lung/pleura
Prostate-Infiltrating malignant neoplasm-pM-pM1: Distant metastasis
pM1: Distant metastasis
Salivary gland-Infiltrating malignant neoplasm-Lymph node capsule involvement
Lymph node capsule involvement
Prostate-Infiltrating malignant neoplasm-pM-pM1a: Nonregional lymph nodes(s)
pM1a: Nonregional lymph nodes(s)
Prostate-Infiltrating malignant neoplasm-pM-pM1b: Bone(s)
pM1b: Bone(s)
Prostate-Infiltrating malignant neoplasm-pM-pM1c: Other site(s) with or without bone disease
pM1c: Other site(s) with or without bone disease
Kidney-Infiltrating malignant neoplasm-pM-pM1: Distant metastasis
pM1: Distant metastasis
Breast-Infiltrating malignant neoplasm-pM-cM0(i+) - No clinical or radiographic evidence of distant metastasis, but deposits of molecularly or microscopically detected tumor cells in circulating blood, bone marrow, or other nonregional nodal tissue that are < = 0.2 mm in a patient without symptoms or signs of metastasis
cM0(i+) - No clinical or radiographic evidence of distant metastasis, but deposits of molecularly or microscopically detected tumor cells in circulating blood, bone marrow, or other nonregional nodal tissue that are < = 0.2 mm in a patient without symptoms or signs of metastasis
Breast-Infiltrating malignant neoplasm-pM-pM1 - Distant detectable metastasis as determined by classic clinical and radiographic means and/or histologically proven >0.2 mm
pM1 - Distant detectable metastasis as determined by classic clinical and radiographic means and/or histologically proven >0.2 mm
Thyroid-Infiltrating malignant neoplasm-pM-pM1: Distant metastasis
pM1: Distant metastasis
Generic-Infiltrating malignant neoplasm-Lymph node sampling-Performed
Performed
Salivary gland-Infiltrating malignant neoplasm-Lymph node site
Lymph node site
Generic-Infiltrating malignant neoplasm-Lymph node sampling-Sentinel lymph node(s)
Sentinel lymph node(s)
Generic-Infiltrating malignant neoplasm-Lymph node sampling-Not performed
Not performed
Cervix-Specimen-Specimen collection procedure-Pelvic Exenteration
Pelvic Exenteration
Cervix-Specimen-Specimen collection procedure-Cold knife cone excision
Cold knife cone excision
Cervix-Specimen-Specimen collection procedure-Loop electrical excision procedure (LEEP)
Loop electrical excision procedure (LEEP)
Cervix-Specimen-Specimen collection procedure-Large loop excision of the transformation zone (LLETZ)
Large loop excision of the transformation zone (LLETZ)
Cervix-Specimen-Specimen collection procedure-Radical trachelectomy
Radical trachelectomy
Colon-Specimen-Specimen collection procedure-Resection
Resection
Colon-Specimen-Specimen collection procedure-Excisional Biopsy (Polypectomy)
Excisional Biopsy (Polypectomy)
Colon-Specimen-Specimen collection procedure-Transanal Disk Excision of Rectal Neoplasms
Transanal Disk Excision of Rectal Neoplasms
Salivary gland-Infiltrating malignant neoplasm-Number of lymph nodes involved
Number of lymph nodes involved
Endometrium-Specimen-Specimen collection procedure-Simple hysterectomy
Simple hysterectomy
Endometrium-Specimen-Specimen collection procedure-Oophorectomy (Qualifier: laterality - Right,Left) Bilateral?
Oophorectomy (Qualifier: laterality - Right,Left) Bilateral?
Endometrium-Specimen-Specimen collection procedure-Salpingectomy (Qualifier: laterality - Right,Left) Bilateral?
Salpingectomy (Qualifier: laterality - Right,Left) Bilateral?
Endometrium-Specimen-Specimen collection procedure-Salpingo-oophorectomy (Qualifier: laterality - Right,Left, Bilateral)
Salpingo-oophorectomy (Qualifier: laterality - Right,Left, Bilateral)
Endometrium-Specimen-Specimen collection procedure-Omentectomy
Omentectomy
Endometrium-Specimen-Specimen collection procedure-Peritoneal biopsies
Peritoneal biopsies
Stomach-Specimen-Specimen collection procedure-Partial gastrectomy, Other
Partial gastrectomy, Other
Liver-Specimen-Specimen collection procedure-Wedge resection
Wedge resection
Liver-Specimen-Specimen collection procedure-Partial hepatectomy: Major hepatectomy (3 segments or more)
Partial hepatectomy: Major hepatectomy (3 segments or more)
Liver-Specimen-Specimen collection procedure-Partial hepatectomy: Minor hepatectomy (less than 3 segments)
Partial hepatectomy: Minor hepatectomy (less than 3 segments)
Salivary gland-Infiltrating malignant neoplasm-Number of lymph nodes examined
Number of lymph nodes examined
Salivary gland-Specimen-Specimen collection procedure-Incisional biopsy (qualifier: right, left)
Incisional biopsy (qualifier: right, left)
Salivary gland-Specimen-Specimen collection procedure-Excisional biopsy (qualifier: right, left)
Excisional biopsy (qualifier: right, left)
Salivary gland-Specimen-Specimen collection procedure-Resection, parotid gland (qualifier: right, left)
Resection, parotid gland (qualifier: right, left)
Salivary gland-Specimen-Specimen collection procedure-Resection, submandibular gland (qualifier: right, left)
Resection, submandibular gland (qualifier: right, left)
Salivary gland-Specimen-Specimen collection procedure-Resection, sublingual gland (qualifier: right, left)
Resection, sublingual gland (qualifier: right, left)
Salivary gland-Specimen-Specimen collection procedure-Neck (lymph node) dissection (specify)
Neck (lymph node) dissection (specify)
Larynx-Specimen-Specimen collection procedure-Incisional biopsy
Incisional biopsy
Larynx-Specimen-Specimen collection procedure-Excisional biopsy
Excisional biopsy
Larynx-Specimen-Specimen collection procedure-Resection
Resection
Larynx-Specimen-Specimen collection procedure-Stripping (glottis)
Stripping (glottis)
Larynx-Specimen-Specimen collection procedure-Transoral laser excision (glottis)
Transoral laser excision (glottis)
Larynx-Specimen-Specimen collection procedure-Supraglottic laryngectomy
Supraglottic laryngectomy
Larynx-Specimen-Specimen collection procedure-Supracricoid laryngectomy
Supracricoid laryngectomy
Larynx-Specimen-Specimen collection procedure-Vertical hemilaryngectomy (qualifier: right, left)
Vertical hemilaryngectomy (qualifier: right, left)
Larynx-Specimen-Specimen collection procedure-Neck (lymph node) dissection (specify)
Neck (lymph node) dissection (specify)
Esophagus-Specimen-Specimen collection procedure-Esophagogastrectomy
Esophagogastrectomy
Esophagus-Specimen-Specimen collection procedure-Esophagectomy
Esophagectomy
Ovary-Specimen-Specimen collection procedure-Subtotal oophorectomy
Subtotal oophorectomy
Ovary-Specimen-Specimen collection procedure-Supracervical hysterectomy
Supracervical hysterectomy
Salivary gland-Infiltrating malignant neoplasm-pN
pN
Ovary-Specimen-Specimen collection procedure-Hysterectomy
Hysterectomy
Ovary-Specimen-Specimen collection procedure-Peritoneal biopsies
Peritoneal biopsies
Pancreas-Specimen-Specimen collection procedure-Pancreaticoduodenectomy (Whipple resection), partial pancreatectomy
Pancreaticoduodenectomy (Whipple resection), partial pancreatectomy
Skin (melanoma)-Specimen-Specimen collection procedure-Biopsy, shave
Biopsy, shave
Skin (melanoma)-Specimen-Specimen collection procedure-Biopsy, punch
Biopsy, punch
Skin (melanoma)-Specimen-Specimen collection procedure-Biopsy, incisional
Biopsy, incisional
Skin (melanoma)-Specimen-Specimen collection procedure-Re-excision
Re-excision
Pharynx-Specimen-Specimen collection procedure-Incisional biopsy
Incisional biopsy
Pharynx-Specimen-Specimen collection procedure-Excisional biopsy
Excisional biopsy
Pharynx-Specimen-Specimen collection procedure-Resection
Resection
Pharynx-Specimen-Specimen collection procedure-Tonsillectomy
Tonsillectomy
Lung-Specimen-Specimen collection procedure-Major airway resection
Major airway resection
Lung-Specimen-Specimen collection procedure-Wedge resection
Wedge resection
Prostate-Specimen-Specimen collection procedure-Transurethral prostatic resection (enucleation)
Transurethral prostatic resection (enucleation)
Kidney-Specimen-Specimen collection procedure-Incisional biopsy, needle
Incisional biopsy, needle
Kidney-Specimen-Specimen collection procedure-Incisional biopsy, wedge
Incisional biopsy, wedge
Breast-Specimen-Specimen collection procedure-Excision without wire-guided localization
Excision without wire-guided localization
Breast-Specimen-Specimen collection procedure-Excision with wire-guided localization
Excision with wire-guided localization
Thyroid-Specimen-Specimen collection procedure-Total thyroidectomy with central compartment dissection
Total thyroidectomy with central compartment dissection
Thyroid-Specimen-Specimen collection procedure-Total thyroidectomy with neck dissection
Total thyroidectomy with neck dissection
Salivary gland-Infiltrating malignant neoplasm-pT
pT
Pharynx-Infiltrating malignant neoplasm-pT oropharynx carcinoma-pT0: No evidence of primary tumor
pT0: No evidence of primary tumor
Pharynx-Infiltrating malignant neoplasm-pT oropharynx carcinoma-pTis: Carcinoma in situ
pTis: Carcinoma in situ
Pharynx-Infiltrating malignant neoplasm-pT oropharynx carcinoma-pT1: Tumor 2 cm or less in greatest dimension
pT1: Tumor 2 cm or less in greatest dimension
Pharynx-Infiltrating malignant neoplasm-pT oropharynx carcinoma-pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension
pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension
Pharynx-Infiltrating malignant neoplasm-pT oropharynx carcinoma-pT3: Tumor more than 4 cm in greatest dimension or extension to lingual surface of epiglottis
pT3: Tumor more than 4 cm in greatest dimension or extension to lingual surface of epiglottis
Pharynx-Infiltrating malignant neoplasm-pT oropharynx carcinoma-pT4a: Moderately advanced local disease. Tumor invades larynx, deep/extrinsic muscle of tongue, medial pterygoid muscles, hard palate, or mandible
pT4a: Moderately advanced local disease. Tumor invades larynx, deep/extrinsic muscle of tongue, medial pterygoid muscles, hard palate, or mandible
Pharynx-Infiltrating malignant neoplasm-pT oropharynx carcinoma-pT4b: Very advanced local disease. Tumor invades lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, or skull base, or encases carotid artery
pT4b: Very advanced local disease. Tumor invades lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, or skull base, or encases carotid artery
Breast-Infiltrating malignant neoplasm-Progesterone receptor-Immunoreactive tumor cells present (> = 1%) (Specify Quantitation)
Immunoreactive tumor cells present (> = 1%) (Specify Quantitation)
Breast-Infiltrating malignant neoplasm-Progesterone receptor-Less than 1% immunoreactive cells present
Less than 1% immunoreactive cells present
Breast-Infiltrating malignant neoplasm-Estrogen receptor-Immunoreactive tumor cells present (> = 1%) (Specify Quantitation)
Immunoreactive tumor cells present (> = 1%) (Specify Quantitation)
Salivary gland-Infiltrating malignant neoplasm-Lymph node metastasis size
Lymph node metastasis size
Breast-Infiltrating malignant neoplasm-Estrogen receptor-Less than 1% immunoreactive cells present
Less than 1% immunoreactive cells present
Generic-Infiltrating malignant neoplasm-Treatment effect-Marked response (grade 1, minimal residual cancer)
Marked response (grade 1, minimal residual cancer)
Colon-Infiltrating malignant neoplasm-Histologic Features Suggestive of Microsatellite Instability-No Intratumoral Lymphocytic Response (tumor-infiltrating lymphocytes)
No Intratumoral Lymphocytic Response (tumor-infiltrating lymphocytes)
Colon-Infiltrating malignant neoplasm-Histologic Features Suggestive of Microsatellite Instability-Mild to moderate (0-2 per high-power [X400] field) Intratumoral Lymphocytic Response (tumor-infiltrating lymphocytes)
Mild to moderate (0-2 per high-power [X400] field) Intratumoral Lymphocytic Response (tumor-infiltrating lymphocytes)
Colon-Infiltrating malignant neoplasm-Histologic Features Suggestive of Microsatellite Instability-Marked (3 or more per high-power field) Intratumoral Lymphocytic Response (tumor-infiltrating lymphocytes)
Marked (3 or more per high-power field) Intratumoral Lymphocytic Response (tumor-infiltrating lymphocytes)
Colon-Infiltrating malignant neoplasm-Histologic Features Suggestive of Microsatellite Instability-No Peritumor Lymphocytic Response (Crohn-like response)
No Peritumor Lymphocytic Response (Crohn-like response)
Colon-Infiltrating malignant neoplasm-Histologic Features Suggestive of Microsatellite Instability-Mild to moderate Peritumor Lymphocytic Response (Crohn-like response)
Mild to moderate Peritumor Lymphocytic Response (Crohn-like response)
Colon-Infiltrating malignant neoplasm-Histologic Features Suggestive of Microsatellite Instability-Marked Peritumor Lymphocytic Response (Crohn-like response)
Marked Peritumor Lymphocytic Response (Crohn-like response)
Colon-Infiltrating malignant neoplasm-Histologic Features Suggestive of Microsatellite Instability-Mucinous tumor component (specify percentage: ____)
Mucinous tumor component (specify percentage: ____)
Colon-Infiltrating malignant neoplasm-Histologic Features Suggestive of Microsatellite Instability-Medullary tumor component
Medullary tumor component
Salivary gland-Infiltrating malignant neoplasm-Lesion size, largest dimension
Lesion size, largest dimension
Colon-Infiltrating malignant neoplasm-Histologic Features Suggestive of Microsatellite Instability-High histologic grade (poorly differentiated)
High histologic grade (poorly differentiated)
Cervix-Infiltrating malignant neoplasm-Histologic type-Nonkeratinizing squamous cell carcinoma
Nonkeratinizing squamous cell carcinoma
Colon-Infiltrating malignant neoplasm-Histologic type-Small cell carcinoma
Small cell carcinoma
Colon-Infiltrating malignant neoplasm-Histologic type-Squamous cell carcinoma
Squamous cell carcinoma
Colon-Infiltrating malignant neoplasm-Histologic type-Adenosquamous carcinoma
Adenosquamous carcinoma
Colon-Infiltrating malignant neoplasm-Histologic type-Carcinoma, type cannot be determinedd
Carcinoma, type cannot be determinedd
Colon-Lesion-Histologic type-Active inflammatory bowel disease
Active inflammatory bowel disease
Colon-Lesion-Histologic type-Quiescent inflammatory bowel disease
Quiescent inflammatory bowel disease
Colon-Lesion-Histologic type-Dysplasia arising in inflammatory bowel disease
Dysplasia arising in inflammatory bowel disease
Colon-Lesion-Histologic type-Chronic ulcerative proctocolitis
Chronic ulcerative proctocolitis
Salivary gland-Infiltrating malignant neoplasm-Specimen size, largest dimension
Specimen size, largest dimension
Colon-Lesion-Histologic type-Crohn disease
Crohn disease
Colon-Lesion-Histologic type-Adenoma(s)
Adenoma(s)
Colon-Lesion-Histologic type-Other polyps (specify)
Other polyps (specify)
Endometrium-Infiltrating malignant neoplasm-Histologic type-Small cell carcinoma
Small cell carcinoma
Endometrium-Infiltrating malignant neoplasm-Histologic type-Mixed carcinoma (specify types and percentages)
Mixed carcinoma (specify types and percentages)
Endometrium-Infiltrating malignant neoplasm-Histologic type-Transitional cell carcinoma
Transitional cell carcinoma
Endometrium-Lesion-Histologic type-Simple hyperplasia without cytologic atypia
Simple hyperplasia without cytologic atypia
Endometrium-Lesion-Histologic type-Complex hyperplasia without cytologic atypia
Complex hyperplasia without cytologic atypia
Endometrium-Lesion-Histologic type-Simple atypical hyperplasia
Simple atypical hyperplasia
Endometrium-Lesion-Histologic type-Complex atypical hyperplasia
Complex atypical hyperplasia
Generic-Lesion-Histologic type
Histologic type
Salivary gland-Infiltrating malignant neoplasm-Histologic type
Histologic type
Endometrium-Lesion-Histologic type-Endometrial intraepithelial neoplasia (EIN)
Endometrial intraepithelial neoplasia (EIN)
Breast-Infiltrating malignant neoplasm-Histologic type-Invasive mucinous carcinoma
Invasive mucinous carcinoma
Breast-Infiltrating malignant neoplasm-Histologic type-Invasive medullary carcinoma
Invasive medullary carcinoma
Breast-Infiltrating malignant neoplasm-Histologic type-Invasive papillary carcinoma
Invasive papillary carcinoma
Breast-Infiltrating malignant neoplasm-Histologic type-Invasive micropapillary carcinoma
Invasive micropapillary carcinoma
Breast-Infiltrating malignant neoplasm-Histologic type-Invasive tubular carcinoma
Invasive tubular carcinoma
Breast-Infiltrating malignant neoplasm-Histologic type-Invasive cribriform carcinoma
Invasive cribriform carcinoma
Breast-In situ neoplasm-Histologic type-Ductal carcinoma in situ with microinvasion
Ductal carcinoma in situ with microinvasion
Breast-In situ neoplasm-Histologic type-Lobular carcinoma in situ with microinvasion
Lobular carcinoma in situ with microinvasion
Larynx-Infiltrating malignant neoplasm-Margins involvement
Margins involvement
Breast-In situ neoplasm-Histologic type-Ductal carcinoma in situ involving nipple skin (Paget disease) with microinvasion
Ductal carcinoma in situ involving nipple skin (Paget disease) with microinvasion
Breast-In situ neoplasm-Histologic type-Invasive carcinoma with ductal and lobular features (“mixed type carcinoma”)
Invasive carcinoma with ductal and lobular features (“mixed type carcinoma”)
Cervix-Lesion-Histologic type-Koilocytosis
Koilocytosis
Stomach-Infiltrating malignant neoplasm-Histologic type-Adenocarcinoma, diffuse type
Adenocarcinoma, diffuse type
Stomach-Infiltrating malignant neoplasm-Histologic type-Signet-ring cell carcinoma (greater than 50% signet-ring cells)
Signet-ring cell carcinoma (greater than 50% signet-ring cells)
Stomach-Infiltrating malignant neoplasm-Histologic type-Adenocarcinoma, intestinal type
Adenocarcinoma, intestinal type
Stomach-Lesion-Histologic type-Intestinal metaplasia
Intestinal metaplasia
Stomach-Lesion-Histologic type-Dysplasia
Dysplasia
Stomach-Lesion-Histologic type-Helicobacter pylori-type gastritis
Helicobacter pylori-type gastritis
Stomach-Lesion-Histologic type-Other gastritis (specify)
Other gastritis (specify)
Stomach-Lesion-Histologic type-Polyp(s) (specify)
Polyp(s) (specify)
Liver-Infiltrating malignant neoplasm-Histologic type-Fibrolamellar hepatocellular carcinoma
Fibrolamellar hepatocellular carcinoma
Liver-Infiltrating malignant neoplasm-Histologic type-Undifferentiated carcinoma
Undifferentiated carcinoma
Liver-Infiltrating malignant neoplasm-Histologic type-Carcinoma, type cannot be determinedd
Carcinoma, type cannot be determinedd
Liver-Lesion-Histologic type-Cirrhosis/severe fibrosis (Ishak score 5-6) (F1)
Cirrhosis/severe fibrosis (Ishak score 5-6) (F1)
Liver-Lesion-Histologic type-None to moderate fibrosis (Ishak score 0-4) (F2)
None to moderate fibrosis (Ishak score 0-4) (F2)
Liver-Lesion-Histologic type-Low-grade hepatocellular dysplastic nodule
Low-grade hepatocellular dysplastic nodule
Liver-Lesion-Histologic type-High-grade hepatocellular dysplastic nodule
High-grade hepatocellular dysplastic nodule
Liver-Lesion-Histologic type-Steatosis
Steatosis
Liver-Lesion-Histologic type-Iron overload
Iron overload
Larynx-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin
Distance of lesion from closest uninvolved margin
Liver-Lesion-Histologic type-Chronic hepatitis (specify)
Chronic hepatitis (specify)
Salivary gland-Infiltrating malignant neoplasm-Histologic type-Acinic cell carcinoma
Acinic cell carcinoma
Salivary gland-Infiltrating malignant neoplasm-Histologic type-Clear cell adenocarcinoma
Clear cell adenocarcinoma
Salivary gland-Infiltrating malignant neoplasm-Histologic type-Cystadenocarcinoma
Cystadenocarcinoma
Salivary gland-Infiltrating malignant neoplasm-Histologic type-Large cell carcinoma
Large cell carcinoma
Salivary gland-Infiltrating malignant neoplasm-Histologic type-Low-grade cribriform cystadenocarcinoma
Low-grade cribriform cystadenocarcinoma
Salivary gland-Infiltrating malignant neoplasm-Histologic type-Lymphoepithelial carcinoma
Lymphoepithelial carcinoma
Salivary gland-Infiltrating malignant neoplasm-Histologic type-Metastasizing pleomorphic adenoma
Metastasizing pleomorphic adenoma
Larynx-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin
Distance of lesion from closest uninvolved margin
Salivary gland-Infiltrating malignant neoplasm-Histologic type-Mucinous adenocarcinoma (colloid carcinoma)
Mucinous adenocarcinoma (colloid carcinoma)
Salivary gland-Infiltrating malignant neoplasm-Histologic type-Myoepithelial carcinoma (malignant myoepithelioma)
Myoepithelial carcinoma (malignant myoepithelioma)
Salivary gland-Infiltrating malignant neoplasm-Histologic type-Oncocytic carcinoma
Oncocytic carcinoma
Salivary gland-Infiltrating malignant neoplasm-Histologic type-Polymorphous low-grade adenocarcinoma
Polymorphous low-grade adenocarcinoma
Salivary gland-Infiltrating malignant neoplasm-Histologic type-Salivary duct carcinoma
Salivary duct carcinoma
Salivary gland-Infiltrating malignant neoplasm-Histologic type-Sebaceous lymphadenocarcinoma
Sebaceous lymphadenocarcinoma
Salivary gland-Infiltrating malignant neoplasm-Histologic type-Sialoblastoma
Sialoblastoma
Salivary gland-Infiltrating malignant neoplasm-Histologic type-Squamous cell carcinoma, primary
Squamous cell carcinoma, primary
Salivary gland-Infiltrating malignant neoplasm-Histologic type-Other
Other
Salivary gland-Infiltrating malignant neoplasm-Histologic type-Carcinoma, type cannot be determinedd
Carcinoma, type cannot be determinedd
Larynx-Infiltrating malignant neoplasm-Lymph-vascular invasion
Lymph-vascular invasion
Salivary gland-Lesion-Histologic type-Sialadenitis
Sialadenitis
Salivary gland-Lesion-Histologic type-Tumor associated lymphoid proliferation (TALP)
Tumor associated lymphoid proliferation (TALP)
Salivary gland-Lesion-Histologic type-Severe keratinizing dysplasia (carcinoma in situ)
Severe keratinizing dysplasia (carcinoma in situ)
Salivary gland-Lesion-Histologic type-Mild keratinizing dysplasia
Mild keratinizing dysplasia
Salivary gland-Lesion-Histologic type-Moderate keratinizing dysplasia
Moderate keratinizing dysplasia
Larynx-Infiltrating malignant neoplasm-Histologic type-Variants of Squamous Cell Carcinoma
Variants of Squamous Cell Carcinoma
Larynx-Infiltrating malignant neoplasm-Histologic type-Acantholytic squamous cell carcinoma
Acantholytic squamous cell carcinoma
Larynx-Infiltrating malignant neoplasm-Histologic type-Papillary squamous cell carcinoma
Papillary squamous cell carcinoma
Larynx-Infiltrating malignant neoplasm-Histologic type-Giant cell carcinoma
Giant cell carcinoma
Larynx-Infiltrating malignant neoplasm-Histologic type-Neuroendocrine Carcinoma
Neuroendocrine Carcinoma
Larynx-Infiltrating malignant neoplasm-Lymph node sampling
Lymph node sampling
Larynx-Infiltrating malignant neoplasm-Histologic type-Typical carcinoid tumor (well differentiated neuroendocrine carcinoma)
Typical carcinoid tumor (well differentiated neuroendocrine carcinoma)
Larynx-Infiltrating malignant neoplasm-Histologic type-Atypical carcinoid tumor (moderately differentiated neuroendocrine carcinoma)
Atypical carcinoid tumor (moderately differentiated neuroendocrine carcinoma)
Larynx-Infiltrating malignant neoplasm-Histologic type-Small cell carcinoma, neuroendocrine type (poorly differentiated neuroendocrine
Small cell carcinoma, neuroendocrine type (poorly differentiated neuroendocrine
Larynx-Infiltrating malignant neoplasm-Histologic type-carcinoma)
carcinoma)
Larynx-Infiltrating malignant neoplasm-Histologic type-Combined (or composite) small cell carcinoma, neuroendocrine type
Combined (or composite) small cell carcinoma, neuroendocrine type
Larynx-Infiltrating malignant neoplasm-Histologic type-Mucosal malignant melanoma
Mucosal malignant melanoma
Larynx-Infiltrating malignant neoplasm-Histologic type-Adenoid cystic carcinoma
Adenoid cystic carcinoma
Larynx-Infiltrating malignant neoplasm-Histologic type-Mucoepidermoid carcinoma
Mucoepidermoid carcinoma
Larynx-Infiltrating malignant neoplasm-Histologic type-Other carcinoma (specify)
Other carcinoma (specify)
Larynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma, type cannot be determinedd
Carcinoma, type cannot be determinedd
Larynx-Infiltrating malignant neoplasm-Extent
Extent
Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Acantholytic squamous cell carcinoma
Acantholytic squamous cell carcinoma
Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma cuniculatum
Carcinoma cuniculatum
Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Papillary squamous cell carcinoma
Papillary squamous cell carcinoma
Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Lymphoepithelial carcinoma (non-nasopharyngeal)
Lymphoepithelial carcinoma (non-nasopharyngeal)
Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Acinic cell carcinoma
Carcinoma of Minor Salivary Glands: Acinic cell carcinoma
Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Adenoid cystic carcinoma
Carcinoma of Minor Salivary Glands: Adenoid cystic carcinoma
Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Adenocarcinoma, not otherwise specified (NOS)
Carcinoma of Minor Salivary Glands: Adenocarcinoma, not otherwise specified (NOS)
Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Basal cell adenocarcinoma
Carcinoma of Minor Salivary Glands: Basal cell adenocarcinoma
Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Carcinoma ex pleomorphic adenoma (malignant mixed tumor)
Carcinoma of Minor Salivary Glands: Carcinoma ex pleomorphic adenoma (malignant mixed tumor)
Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Carcinoma, type cannot be determinedd
Carcinoma of Minor Salivary Glands: Carcinoma, type cannot be determinedd
Larynx-Infiltrating malignant neoplasm-Perineural invasion
Perineural invasion
Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Carcinosarcoma
Carcinoma of Minor Salivary Glands: Carcinosarcoma
Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Clear cell adenocarcinoma
Carcinoma of Minor Salivary Glands: Clear cell adenocarcinoma
Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Cystadenocarcinoma
Carcinoma of Minor Salivary Glands: Cystadenocarcinoma
Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Epithelial-myoepithelial carcinoma
Carcinoma of Minor Salivary Glands: Epithelial-myoepithelial carcinoma
Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Mucoepidermoid carcinoma
Carcinoma of Minor Salivary Glands: Mucoepidermoid carcinoma
Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Mucinous adenocarcinoma (colloid carcinoma)
Carcinoma of Minor Salivary Glands: Mucinous adenocarcinoma (colloid carcinoma)
Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Myoepithelial carcinoma (malignant myoepithelioma)
Carcinoma of Minor Salivary Glands: Myoepithelial carcinoma (malignant myoepithelioma)
Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Oncocytic carcinoma
Carcinoma of Minor Salivary Glands: Oncocytic carcinoma
Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Polymorphous low-grade adenocarcinoma
Carcinoma of Minor Salivary Glands: Polymorphous low-grade adenocarcinoma
Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Salivary duct carcinoma
Carcinoma of Minor Salivary Glands: Salivary duct carcinoma
Larynx-Infiltrating malignant neoplasm-Lymph node capsule involvement
Lymph node capsule involvement
Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Other
Carcinoma of Minor Salivary Glands: Other
Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Adenocarcinoma, Non-Salivary Gland Type: Adenocarcinoma, not otherwise specified (NOS)
Adenocarcinoma, Non-Salivary Gland Type: Adenocarcinoma, not otherwise specified (NOS)
Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Adenocarcinoma, Non-Salivary Gland Type: Other
Adenocarcinoma, Non-Salivary Gland Type: Other
Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Neuroendocrine Carcinoma
Neuroendocrine Carcinoma
Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Neuroendocrine Carcinoma: Typical carcinoid tumor (well differentiated neuroendocrine carcinoma)
Neuroendocrine Carcinoma: Typical carcinoid tumor (well differentiated neuroendocrine carcinoma)
Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Neuroendocrine Carcinoma: Atypical carcinoid tumor (moderately differentiated neuroendocrine carcinoma)
Neuroendocrine Carcinoma: Atypical carcinoid tumor (moderately differentiated neuroendocrine carcinoma)
Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Neuroendocrine Carcinoma: Small cell carcinoma (poorly differentiated neuroendocrine carcinoma)
Neuroendocrine Carcinoma: Small cell carcinoma (poorly differentiated neuroendocrine carcinoma)
Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Neuroendocrine Carcinoma: Combined (or composite) small cell carcinoma, neuroendocrine type
Neuroendocrine Carcinoma: Combined (or composite) small cell carcinoma, neuroendocrine type
Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Neuroendocrine Carcinoma: Other
Neuroendocrine Carcinoma: Other
Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma, type cannot be determined
Carcinoma, type cannot be determined
Larynx-Infiltrating malignant neoplasm-Lesion site
Lesion site
Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Mucosal malignant melanoma
Mucosal malignant melanoma
Lip, oral cavity-Lesion-Histologic type-Severe keratinizing dysplasia (carcinoma in situ)
Severe keratinizing dysplasia (carcinoma in situ)
Lip, oral cavity-Lesion-Histologic type-Mild non-keratinizing dysplasia
Mild non-keratinizing dysplasia
Lip, oral cavity-Lesion-Histologic type-Moderate non-keratinizing dysplasia
Moderate non-keratinizing dysplasia
Lip, oral cavity-Lesion-Histologic type-Severe non-keratinizing dysplasia (carcinoma in situ)
Severe non-keratinizing dysplasia (carcinoma in situ)
Lip, oral cavity-Lesion-Histologic type-Inflammation (specify)
Inflammation (specify)
Lip, oral cavity-Lesion-Histologic type-Epithelial hyperplasia
Epithelial hyperplasia
Lip, oral cavity-Lesion-Histologic type-Fungal colonization
Fungal colonization
Lip, oral cavity-Lesion-Histologic type-Bacterial colonization
Bacterial colonization
Esophagus-Infiltrating malignant neoplasm-Histologic type-Small cell carcinoma
Small cell carcinoma
Larynx-Infiltrating malignant neoplasm-Lymph node site
Lymph node site
Esophagus-Infiltrating malignant neoplasm-Histologic type-Undifferentiated carcinoma
Undifferentiated carcinoma
Esophagus-Infiltrating malignant neoplasm-Histologic type-Carcinoma, type cannot be determinedd
Carcinoma, type cannot be determinedd
Esophagus-Lesion-Histologic type-Intestinal metaplasia (Barrett’s esophagus)
Intestinal metaplasia (Barrett’s esophagus)
Esophagus-Lesion-Histologic type-Low grade dysplasia
Low grade dysplasia
Esophagus-Lesion-Histologic type-High grade dysplasia
High grade dysplasia
Esophagus-Lesion-Histologic type-Esophagitis (specify)
Esophagitis (specify)
Esophagus-Lesion-Histologic type-Gastritis (specify)
Gastritis (specify)
Ovary-Infiltrating malignant neoplasm-Histologic type-Mucinous, borderline tumor, intestinal type
Mucinous, borderline tumor, intestinal type
Ovary-Infiltrating malignant neoplasm-Histologic type-Mucinous, borderline tumor, endocervical type (seromucinous type)
Mucinous, borderline tumor, endocervical type (seromucinous type)
Ovary-Infiltrating malignant neoplasm-Histologic type-Brenner tumor, malignant type
Brenner tumor, malignant type
Larynx-Infiltrating malignant neoplasm-Number of lymph nodes involved
Number of lymph nodes involved
Ovary-Infiltrating malignant neoplasm-Histologic type-Squamous cell carcinoma
Squamous cell carcinoma
Ovary-Infiltrating malignant neoplasm-Histologic type-Mixed epithelial borderline tumor (specify types and percentages)
Mixed epithelial borderline tumor (specify types and percentages)
Ovary-Infiltrating malignant neoplasm-Histologic type-Mixed epithelial carcinoma (specify types and percentages)
Mixed epithelial carcinoma (specify types and percentages)
Ovary-Infiltrating malignant neoplasm-Histologic type-Undifferentiated carcinoma
Undifferentiated carcinoma
Ovary-Infiltrating malignant neoplasm-Histologic type-Carcinosarcoma (Malignant müllerian mixed tumor)
Carcinosarcoma (Malignant müllerian mixed tumor)
Ovary-Infiltrating malignant neoplasm-Histologic type-Granulosa cell tumor
Granulosa cell tumor
Ovary-Lesion-Histologic type-Ovarian endometriosis
Ovarian endometriosis
Ovary-Lesion-Histologic type-Extraovarian endometriosis
Extraovarian endometriosis
Ovary-Lesion-Histologic type-Endosalpingiosis
Endosalpingiosis
Pancreas-Infiltrating malignant neoplasm-Histologic type-Undifferentiated (anaplastic) carcinoma
Undifferentiated (anaplastic) carcinoma
Larynx-Infiltrating malignant neoplasm-Number of lymph nodes examined
Number of lymph nodes examined
Pancreas-Infiltrating malignant neoplasm-Histologic type-Undifferentiated carcinoma with osteoclast-like giant cells
Undifferentiated carcinoma with osteoclast-like giant cells
Pancreas-Infiltrating malignant neoplasm-Histologic type-Mixed ductal-endocrine carcinoma
Mixed ductal-endocrine carcinoma
Pancreas-Infiltrating malignant neoplasm-Histologic type-Noninvasive mucinous cystic neoplasm
Noninvasive mucinous cystic neoplasm
Pancreas-Infiltrating malignant neoplasm-Histologic type-Noninvasive intraductal papillary-mucinous carcinoma
Noninvasive intraductal papillary-mucinous carcinoma
Pancreas-Infiltrating malignant neoplasm-Histologic type-Mixed acinar-endocrine carcinoma
Mixed acinar-endocrine carcinoma
Pancreas-Lesion-Histologic type-Pancreatic intraepithelial neoplasia
Pancreatic intraepithelial neoplasia
Skin (melanoma)-Infiltrating malignant neoplasm-Histologic type-Malignant melanoma
Malignant melanoma
Skin (melanoma)-Infiltrating malignant neoplasm-Histologic type-Melanoma, not otherwise classified
Melanoma, not otherwise classified
Skin (melanoma)-Infiltrating malignant neoplasm-Histologic type-Lentigo maligna melanoma
Lentigo maligna melanoma
Skin (melanoma)-Infiltrating malignant neoplasm-Histologic type-Acral-lentiginous melanoma
Acral-lentiginous melanoma
Skin (melanoma)-Infiltrating malignant neoplasm-Histologic type-Desmoplastic and/or desmoplastic neurotropic melanoma
Desmoplastic and/or desmoplastic neurotropic melanoma
Skin (melanoma)-Infiltrating malignant neoplasm-Histologic type-Melanoma arising from blue nevus
Melanoma arising from blue nevus
Skin (melanoma)-Infiltrating malignant neoplasm-Histologic type-Melanoma arising in a giant congenital nevus
Melanoma arising in a giant congenital nevus
Skin (melanoma)-Infiltrating malignant neoplasm-Histologic type-Melanoma of childhood
Melanoma of childhood
Skin (melanoma)-Infiltrating malignant neoplasm-Histologic type-Nevoid melanoma
Nevoid melanoma
Skin (melanoma)-Infiltrating malignant neoplasm-Histologic type-Persistent melanoma
Persistent melanoma
Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of the Oropharynx and Hypopharynx: Squamous cell carcinoma, conventional
Carcinoma of the Oropharynx and Hypopharynx: Squamous cell carcinoma, conventional
Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of the Oropharynx and Hypopharynx: Acantholytic squamous cell carcinoma
Carcinoma of the Oropharynx and Hypopharynx: Acantholytic squamous cell carcinoma
Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of the Oropharynx and Hypopharynx: Adenosquamous carcinoma
Carcinoma of the Oropharynx and Hypopharynx: Adenosquamous carcinoma
Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of the Oropharynx and Hypopharynx: Basaloid squamous cell carcinoma
Carcinoma of the Oropharynx and Hypopharynx: Basaloid squamous cell carcinoma
Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of the Oropharynx and Hypopharynx: Papillary squamous cell carcinoma
Carcinoma of the Oropharynx and Hypopharynx: Papillary squamous cell carcinoma
Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of the Oropharynx and Hypopharynx: Spindle cell squamous carcinoma
Carcinoma of the Oropharynx and Hypopharynx: Spindle cell squamous carcinoma
Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of the Oropharynx and Hypopharynx: Verrucous carcinoma
Carcinoma of the Oropharynx and Hypopharynx: Verrucous carcinoma
Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of the Oropharynx and Hypopharynx: Lymphoepithelial carcinoma (non-nasopharyngeal)
Carcinoma of the Oropharynx and Hypopharynx: Lymphoepithelial carcinoma (non-nasopharyngeal)
Pharynx-Infiltrating malignant neoplasm-Histologic type-Keratinizing squamous cell carcinoma (formerly WHO-1) of the Nasopharynx
Keratinizing squamous cell carcinoma (formerly WHO-1) of the Nasopharynx
Pharynx-Infiltrating malignant neoplasm-Histologic type-Nonkeratinizing carcinoma of the Nasopharynx
Nonkeratinizing carcinoma of the Nasopharynx
Pharynx-Infiltrating malignant neoplasm-Histologic type-Differentiated carcinoma (formerly WHO-2; transitional carcinoma) of the Nasopharynx
Differentiated carcinoma (formerly WHO-2; transitional carcinoma) of the Nasopharynx
Pharynx-Infiltrating malignant neoplasm-Histologic type-Undifferentiated carcinoma (formerly WHO-3; lymphoepithelioma) of the Nasopharynx
Undifferentiated carcinoma (formerly WHO-3; lymphoepithelioma) of the Nasopharynx
Pharynx-Infiltrating malignant neoplasm-Histologic type-Basaloid squamous cell carcinoma of the Nasopharynx
Basaloid squamous cell carcinoma of the Nasopharynx
Pharynx-Infiltrating malignant neoplasm-Histologic type-AdenoCarcinoma (Non-Salivary Gland Type): Nasopharyngeal papillary adenocarcinoma
AdenoCarcinoma (Non-Salivary Gland Type): Nasopharyngeal papillary adenocarcinoma
Larynx-Infiltrating malignant neoplasm-Lesion size, largest dimension
Lesion size, largest dimension
Pharynx-Infiltrating malignant neoplasm-Histologic type-AdenoCarcinoma (Non-Salivary Gland Type): Adenocarcinoma, not otherwise specified (NOS)
AdenoCarcinoma (Non-Salivary Gland Type): Adenocarcinoma, not otherwise specified (NOS)
Pharynx-Infiltrating malignant neoplasm-Histologic type-AdenoCarcinoma (Non-Salivary Gland Type): Other:
AdenoCarcinoma (Non-Salivary Gland Type): Other:
Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Acinic cell carcinoma
Carcinoma of Minor Salivary Glands: Acinic cell carcinoma
Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Adenoid cystic carcinoma
Carcinoma of Minor Salivary Glands: Adenoid cystic carcinoma
Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Adenocarcinoma, not otherwise specified (NOS)
Carcinoma of Minor Salivary Glands: Adenocarcinoma, not otherwise specified (NOS)
Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Basal cell adenocarcinoma
Carcinoma of Minor Salivary Glands: Basal cell adenocarcinoma
Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Carcinoma ex pleomorphic adenoma (malignant mixed tumor)
Carcinoma of Minor Salivary Glands: Carcinoma ex pleomorphic adenoma (malignant mixed tumor)
Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Carcinoma, type cannot be determinedd
Carcinoma of Minor Salivary Glands: Carcinoma, type cannot be determinedd
Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Clear cell adenocarcinoma
Carcinoma of Minor Salivary Glands: Clear cell adenocarcinoma
Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Cystadenocarcinoma
Carcinoma of Minor Salivary Glands: Cystadenocarcinoma
Larynx-Infiltrating malignant neoplasm-Specimen size, largest dimension
Specimen size, largest dimension
Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Epithelial-myoepithelial carcinoma
Carcinoma of Minor Salivary Glands: Epithelial-myoepithelial carcinoma
Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Mucoepidermoid carcinoma
Carcinoma of Minor Salivary Glands: Mucoepidermoid carcinoma
Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Mucinous adenocarcinoma (colloid carcinoma)
Carcinoma of Minor Salivary Glands: Mucinous adenocarcinoma (colloid carcinoma)
Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Myoepithelial carcinoma (malignant myoepithelioma)
Carcinoma of Minor Salivary Glands: Myoepithelial carcinoma (malignant myoepithelioma)
Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Oncocytic carcinoma
Carcinoma of Minor Salivary Glands: Oncocytic carcinoma
Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Polymorphous low-grade adenocarcinoma
Carcinoma of Minor Salivary Glands: Polymorphous low-grade adenocarcinoma
Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Salivary duct carcinoma
Carcinoma of Minor Salivary Glands: Salivary duct carcinoma
Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Other
Carcinoma of Minor Salivary Glands: Other
Pharynx-Infiltrating malignant neoplasm-Histologic type-Neuroendocrine Carcinoma: Typical carcinoid tumor (well differentiated neuroendocrine carcinoma)
Neuroendocrine Carcinoma: Typical carcinoid tumor (well differentiated neuroendocrine carcinoma)
Pharynx-Infiltrating malignant neoplasm-Histologic type-Neuroendocrine Carcinoma: Atypical carcinoid tumor (moderately differentiated neuroendocrine carcinoma)
Neuroendocrine Carcinoma: Atypical carcinoid tumor (moderately differentiated neuroendocrine carcinoma)
Larynx-Infiltrating malignant neoplasm-Histologic type
Histologic type
Pharynx-Infiltrating malignant neoplasm-Histologic type-Neuroendocrine Carcinoma: Small cell carcinoma (poorly differentiated neuroendocrine carcinoma)
Neuroendocrine Carcinoma: Small cell carcinoma (poorly differentiated neuroendocrine carcinoma)
Pharynx-Infiltrating malignant neoplasm-Histologic type-Neuroendocrine Carcinoma: Combined (or composite) small cell carcinoma, neuroendocrine type
Neuroendocrine Carcinoma: Combined (or composite) small cell carcinoma, neuroendocrine type
Pharynx-Infiltrating malignant neoplasm-Histologic type-Mucosal malignant melanoma
Mucosal malignant melanoma
Pharynx-Infiltrating malignant neoplasm-Histologic type-Other carcinoma (specify)
Other carcinoma (specify)
Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma, type cannot be determinedd
Carcinoma, type cannot be determinedd
Pharynx-Lesion-Histologic type-Mild Keratinizing dysplasia
Mild Keratinizing dysplasia
Pharynx-Lesion-Histologic type-Moderate Keratinizing dysplasia
Moderate Keratinizing dysplasia
Pharynx-Lesion-Histologic type-Severe Keratinizing dysplasia (carcinoma in situ)
Severe Keratinizing dysplasia (carcinoma in situ)
Pharynx-Lesion-Histologic type-Mild Nonkeratinizing dysplasia
Mild Nonkeratinizing dysplasia
Pharynx-Lesion-Histologic type-Moderate Nonkeratinizing dysplasia
Moderate Nonkeratinizing dysplasia
Lip, oral cavity-Infiltrating malignant neoplasm-Margins involvement
Margins involvement
Pharynx-Lesion-Histologic type-Severe Nonkeratinizing dysplasia (carcinoma in situ)
Severe Nonkeratinizing dysplasia (carcinoma in situ)
Pharynx-Lesion-Histologic type-Inflammation (specify type)
Inflammation (specify type)
Pharynx-Lesion-Histologic type-Squamous metaplasia
Squamous metaplasia
Pharynx-Lesion-Histologic type-Epithelial hyperplasia
Epithelial hyperplasia
Pharynx-Lesion-Histologic type-Fungal Colonization
Fungal Colonization
Pharynx-Lesion-Histologic type-Bacterial Colonization
Bacterial Colonization
Lung-Infiltrating malignant neoplasm-Histologic type-Carcinoma, type cannot be determinedd
Carcinoma, type cannot be determinedd
Lung-Infiltrating malignant neoplasm-Histologic type-Non-small cell carcinoma, subtype cannot be determined
Non-small cell carcinoma, subtype cannot be determined
Lung-Infiltrating malignant neoplasm-Histologic type-Combined small cell carcinoma (small cell carcinoma and non-small cell component)
Combined small cell carcinoma (small cell carcinoma and non-small cell component)
Lung-Infiltrating malignant neoplasm-Histologic type-Squamous cell carcinoma
Squamous cell carcinoma
Lip, oral cavity-Infiltrating malignant neoplasm-Margins involvement
Margins involvement
Lung-Infiltrating malignant neoplasm-Histologic type-Squamous cell carcinoma, papillary variant
Squamous cell carcinoma, papillary variant
Lung-Infiltrating malignant neoplasm-Histologic type-Squamous cell carcinoma, clear cell variant
Squamous cell carcinoma, clear cell variant
Lung-Infiltrating malignant neoplasm-Histologic type-Squamous cell carcinoma, small cell variant
Squamous cell carcinoma, small cell variant
Lung-Infiltrating malignant neoplasm-Histologic type-Squamous cell carcinoma, basaloid variant
Squamous cell carcinoma, basaloid variant
Lung-Infiltrating malignant neoplasm-Histologic type-Adenocarcinoma, mixed subtype
Adenocarcinoma, mixed subtype
Lung-Infiltrating malignant neoplasm-Histologic type-Acinar adenocarcinoma
Acinar adenocarcinoma
Lung-Infiltrating malignant neoplasm-Histologic type-Papillary adenocarcinoma
Papillary adenocarcinoma
Lung-Infiltrating malignant neoplasm-Histologic type-Bronchioloalveolar carcinoma
Bronchioloalveolar carcinoma
Lung-Infiltrating malignant neoplasm-Histologic type-Bronchioloalveolar carcinoma, nonmucinous
Bronchioloalveolar carcinoma, nonmucinous
Lung-Infiltrating malignant neoplasm-Histologic type-Bronchioloalveolar carcinoma, mucinous
Bronchioloalveolar carcinoma, mucinous
Lip, oral cavity-Infiltrating malignant neoplasm-Margins involvement
Margins involvement
Lung-Infiltrating malignant neoplasm-Histologic type-Bronchioloalveolar carcinoma, mixed nonmucinous and mucinous
Bronchioloalveolar carcinoma, mixed nonmucinous and mucinous
Lung-Infiltrating malignant neoplasm-Histologic type-Solid adenocarcinoma
Solid adenocarcinoma
Lung-Infiltrating malignant neoplasm-Histologic type-Fetal adenocarcinoma
Fetal adenocarcinoma
Lung-Infiltrating malignant neoplasm-Histologic type-Mucinous (colloid) adenocarcinoma
Mucinous (colloid) adenocarcinoma
Lung-Infiltrating malignant neoplasm-Histologic type-Mucinous cystadenocarcinoma
Mucinous cystadenocarcinoma
Lung-Infiltrating malignant neoplasm-Histologic type-Signet ring adenocarcinoma
Signet ring adenocarcinoma
Lung-Infiltrating malignant neoplasm-Histologic type-Clear cell adenocarcinoma
Clear cell adenocarcinoma
Lung-Infiltrating malignant neoplasm-Histologic type-Large cell neuroendocrine carcinoma
Large cell neuroendocrine carcinoma
Lung-Infiltrating malignant neoplasm-Histologic type-Combined large cell neuroendocrine carcinoma (specify type of other non-small cell carcinoma component)
Combined large cell neuroendocrine carcinoma (specify type of other non-small cell carcinoma component)
Lung-Infiltrating malignant neoplasm-Histologic type-Basaloid carcinoma
Basaloid carcinoma
Lip, oral cavity-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin
Distance of lesion from closest uninvolved margin
Lung-Infiltrating malignant neoplasm-Histologic type-Lymphoepithelioma-like carcinoma
Lymphoepithelioma-like carcinoma
Lung-Infiltrating malignant neoplasm-Histologic type-Clear cell carcinoma
Clear cell carcinoma
Lung-Infiltrating malignant neoplasm-Histologic type-Large cell carcinoma with rhabdoid phenotype
Large cell carcinoma with rhabdoid phenotype
Lung-Infiltrating malignant neoplasm-Histologic type-Pleomorphic carcinoma
Pleomorphic carcinoma
Lung-Infiltrating malignant neoplasm-Histologic type-Spindle cell carcinoma
Spindle cell carcinoma
Lung-Infiltrating malignant neoplasm-Histologic type-Giant cell carcinoma
Giant cell carcinoma
Lung-Infiltrating malignant neoplasm-Histologic type-Carcinosarcoma
Carcinosarcoma
Lung-Infiltrating malignant neoplasm-Histologic type-Pulmonary blastoma
Pulmonary blastoma
Lung-Infiltrating malignant neoplasm-Histologic type-Atypical carcinoid tumor
Atypical carcinoid tumor
Lung-Infiltrating malignant neoplasm-Histologic type-Mucoepidermoid carcinoma
Mucoepidermoid carcinoma
Lip, oral cavity-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin
Distance of lesion from closest uninvolved margin
Lung-Infiltrating malignant neoplasm-Histologic type-Adenoid cystic carcinoma
Adenoid cystic carcinoma
Lung-Infiltrating malignant neoplasm-Histologic type-Epithelial-myoepithelial carcinoma
Epithelial-myoepithelial carcinoma
Lung-Lesion-Histologic type-Atelectasis Extends to the hilar region but does not involve entire lung
Atelectasis Extends to the hilar region but does not involve entire lung
Lung-Lesion-Histologic type-Atelectasis involves entire lung
Atelectasis involves entire lung
Lung-Lesion-Histologic type-Obstructive Pneumonitis extends to the hilar region but does not involve entire lung
Obstructive Pneumonitis extends to the hilar region but does not involve entire lung
Lung-Lesion-Histologic type-Obstructive Pneumonitis involves entire lung
Obstructive Pneumonitis involves entire lung
Lung-Lesion-Histologic type-Atypical adenomatous hyperplasia
Atypical adenomatous hyperplasia
Lung-Lesion-Histologic type-Squamous dysplasia
Squamous dysplasia
Lung-Lesion-Histologic type-Metaplasia (specify)
Metaplasia (specify)
Lung-Lesion-Histologic type-Diffuse neuroendocrine hyperplasia
Diffuse neuroendocrine hyperplasia
Lip, oral cavity-Infiltrating malignant neoplasm-Lymph-vascular invasion
Lymph-vascular invasion
Lung-Lesion-Histologic type-Inflammation
Inflammation
Prostate-Lesion-Histologic type-High-grade prostatic intraepithelial neoplasia (PIN)
High-grade prostatic intraepithelial neoplasia (PIN)
Prostate-Lesion-Histologic type-Atypical adenomatous hyperplasia (adenosis)
Atypical adenomatous hyperplasia (adenosis)
Prostate-Lesion-Histologic type-Nodular prostatic hyperplasia
Nodular prostatic hyperplasia
Prostate-Lesion-Histologic type-Inflammation
Inflammation
Kidney-Infiltrating malignant neoplasm-Histologic type-Multilocular clear cell renal cell carcinoma
Multilocular clear cell renal cell carcinoma
Kidney-Infiltrating malignant neoplasm-Histologic type-Papillary renal cell carcinoma
Papillary renal cell carcinoma
Kidney-Infiltrating malignant neoplasm-Histologic type-Translocation carcinoma (Xp11 or others)
Translocation carcinoma (Xp11 or others)
Kidney-Infiltrating malignant neoplasm-Histologic type-Carcinoma associated with neuroblastoma
Carcinoma associated with neuroblastoma
Kidney-Infiltrating malignant neoplasm-Histologic type-Mucinous tubular and spindle cell carcinoma
Mucinous tubular and spindle cell carcinoma
Lip, oral cavity-Infiltrating malignant neoplasm-Extent
Extent
Kidney-Infiltrating malignant neoplasm-Histologic type-Tubulocystic renal cell carcinoma
Tubulocystic renal cell carcinoma
Kidney-Infiltrating malignant neoplasm-Histologic type-Renal cell carcinoma, unclassified
Renal cell carcinoma, unclassified
Kidney-Lesion-Histologic type-Glomerular disease (specify)
Glomerular disease (specify)
Kidney-Lesion-Histologic type-Tubulointerstitial disease (specify)
Tubulointerstitial disease (specify)
Kidney-Lesion-Histologic type-Vascular disease (specify)
Vascular disease (specify)
Kidney-Lesion-Histologic type-Cyst(s) (specify)
Cyst(s) (specify)
Kidney-Lesion-Histologic type-Tubular (papillary) adenoma(s)
Tubular (papillary) adenoma(s)
Breast-In situ neoplasm-Histologic type-DCIS Comedo
DCIS Comedo
Breast-In situ neoplasm-Histologic type-DCIS Paget disease (DCIS involving nipple skin)
DCIS Paget disease (DCIS involving nipple skin)
Breast-In situ neoplasm-Histologic type-DCIS Cribriform
DCIS Cribriform
Lip, oral cavity-Infiltrating malignant neoplasm-Perineural invasion
Perineural invasion
Breast-In situ neoplasm-Histologic type-DCIS Micropapillary
DCIS Micropapillary
Breast-In situ neoplasm-Histologic type-DCIS Papillary
DCIS Papillary
Breast-In situ neoplasm-Histologic type-DCIS Solid
DCIS Solid
Testis-Lesion-Histologic type-Intratubular germ cell neoplasia
Intratubular germ cell neoplasia
Thyroid-Lesion-Histologic type-Adenoma
Adenoma
Thyroid-Lesion-Histologic type-Adenomatoid nodule(s)
Adenomatoid nodule(s)
Thyroid-Lesion-Histologic type-Nodular follicular disease (eg, nodular hyperplasia,goitrous thyroid)
Nodular follicular disease (eg, nodular hyperplasia,goitrous thyroid)
Thyroid-Lesion-Histologic type-Diffuse hyperplasia (Graves’ disease)
Diffuse hyperplasia (Graves’ disease)
Thyroid-Lesion-Histologic type-Advanced thyroiditis
Advanced thyroiditis
Thyroid-Lesion-Histologic type-Focal (nonspecific) thyroiditis
Focal (nonspecific) thyroiditis
Lip, oral cavity-Infiltrating malignant neoplasm-Lymph node capsule involvement
Lymph node capsule involvement
Thyroid-Lesion-Histologic type-Parathyroid gland(s) within normal limits
Parathyroid gland(s) within normal limits
Thyroid-Lesion-Histologic type-Hypercellular parathyroid gland(s)
Hypercellular parathyroid gland(s)
Thyroid-Lesion-Histologic type-C-cell hyperplasia
C-cell hyperplasia
Urinary bladder-Lesion-Histologic type-Inflammation/regenerative changes
Inflammation/regenerative changes
Urinary bladder-Lesion-Histologic type-Therapy-related changes
Therapy-related changes
Urinary bladder-Lesion-Histologic type-Cautery artifact
Cautery artifact
Urinary bladder-Lesion-Histologic type-Cystitis cystica glandularis
Cystitis cystica glandularis
Urinary bladder-Lesion-Histologic type-Keratinizing squamous metaplasia
Keratinizing squamous metaplasia
Urinary bladder-Lesion-Histologic type-Intestinal metaplasia
Intestinal metaplasia
Colon-Infiltrating malignant neoplasm-Macroscopic type-Tubular adenoma
Tubular adenoma
Lip, oral cavity-Infiltrating malignant neoplasm-Lymph node site
Lymph node site
Colon-Infiltrating malignant neoplasm-Macroscopic type-Villous adenoma
Villous adenoma
Colon-Infiltrating malignant neoplasm-Macroscopic type-Tubulovillous adenoma
Tubulovillous adenoma
Colon-Infiltrating malignant neoplasm-Macroscopic type-Traditional serrated adenoma
Traditional serrated adenoma
Colon-Infiltrating malignant neoplasm-Macroscopic type-Sessile serrated adenoma
Sessile serrated adenoma
Colon-Infiltrating malignant neoplasm-Macroscopic type-Hamartomatous polyp
Hamartomatous polyp
Colon-Infiltrating malignant neoplasm-Macroscopic type-Indeterminate
Indeterminate
Colon-Lesion-Macroscopic type-Pedunculated polyp with stalk (Stalk length: cm)
Pedunculated polyp with stalk (Stalk length: cm)
Colon-Lesion-Macroscopic type-Sessile polyp
Sessile polyp
Salivary gland-Infiltrating malignant neoplasm-Macroscopic type-Encapsulated/circumscribed lesion
Encapsulated/circumscribed lesion
Lip, oral cavity-Infiltrating malignant neoplasm-Number of lymph nodes involved
Number of lymph nodes involved
Salivary gland-Infiltrating malignant neoplasm-Macroscopic type-Invasive lesion
Invasive lesion
Salivary gland-Infiltrating malignant neoplasm-Macroscopic type-Solid lesion
Solid lesion
Salivary gland-Infiltrating malignant neoplasm-Macroscopic type-Cystic lesion
Cystic lesion
Salivary gland-Infiltrating malignant neoplasm-Macroscopic type-Epithelial-myoepithelial carcinoma
Epithelial-myoepithelial carcinoma
Larynx-Infiltrating malignant neoplasm-Macroscopic type-Sessile lesion
Sessile lesion
Larynx-Infiltrating malignant neoplasm-Macroscopic type-Polypoid lesion
Polypoid lesion
Larynx-Infiltrating malignant neoplasm-Macroscopic type-Exophytic lesion
Exophytic lesion
Larynx-Infiltrating malignant neoplasm-Macroscopic type-Endophytic lesion
Endophytic lesion
Larynx-Infiltrating malignant neoplasm-Macroscopic type-Ulcerated lesion
Ulcerated lesion
Larynx-Infiltrating malignant neoplasm-Macroscopic type-Mild keratinizing dysplasia
Mild keratinizing dysplasia
Lip, oral cavity-Infiltrating malignant neoplasm-Number of lymph nodes examined
Number of lymph nodes examined
Larynx-Infiltrating malignant neoplasm-Macroscopic type-Moderate keratinizing dysplasia
Moderate keratinizing dysplasia
Larynx-Infiltrating malignant neoplasm-Macroscopic type-Severe keratinizing dysplasia (carcinoma in situ)
Severe keratinizing dysplasia (carcinoma in situ)
Larynx-Infiltrating malignant neoplasm-Macroscopic type-Mild non-keratinizing dysplasia
Mild non-keratinizing dysplasia
Larynx-Infiltrating malignant neoplasm-Macroscopic type-Moderate non-keratinizing dysplasia
Moderate non-keratinizing dysplasia
Larynx-Infiltrating malignant neoplasm-Macroscopic type-Severe non-keratinizing dysplasia (carcinoma in situ)
Severe non-keratinizing dysplasia (carcinoma in situ)
Larynx-Infiltrating malignant neoplasm-Macroscopic type-Inflammation (specify)
Inflammation (specify)
Larynx-Infiltrating malignant neoplasm-Macroscopic type-Squamous metaplasia
Squamous metaplasia
Larynx-Infiltrating malignant neoplasm-Macroscopic type-Epithelial hyperplasia
Epithelial hyperplasia
Larynx-Infiltrating malignant neoplasm-Macroscopic type-Fungal colonization
Fungal colonization
Larynx-Infiltrating malignant neoplasm-Macroscopic type-Bacterial colonization
Bacterial colonization
Pharynx-Infiltrating malignant neoplasm-Macroscopic type-Polypoid lesion
Polypoid lesion
Pharynx-Infiltrating malignant neoplasm-Macroscopic type-Exophytic lesion
Exophytic lesion
Pharynx-Infiltrating malignant neoplasm-Macroscopic type-Endophytic lesion
Endophytic lesion
Pharynx-Infiltrating malignant neoplasm-Macroscopic type-Ulcerated lesion
Ulcerated lesion
Pharynx-Infiltrating malignant neoplasm-Macroscopic type-Sessile lesion
Sessile lesion
Urinary bladder-Infiltrating malignant neoplasm-Macroscopic type-Papillary
Papillary
Urinary bladder-Infiltrating malignant neoplasm-Macroscopic type-Solid/nodule
Solid/nodule
Urinary bladder-Infiltrating malignant neoplasm-Macroscopic type-Flat
Flat
Urinary bladder-Infiltrating malignant neoplasm-Macroscopic type-Ulcerated
Ulcerated
Urinary bladder-Infiltrating malignant neoplasm-Macroscopic type-Indeterminate
Indeterminate
Lip, oral cavity-Infiltrating malignant neoplasm-pN
pN
Cervix-In situ neoplasm-Histologic type-
Intraepithelial neoplasia
Prostate-Infiltrating malignant neoplasm-Histologic type-Signet-ring cell carcinoma
Signet-ring cell carcinoma
Prostate-Infiltrating malignant neoplasm-Histologic type-Adenosquamous carcinoma
Adenosquamous carcinoma
Prostate-Infiltrating malignant neoplasm-Histologic type-Small cell carcinoma
Small cell carcinoma
Prostate-Infiltrating malignant neoplasm-Histologic type-Sarcomatoid carcinoma
Sarcomatoid carcinoma
Prostate-Infiltrating malignant neoplasm-Histologic type-Undifferentiated carcinoma, not otherwise specified
Undifferentiated carcinoma, not otherwise specified
Testis-Infiltrating malignant neoplasm-Histologic type-Seminoma with associated scar
Seminoma with associated scar
Testis-Infiltrating malignant neoplasm-Histologic type-Seminoma with syncytiotrophoblastic cells
Seminoma with syncytiotrophoblastic cells
Testis-Infiltrating malignant neoplasm-Histologic type-Embryonal carcinoma
Embryonal carcinoma
Testis-Infiltrating malignant neoplasm-Histologic type-Choriocarcinoma, biphasic
Choriocarcinoma, biphasic
Testis-Infiltrating malignant neoplasm-Histologic type-Choriocarcinoma, monophasic
Choriocarcinoma, monophasic
Testis-Infiltrating malignant neoplasm-Histologic type-Placental site trophoblastic tumor
Placental site trophoblastic tumor
Testis-Infiltrating malignant neoplasm-Histologic type-Teratoma with a secondary somatic-type malignant component (specify type)
Teratoma with a secondary somatic-type malignant component (specify type)
Testis-Infiltrating malignant neoplasm-Histologic type-Monodermal teratoma, carcinoid
Monodermal teratoma, carcinoid
Testis-Infiltrating malignant neoplasm-Histologic type-Monodermal teratoma, primitive neuroectodermal tumor
Monodermal teratoma, primitive neuroectodermal tumor
Testis-Infiltrating malignant neoplasm-Histologic type-Monodermal teratoma, Other
Monodermal teratoma, Other
Testis-Infiltrating malignant neoplasm-Histologic type-Spermatocytic seminoma
Spermatocytic seminoma
Testis-Infiltrating malignant neoplasm-Histologic type-Spermatocytic seminoma with a sarcomatous component
Spermatocytic seminoma with a sarcomatous component
Testis-Infiltrating malignant neoplasm-Histologic type-Mixed germ cell-sex cord-stromal tumor, gonadoblastoma
Mixed germ cell-sex cord-stromal tumor, gonadoblastoma
Testis-Infiltrating malignant neoplasm-Histologic type-Mixed germ cell-sex cord-stromal tumor, others (specify)
Mixed germ cell-sex cord-stromal tumor, others (specify)
Lip, oral cavity-Infiltrating malignant neoplasm-pT mucosal malignant melanoma
pT mucosal malignant melanoma
Testis-Infiltrating malignant neoplasm-Histologic type-Testicular scar with intratubular germ cell neoplasia
Testicular scar with intratubular germ cell neoplasia
Testis-Infiltrating malignant neoplasm-Histologic type-Sex cord-stromal tumor: Leydig cell tumor
Sex cord-stromal tumor: Leydig cell tumor
Testis-Infiltrating malignant neoplasm-Histologic type-Sex cord-stromal tumor: Classic Sertoli cell tumor
Sex cord-stromal tumor: Classic Sertoli cell tumor
Testis-Infiltrating malignant neoplasm-Histologic type-Sex cord-stromal tumor: Sclerosing Sertoli cell tumor
Sex cord-stromal tumor: Sclerosing Sertoli cell tumor
Testis-Infiltrating malignant neoplasm-Histologic type-Sex cord-stromal tumor: Large cell calcifying Sertoli cell tumor
Sex cord-stromal tumor: Large cell calcifying Sertoli cell tumor
Testis-Infiltrating malignant neoplasm-Histologic type-Sex cord-stromal tumor: Adult-type Granulosa cell tumor
Sex cord-stromal tumor: Adult-type Granulosa cell tumor
Testis-Infiltrating malignant neoplasm-Histologic type-Sex cord-stromal tumor: Juvenile-type Granulosa cell tumor
Sex cord-stromal tumor: Juvenile-type Granulosa cell tumor
Testis-Infiltrating malignant neoplasm-Histologic type-Sex cord-stromal tumor: Mixed, with components
Sex cord-stromal tumor: Mixed, with components
Testis-Infiltrating malignant neoplasm-Histologic type-Sex cord-stromal tumor: Unclassified
Sex cord-stromal tumor: Unclassified
Testis-Infiltrating malignant neoplasm-Histologic type-Malignant neoplasm, type cannot be determined
Malignant neoplasm, type cannot be determined
Lip, oral cavity-Infiltrating malignant neoplasm-Lymph node metastasis size
Lymph node metastasis size
Testis-Lesion-Histologic type-Hemosiderin-laden macrophages
Hemosiderin-laden macrophages
Testis-Lesion-Histologic type-Atrophy
Atrophy
Urinary bladder-Infiltrating malignant neoplasm-Histologic type-Urothelial (transitional cell) carcinoma with squamous differentiation
Urothelial (transitional cell) carcinoma with squamous differentiation
Urinary bladder-Infiltrating malignant neoplasm-Histologic type-Urothelial (transitional cell) carcinoma with glandular differentiation
Urothelial (transitional cell) carcinoma with glandular differentiation
Urinary bladder-Infiltrating malignant neoplasm-Histologic type-Urothelial (transitional cell) carcinoma with variant histology - Specify
Urothelial (transitional cell) carcinoma with variant histology - Specify
Urinary bladder-Infiltrating malignant neoplasm-Histologic type-Squamous cell carcinoma, typical
Squamous cell carcinoma, typical
Urinary bladder-Infiltrating malignant neoplasm-Histologic type-Squamous cell carcinoma, variant histology - Specify
Squamous cell carcinoma, variant histology - Specify
Urinary bladder-Infiltrating malignant neoplasm-Histologic type-Adenocarcinoma, typical
Adenocarcinoma, typical
Urinary bladder-Infiltrating malignant neoplasm-Histologic type-Adenocarcinoma, variant histology - Specify
Adenocarcinoma, variant histology - Specify
Urinary bladder-Infiltrating malignant neoplasm-Histologic type-Undifferentiated carcinoma - Specify
Undifferentiated carcinoma - Specify
Lip, oral cavity-Infiltrating malignant neoplasm-Lesion size, largest dimension
Lesion size, largest dimension
Urinary bladder-Infiltrating malignant neoplasm-Histologic type-Mixed cell type - Specify
Mixed cell type - Specify
Pancreas-Lesion-Histologic type-Chronic pancreatitis
Chronic pancreatitis
Pancreas-Lesion-Histologic type-Acute pancreatitis
Acute pancreatitis
Lip, oral cavity-Infiltrating malignant neoplasm-Specimen size, largest dimension
Specimen size, largest dimension
Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type
Histologic type
Skin (melanoma)-Infiltrating malignant neoplasm-Margins involvement
Margins involvement
Esophagus-Infiltrating malignant neoplasm-Margins involvement
Margins involvement
Esophagus-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin
Distance of lesion from closest uninvolved margin
Esophagus-Infiltrating malignant neoplasm-Lymph-vascular invasion
Lymph-vascular invasion
Esophagus-Infiltrating malignant neoplasm-Extent
Extent
Esophagus-Infiltrating malignant neoplasm-Perineural invasion
Perineural invasion
Esophagus-Infiltrating malignant neoplasm-Lesion site
Lesion site
Esophagus-Infiltrating malignant neoplasm-Margin site
Margin site
Esophagus-Infiltrating malignant neoplasm-Number of lymph nodes involved
Number of lymph nodes involved
Esophagus-Infiltrating malignant neoplasm-Number of lymph nodes examined
Number of lymph nodes examined
Esophagus-Infiltrating malignant neoplasm-pN
pN
Esophagus-Infiltrating malignant neoplasm-pT
pT
Esophagus-Infiltrating malignant neoplasm-Lesion size, largest dimension
Lesion size, largest dimension
Esophagus-Infiltrating malignant neoplasm-Histologic type
Histologic type
Ovary-Infiltrating malignant neoplasm-Extent
Extent
Ovary-Infiltrating malignant neoplasm-Histologic grade of ovary mucinous carcinoma
Histologic grade of ovary mucinous carcinoma
Ovary-Infiltrating malignant neoplasm-Histologic grade (FIGO)
Histologic grade (FIGO)
Ovary-Infiltrating malignant neoplasm-Histologic grade of ovarry immature teratoma
Histologic grade of ovarry immature teratoma
Ovary-Infiltrating malignant neoplasm-Lymph node site
Lymph node site
Ovary-Infiltrating malignant neoplasm-pN
pN
Ovary-Infiltrating malignant neoplasm-pT
pT
Ovary-Infiltrating malignant neoplasm-Lymph-vascular invasion
Lymph-vascular invasion
Ovary-Infiltrating malignant neoplasm-Lymph node sampling
Lymph node sampling
Ovary-Infiltrating malignant neoplasm-Number of lymph nodes involved
Number of lymph nodes involved
Ovary-Infiltrating malignant neoplasm-Number of lymph nodes examined
Number of lymph nodes examined
Ovary-Infiltrating malignant neoplasm-Lesion size, largest dimension
Lesion size, largest dimension
Ovary-Infiltrating malignant neoplasm-Histologic type
Histologic type
Generic-Infiltrating malignant neoplasm-Specimen size, additional dimension
Specimen size, additional dimension
Pancreas-Infiltrating malignant neoplasm-Margins involvement
Margins involvement
Pancreas-Infiltrating malignant neoplasm-Margins involvement
Margins involvement
Pancreas-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin
Distance of lesion from closest uninvolved margin
Pancreas-Infiltrating malignant neoplasm-Lymph-vascular invasion
Lymph-vascular invasion
Pancreas-Infiltrating malignant neoplasm-Extent
Extent
Pancreas-Infiltrating malignant neoplasm-Perineural invasion
Perineural invasion
Pancreas-Infiltrating malignant neoplasm-Lesion site
Lesion site
Pancreas-Infiltrating malignant neoplasm-Margin site
Margin site
Pancreas-Infiltrating malignant neoplasm-Number of lymph nodes involved
Number of lymph nodes involved
Pancreas-Infiltrating malignant neoplasm-Number of lymph nodes examined
Number of lymph nodes examined
Generic-Infiltrating malignant neoplasm-Histologic grade (WHO)
Histologic grade (WHO)
Pancreas-Infiltrating malignant neoplasm-pN
pN
Pancreas-Infiltrating malignant neoplasm-pT
pT
Pancreas-Infiltrating malignant neoplasm-Lesion size, largest dimension
Lesion size, largest dimension
Pancreas-Infiltrating malignant neoplasm-Histologic type
Histologic type
Skin (melanoma)-Infiltrating malignant neoplasm-Margins involvement
Margins involvement
Skin (melanoma)-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin
Distance of lesion from closest uninvolved margin
Skin (melanoma)-Infiltrating malignant neoplasm-Lymph-vascular invasion
Lymph-vascular invasion
Skin (melanoma)-Infiltrating malignant neoplasm-Lymph node sampling
Lymph node sampling
Skin (melanoma)-Infiltrating malignant neoplasm-Perineural invasion
Perineural invasion
Skin (melanoma)-Infiltrating malignant neoplasm-Lymph node capsule involvement
Lymph node capsule involvement
Skin (melanoma)-Infiltrating malignant neoplasm-Lesion site
Lesion site
Skin (melanoma)-Infiltrating malignant neoplasm-Margin site
Margin site
Skin (melanoma)-Infiltrating malignant neoplasm-Number of lymph nodes involved
Number of lymph nodes involved
Skin (melanoma)-Infiltrating malignant neoplasm-Number of lymph nodes examined
Number of lymph nodes examined
Skin (melanoma)-Infiltrating malignant neoplasm-pN
pN
Skin (melanoma)-Infiltrating malignant neoplasm-pT
pT
Skin (melanoma)-Infiltrating malignant neoplasm-Lymph node metastasis size
Lymph node metastasis size
Skin (melanoma)-Infiltrating malignant neoplasm-Lesion size, largest dimension
Lesion size, largest dimension
Skin (melanoma)-Infiltrating malignant neoplasm-Specimen size, largest dimension
Specimen size, largest dimension
Skin (melanoma)-Infiltrating malignant neoplasm-Histologic type
Histologic type
Skin (melanoma)-Infiltrating malignant neoplasm-Lesion ulceration
Lesion ulceration
Pharynx-Infiltrating malignant neoplasm-Margins involvement
Margins involvement
Pharynx-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin
Distance of lesion from closest uninvolved margin
Pharynx-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin
Distance of lesion from closest uninvolved margin
Pharynx-Infiltrating malignant neoplasm-Lymph-vascular invasion
Lymph-vascular invasion
Pharynx-Infiltrating malignant neoplasm-Extent
Extent
Pharynx-Infiltrating malignant neoplasm-Perineural invasion
Perineural invasion
Pharynx-Infiltrating malignant neoplasm-Lymph node capsule involvement
Lymph node capsule involvement
Pharynx-Infiltrating malignant neoplasm-Lesion site
Lesion site
Pharynx-Infiltrating malignant neoplasm-Lymph node site
Lymph node site
Pharynx-Infiltrating malignant neoplasm-Number of lymph nodes involved
Number of lymph nodes involved
Pharynx-Infiltrating malignant neoplasm-Number of lymph nodes examined
Number of lymph nodes examined
Pharynx-Infiltrating malignant neoplasm-pN hypopharynx carcinoma
pN hypopharynx carcinoma
Pharynx-Infiltrating malignant neoplasm-pN nasopharynx carcinoma
pN nasopharynx carcinoma
Colon-Infiltrating malignant neoplasm-Tumor deposits
Tumor deposits
Pharynx-Infiltrating malignant neoplasm-pN mucosal malignant melanoma
pN mucosal malignant melanoma
Pharynx-Infiltrating malignant neoplasm-pT hypopharynx carcinoma
pT hypopharynx carcinoma
Pharynx-Infiltrating malignant neoplasm-pT nasopharynx carcinoma
pT nasopharynx carcinoma
Pharynx-Infiltrating malignant neoplasm-pT mucosal malignant melanoma
pT mucosal malignant melanoma
Pharynx-Infiltrating malignant neoplasm-Lymph node metastasis size
Lymph node metastasis size
Pharynx-Infiltrating malignant neoplasm-Lesion size, largest dimension
Lesion size, largest dimension
Pharynx-Infiltrating malignant neoplasm-Specimen size, largest dimension
Specimen size, largest dimension
Pharynx-Infiltrating malignant neoplasm-Histologic type
Histologic type
Lung-Infiltrating malignant neoplasm-Margins involvement
Margins involvement
Generic-Infiltrating malignant neoplasm-Extent
Extent
Lung-Infiltrating malignant neoplasm-Margins involvement
Margins involvement
Lung-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin
Distance of lesion from closest uninvolved margin
Lung-Infiltrating malignant neoplasm-Lymph-vascular invasion
Lymph-vascular invasion
Lung-Infiltrating malignant neoplasm-Extent
Extent
Lung-Infiltrating malignant neoplasm-Perineural invasion
Perineural invasion
Lung-Infiltrating malignant neoplasm-Lymph node capsule involvement
Lymph node capsule involvement
Lung-Infiltrating malignant neoplasm-Lymph node site
Lymph node site
Lung-Infiltrating malignant neoplasm-Margin site
Margin site
Lung-Infiltrating malignant neoplasm-Number of lymph nodes involved
Number of lymph nodes involved
Lung-Infiltrating malignant neoplasm-Number of lymph nodes examined
Number of lymph nodes examined
Lung-Infiltrating malignant neoplasm-pN
pN
Lung-Infiltrating malignant neoplasm-pT
pT
Lung-Infiltrating malignant neoplasm-Lesion size, largest dimension
Lesion size, largest dimension
Lung-Infiltrating malignant neoplasm-Lesion size, largest dimension
Lesion size, largest dimension
Lung-Infiltrating malignant neoplasm-Histologic type
Histologic type
Prostate-Infiltrating malignant neoplasm-Margins involvement
Margins involvement
Prostate-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin
Distance of lesion from closest uninvolved margin
Prostate-Infiltrating malignant neoplasm-Lymph-vascular invasion
Lymph-vascular invasion
Generic-Infiltrating malignant neoplasm-Number of lymph nodes examined
Number of lymph nodes examined
Prostate-Infiltrating malignant neoplasm-Lymph node sampling
Lymph node sampling
Prostate-Infiltrating malignant neoplasm-Extent
Extent
Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Primary (Predominant) Pattern)
Histologic grade (Gleason-Primary (Predominant) Pattern)
Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Secondary (Worst Remaining) Pattern)
Histologic grade (Gleason-Secondary (Worst Remaining) Pattern)
Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Tertiary Pattern)
Histologic grade (Gleason-Tertiary Pattern)
Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Total Gleason Score)
Histologic grade (Gleason-Total Gleason Score)
Prostate-Infiltrating malignant neoplasm-Perineural invasion
Perineural invasion
Prostate-Infiltrating malignant neoplasm-Lesion site
Lesion site
Prostate-Infiltrating malignant neoplasm-Number of lymph nodes involved
Number of lymph nodes involved
Prostate-Infiltrating malignant neoplasm-Number of lymph nodes examined
Number of lymph nodes examined
Generic-Infiltrating malignant neoplasm-Number of lymph nodes involved
Number of lymph nodes involved
Prostate-Infiltrating malignant neoplasm-pN
pN
Prostate-Infiltrating malignant neoplasm-Specimen weight
Specimen weight
Prostate-Infiltrating malignant neoplasm-pT
pT
Prostate-Infiltrating malignant neoplasm-Lymph node metastasis size
Lymph node metastasis size
Prostate-Infiltrating malignant neoplasm-Specimen size, largest dimension
Specimen size, largest dimension
Prostate-Infiltrating malignant neoplasm-Histologic type
Histologic type
Kidney-Infiltrating malignant neoplasm-Margins involvement
Margins involvement
Kidney-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin
Distance of lesion from closest uninvolved margin
Generic-Specimen-Specimen integrity
Specimen integrity
Breast-Infiltrating malignant neoplasm-Number of lymph nodes with isolated tumor cells (< = 0.2 mm and < = 200 cells)
Number of lymph nodes with isolated tumor cells (< = 0.2 mm and < = 200 cells)
Kidney-Infiltrating malignant neoplasm-Lymph-vascular invasion
Lymph-vascular invasion
Kidney-Infiltrating malignant neoplasm-Extent
Extent
Kidney-Infiltrating malignant neoplasm-Histologic grade (Fuhrman Nuclear Grade)
Histologic grade (Fuhrman Nuclear Grade)
Kidney-Infiltrating malignant neoplasm-Lesion site
Lesion site
Kidney-Infiltrating malignant neoplasm-Margin site
Margin site
Kidney-Infiltrating malignant neoplasm-Number of lymph nodes involved
Number of lymph nodes involved
Kidney-Infiltrating malignant neoplasm-Number of lymph nodes examined
Number of lymph nodes examined
Kidney-Infiltrating malignant neoplasm-pN
pN
Breast-Infiltrating malignant neoplasm-Number of lymph nodes with macrometastases (>0.2 cm)
Number of lymph nodes with macrometastases (>0.2 cm)
Kidney-Infiltrating malignant neoplasm-pT
pT
Kidney-Infiltrating malignant neoplasm-Lesion size, largest dimension
Lesion size, largest dimension
Kidney-Infiltrating malignant neoplasm-Histologic type
Histologic type
Margins involvement
Breast-In situ neoplasm-Margins involvement
Breast-Margins involvement
Breast-In situ neoplasm-Distance of lesion from closest uninvolved margin
Distance of lesion from closest uninvolved margin
Lymph-vascular invasion
Breast-Infiltrating malignant neoplasm-Lymph-vascular invasion
Breast-Lymph-vascular invasion
Lymph node sampling
Breast-Infiltrating malignant neoplasm-Lymph node sampling
Breast-Lymph node sampling
Breast-In situ neoplasm-Histologic grade of ductal carcinoma in situ (DCIS)
Histologic grade of ductal carcinoma in situ (DCIS)
Breast-Infiltrating malignant neoplasm-Histologic grade (Nottingham Histologic Score-Glandular (Acinar)/Tubular Differentiation)
Histologic grade (Nottingham Histologic Score-Glandular (Acinar)/Tubular Differentiation)
Breast-Infiltrating malignant neoplasm-Histologic grade (Nottingham Histologic Score-Mitotic Count)
Histologic grade (Nottingham Histologic Score-Mitotic Count)
Breast-Infiltrating malignant neoplasm-Number of lymph nodes with micrometastases (>0.2 mm to 0.2 cm and/or >200 cells):
Number of lymph nodes with micrometastases (>0.2 mm to 0.2 cm and/or >200 cells):
Breast-Infiltrating malignant neoplasm-Histologic grade (Nottingham Histologic Score-Nuclear Pleomorphism)
Histologic grade (Nottingham Histologic Score-Nuclear Pleomorphism)
Breast-Infiltrating malignant neoplasm-Histologic grade (Nottingham)
Histologic grade (Nottingham)
Lesion site
Breast-Infiltrating malignant neoplasm-Lesion site
Breast-Lesion site
Lymph node site
Breast-Infiltrating malignant neoplasm-Lymph node site
Breast-Lymph node site
Margin site
Breast-Infiltrating malignant neoplasm-Margin site
Breast-Margin site
Number of lymph nodes involved
Breast-Infiltrating malignant neoplasm-Number of lymph nodes involved
Breast-Number of lymph nodes involved
Number of lymph nodes examined
Breast-Infiltrating malignant neoplasm-Number of lymph nodes examined
Breast-Number of lymph nodes examined
pN
Breast-Infiltrating malignant neoplasm-pN
Breast-Infiltrating malignant neoplasm-pN
Larynx-Infiltrating malignant neoplasm-Lymph node metastasis size
Lymph node metastasis size
pT
Breast-Infiltrating malignant neoplasm-pT
Breast-Infiltrating malignant neoplasm-pT
Breast-Infiltrating malignant neoplasm-Progesterone receptor
Progesterone receptor
Breast-Infiltrating malignant neoplasm-Estrogen receptor
Estrogen receptor
Breast-Infiltrating malignant neoplasm-HER2/neu (FISH method)
HER2/neu (FISH method)
Breast-Infiltrating malignant neoplasm-HER2/neu (immunoperoxidase study)
Specimen size, largest dimension
Breast-In situ neoplasm-Lesion size, largest dimension
Lesion size, largest dimension
Histologic type
Breast-In situ neoplasm-Histologic type
Breast-Histologic type
Histologic type
Breast-Infiltrating malignant neoplasm-Histologic type
Breast-Histologic type
Testis-Infiltrating malignant neoplasm-Margins involvement
Margins involvement
Testis-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin
Distance of lesion from closest uninvolved margin
Cervix-Infiltrating malignant neoplasm-Lymph node capsule involvement
Lymph node capsule involvement
Testis-Infiltrating malignant neoplasm-Lymph-vascular invasion
Lymph-vascular invasion
Testis-Infiltrating malignant neoplasm-Extent
Extent
Testis-Infiltrating malignant neoplasm-Margin site
Margin site
Testis-Infiltrating malignant neoplasm-Number of lymph nodes involved
Number of lymph nodes involved
Testis-Infiltrating malignant neoplasm-Number of lymph nodes examined
Number of lymph nodes examined
Testis-Infiltrating malignant neoplasm-pN
pN
Testis-Infiltrating malignant neoplasm-pT
pT
Testis-Infiltrating malignant neoplasm-Lesion size, largest dimension
Lesion size, largest dimension
Generic-Infiltrating malignant neoplasm-Lymph node site
Lymph node site
Testis-Infiltrating malignant neoplasm-Histologic type
Histologic type
Thyroid-Infiltrating malignant neoplasm-Margins involvement
Margins involvement
Thyroid-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin
Distance of lesion from closest uninvolved margin
Thyroid-Infiltrating malignant neoplasm-Lymph-vascular invasion
Lymph-vascular invasion
Thyroid-Infiltrating malignant neoplasm-Extent
Extent
Thyroid-Infiltrating malignant neoplasm-Perineural invasion
Perineural invasion
Thyroid-Infiltrating malignant neoplasm-Lymph node capsule involvement
Lymph node capsule involvement
Thyroid-Infiltrating malignant neoplasm-Lesion site
Lesion site
Thyroid-Infiltrating malignant neoplasm-Number of lymph nodes involved
Number of lymph nodes involved
Thyroid-Infiltrating malignant neoplasm-Number of lymph nodes examined
Number of lymph nodes examined
Thyroid-Infiltrating malignant neoplasm-pN
pN
Thyroid-Infiltrating malignant neoplasm-Specimen weight
Specimen weight
Thyroid-Infiltrating malignant neoplasm-pT anaplasic carcinoma
pT anaplasic carcinoma
Thyroid-Infiltrating malignant neoplasm-pT exept anaplasic carcinoma
pT exept anaplasic carcinoma
Thyroid-Infiltrating malignant neoplasm-Lesion size, largest dimension
Lesion size, largest dimension
Thyroid-Infiltrating malignant neoplasm-Lesion size, largest dimension
Lesion size, largest dimension
Thyroid-Infiltrating malignant neoplasm-Specimen size, largest dimension
Specimen size, largest dimension
Thyroid-Infiltrating malignant neoplasm-Histologic type
Histologic type
Colon-Infiltrating malignant neoplasm-Margins involvement
Margins involvement
Urinary bladder-Infiltrating malignant neoplasm-Margins involvement
Margins involvement
Urinary bladder-Infiltrating malignant neoplasm-Margins involvement
Margins involvement
Urinary bladder-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin
Distance of lesion from closest uninvolved margin
Urinary bladder-Infiltrating malignant neoplasm-Lymph-vascular invasion
Lymph-vascular invasion
Urinary bladder-Infiltrating malignant neoplasm-Extent
Extent
Urinary bladder-Infiltrating malignant neoplasm-Histologic grade (WHO 2004)
Histologic grade (WHO 2004)
Urinary bladder-Infiltrating malignant neoplasm-Lesion site
Lesion site
Urinary bladder-Infiltrating malignant neoplasm-Margin site
Margin site
Urinary bladder-Infiltrating malignant neoplasm-Number of lymph nodes involved
Number of lymph nodes involved
Urinary bladder-Infiltrating malignant neoplasm-Number of lymph nodes examined
Number of lymph nodes examined
Urinary bladder-Infiltrating malignant neoplasm-pN
pN
Urinary bladder-Infiltrating malignant neoplasm-pT
pT
Urinary bladder-Infiltrating malignant neoplasm-Lesion size, largest dimension
Lesion size, largest dimension
Urinary bladder-Infiltrating malignant neoplasm-Histologic type
Histologic type
Histologic grade (WHO)
Cervix-Infiltrating malignant neoplasm-Histologic grade (WHO)
Cervix-Histologic grade (WHO)
Margin site
Cervix-Infiltrating malignant neoplasm-Margin site
Cervix-Margin site
pM
Cervix-Infiltrating malignant neoplasm-pM
Cervix-Infiltrating malignant neoplasm-pM
Margins involvement
Breast-Infiltrating malignant neoplasm-Margins involvement
Breast-Margins involvement
Lesion site
Cervix-Lesion-Lesion site
Cervix-Lesion site
Lesion site
Cervix-In situ neoplasm-Lesion site
Cervix-Lesion site
Colon-Infiltrating malignant neoplasm-Microsatellite instability
Microsatellite instability
Colon-Infiltrating malignant neoplasm-Mismatch Repair Proteins-MLH1 (Immunohistochemistry Study)
Mismatch Repair Proteins-MLH1 (Immunohistochemistry Study)
Colon-Infiltrating malignant neoplasm-Mismatch Repair Proteins-MLH2 (Immunohistochemistry Study)
Mismatch Repair Proteins-MLH2 (Immunohistochemistry Study)
Colon-Infiltrating malignant neoplasm-Mismatch Repair Proteins-MLH6 (Immunohistochemistry Study)
Mismatch Repair Proteins-MLH6 (Immunohistochemistry Study)
Colon-Infiltrating malignant neoplasm-BRAF V600E mutational analysis
BRAF V600E mutational analysis
Colon-Infiltrating malignant neoplasm-KRAS mutational analysis
KRAS mutational analysis
Colon-Infiltrating malignant neoplasm-Mismatch Repair Proteins-PMS2 (Immunohistochemistry Study)
Mismatch Repair Proteins-PMS2 (Immunohistochemistry Study)
Esophagus-Infiltrating malignant neoplasm-Margins involvement
Margins involvement
Cervix-Specimen-Target site-Col utérin
Cervix
Cervix-Specimen-Specimen collection procedure-Radical hysterectomy
Radical hysterectomy
Cervix-Infiltrating malignant neoplasm-Cytologic type-Invasive carcinoma
Invasive carcinoma
Cervix-Infiltrating malignant neoplasm-Histologic type-Endocervical type Mucinous Adenocarcinoma
Endocervical type Mucinous Adenocarcinoma
Cervix-Infiltrating malignant neoplasm-Histologic type-Intestinal type Mucinous Adenocarcinoma
Intestinal type Mucinous Adenocarcinoma
Esophagus-Infiltrating malignant neoplasm-Margins involvement
Margins involvement
Cervix-Infiltrating malignant neoplasm-Histologic type-Other Mucinous Adenocarcinoma
Other Mucinous Adenocarcinoma
Cervix-Infiltrating malignant neoplasm-Histologic type-Endometrioid Adenocarcinoma
Endometrioid Adenocarcinoma
Cervix-Infiltrating malignant neoplasm-Histologic type-Clear cell Adenocarcinoma
Clear cell Adenocarcinoma
Cervix-Infiltrating malignant neoplasm-Histologic grade (FIGO)-FIGO grade 1
FIGO grade 1
Esophagus-Infiltrating malignant neoplasm-Margins involvement
Margins involvement
Cervix-Infiltrating malignant neoplasm-Histologic grade (FIGO)-FIGO grade 2
FIGO grade 2
Cervix-Infiltrating malignant neoplasm-Histologic grade (FIGO)-FIGO grade 3
FIGO grade 3
Cervix-Infiltrating malignant neoplasm-pT-pT1 [I]: Cervical carcinoma confined to uterus (extension to corpus should be disregarded)
pT1 [I]: Cervical carcinoma confined to uterus (extension to corpus should be disregarded)
Cervix-Infiltrating malignant neoplasm-pT-pT1a [IA]: Invasive carcinoma diagnosed by microscopy only. All macroscopically visible lesions (even with superficial invasion) are pT1b/1B.
pT1a [IA]: Invasive carcinoma diagnosed by microscopy only. All macroscopically visible lesions (even with superficial invasion) are pT1b/1B.
Cervix-Infiltrating malignant neoplasm-pT-pT1a1 [IA1]: Stromal invasion < =3.0 mm in depth and horizontal spread < =7.0 mm
pT1a1 [IA1]: Stromal invasion < =3.0 mm in depth and horizontal spread < =7.0 mm
Cervix-Infiltrating malignant neoplasm-pT-pT1a2 [IA2]: Stromal invasion >3.0 mm but not more than 5.0 mm in depth and horizontal spread 7.0 mm
pT1a2 [IA2]: Stromal invasion >3.0 mm but not more than 5.0 mm in depth and horizontal spread 7.0 mm
Cervix-Infiltrating malignant neoplasm-pT-pT1b [IB]: Clinically visible lesion confined to the cervix or microscopic lesion greater than T1a2/IA2
pT1b [IB]: Clinically visible lesion confined to the cervix or microscopic lesion greater than T1a2/IA2
Cervix-Infiltrating malignant neoplasm-pT-pT1b1 [IB1]: Clinically visible lesion 4.0 cm in greatest dimension
pT1b1 [IB1]: Clinically visible lesion 4.0 cm in greatest dimension
Cervix-Infiltrating malignant neoplasm-pT-pT1b2 [IB2]: Clinically visible lesion >4.0 cm in greatest dimension
pT1b2 [IB2]: Clinically visible lesion >4.0 cm in greatest dimension
Cervix-Infiltrating malignant neoplasm-pT-pT2 [II]: Tumor invades beyond the uterus but not to pelvic wall or to lower third of vagina
pT2 [II]: Tumor invades beyond the uterus but not to pelvic wall or to lower third of vagina
Generic-Infiltrating malignant neoplasm-Margins involvement
Margins involvement
Cervix-Infiltrating malignant neoplasm-pT-pT2a [IIA]: Tumor without parametrial invasion
pT2a [IIA]: Tumor without parametrial invasion
Cervix-Infiltrating malignant neoplasm-pT-pT2a1 [IIA1]: Clinically visible lesion 4.0 cm in greatest dimension
pT2a1 [IIA1]: Clinically visible lesion 4.0 cm in greatest dimension
Cervix-Infiltrating malignant neoplasm-pT-pT2a2 [IIA2] Clinically visible lesion >4.0 cm in greatest dimension
pT2a2 [IIA2] Clinically visible lesion >4.0 cm in greatest dimension
Cervix-Infiltrating malignant neoplasm-pT-pT2b [IIB]: Tumor with parametrial invasion
pT2b [IIB]: Tumor with parametrial invasion
Cervix-Infiltrating malignant neoplasm-pT-pT3 [III]: Tumor extends to the pelvic wall and/or involves the lower third of the vagina and/or causes hydronephrosis or non-functioning kidney
pT3 [III]: Tumor extends to the pelvic wall and/or involves the lower third of the vagina and/or causes hydronephrosis or non-functioning kidney
Cervix-Infiltrating malignant neoplasm-pT-pT3a [IIIA]: Tumor involves lower third of vagina, but not pelvic wall
pT3a [IIIA]: Tumor involves lower third of vagina, but not pelvic wall
Cervix-Infiltrating malignant neoplasm-pT-pT3b [IIIB]: Tumor extends to pelvic wall and/or causes hydronephrosis or non-functioning kidney
pT3b [IIIB]: Tumor extends to pelvic wall and/or causes hydronephrosis or non-functioning kidney
Cervix-Infiltrating malignant neoplasm-pT-pT4 [IVA]: Tumor invades the mucosa of bladder or rectum and/or extends beyond true pelvis (bullous edema is not sufficient evidence to classify a tumor as pT4)
pT4 [IVA]: Tumor invades the mucosa of bladder or rectum and/or extends beyond true pelvis (bullous edema is not sufficient evidence to classify a tumor as pT4)
Cervix-Infiltrating malignant neoplasm-pN-pN0: No regional lymph node metastasis
pN0: No regional lymph node metastasis
Cervix-Infiltrating malignant neoplasm-pN-pN1: Regional lymph node metastasis
pN1: Regional lymph node metastasis
Cervix-Specimen-Target site-Uterine corpus
Uterine corpus
Endometrium-Specimen-Specimen collection procedure-Supracervical hysterectomy
Supracervical hysterectomy
Endometrium-Specimen-Specimen collection procedure-Radical hysterectomy
Radical hysterectomy
Endometrium-Infiltrating malignant neoplasm-Histologic type-Endometrioid adenocarcinoma, not otherwise characterized
Endometrioid adenocarcinoma, not otherwise characterized
Endometrium-Infiltrating malignant neoplasm-Histologic type-Mucinous adenocarcinoma
Mucinous adenocarcinoma
Endometrium-Infiltrating malignant neoplasm-Histologic type-Serous adenocarcinoma
Serous adenocarcinoma
Endometrium-Infiltrating malignant neoplasm-Histologic type-Clear cell adenocarcinoma
Clear cell adenocarcinoma
Endometrium-Infiltrating malignant neoplasm-Histologic type-Squamous cell carcinoma
Squamous cell carcinoma
Endometrium-Infiltrating malignant neoplasm-Histologic type-Undifferentiated carcinoma
Undifferentiated carcinoma
Endometrium-Infiltrating malignant neoplasm-Histologic type-Carcinosarcoma (malignant müllerian mixed tumor)
Carcinosarcoma (malignant müllerian mixed tumor)
Endometrium-Infiltrating malignant neoplasm-Histologic type-Endometrioid adenocarcinoma, variant (specify)
Endometrioid adenocarcinoma, variant (specify)
Endometrium-Infiltrating malignant neoplasm-Histologic type-Endometrioid adenocarcinoma, variant (specify)
Endometrioid adenocarcinoma, variant (specify)
Endometrium-Infiltrating malignant neoplasm-Histologic type-Endometrioid adenocarcinoma, variant (specify)
Endometrioid adenocarcinoma, variant (specify)
Endometrium-Infiltrating malignant neoplasm-Histologic grade (FIGO)-FIGO grade 1
FIGO grade 1
Endometrium-Infiltrating malignant neoplasm-Histologic grade (FIGO)-FIGO grade 2
FIGO grade 2
Endometrium-Infiltrating malignant neoplasm-Histologic grade (FIGO)-FIGO grade 3
FIGO grade 3
Generic-Infiltrating malignant neoplasm-Histologic grade (WHO)-G1: Well differentiated
G1: Well differentiated
Generic-Infiltrating malignant neoplasm-Histologic grade (WHO)-G2: Moderately differentiated
G2: Moderately differentiated
Generic-Infiltrating malignant neoplasm-Histologic grade (WHO)-G3: Poorly differentiated"
G3: Poorly differentiated"
Endometrium-Infiltrating malignant neoplasm-Lymph node site-Pelvic lymph nodes
Pelvic lymph nodes
Endometrium-Infiltrating malignant neoplasm-Lymph node site-Para-aortic lymph nodes
Para-aortic lymph nodes
Endometrium-Infiltrating malignant neoplasm-pT-pT0 [--]: No evidence of primary tumor
pT0 [--]: No evidence of primary tumor
Endometrium-Infiltrating malignant neoplasm-pT-pT1a [IA]: Tumor limited to endometrium or invades less than one-half of the myometrium
pT1a [IA]: Tumor limited to endometrium or invades less than one-half of the myometrium
Endometrium-Infiltrating malignant neoplasm-pT-pT1b [IB]: Tumor invades greater than or equal to one-half of the myometrium
pT1b [IB]: Tumor invades greater than or equal to one-half of the myometrium
Endometrium-Infiltrating malignant neoplasm-pT-pT2 [II]: Tumor invades stromal connective tissue of the cervix, but does not extend beyond uterus
pT2 [II]: Tumor invades stromal connective tissue of the cervix, but does not extend beyond uterus
Endometrium-Infiltrating malignant neoplasm-pT-pT3a [IIIA]: Tumor involves serosa and/or adnexa (direct extension or metastasis)
pT3a [IIIA]: Tumor involves serosa and/or adnexa (direct extension or metastasis)
Endometrium-Infiltrating malignant neoplasm-pT-pT3b [IIIB]: Vaginal involvement (direct extension or metastasis) or parametrial involvement
pT3b [IIIB]: Vaginal involvement (direct extension or metastasis) or parametrial involvement
Endometrium-Infiltrating malignant neoplasm-pT-pT4 [IVA]: Tumor invades bladder mucosa and/or bowel mucosa (bullous edema is not sufficient to classify a tumor as T4)
pT4 [IVA]: Tumor invades bladder mucosa and/or bowel mucosa (bullous edema is not sufficient to classify a tumor as T4)
Endometrium-Infiltrating malignant neoplasm-pN-pN0: No regional lymph node metastasis
pN0: No regional lymph node metastasis
Endometrium-Infiltrating malignant neoplasm-pN-pN1 [IIIC1]: Regional lymph node metastasis to pelvic lymph nodes
pN1 [IIIC1]: Regional lymph node metastasis to pelvic lymph nodes
Endometrium-Infiltrating malignant neoplasm-pN-pN2 [IIIC2]: Regional lymph node metastasis to para-aortic lymph nodes, with or without positive pelvic lymph nodes
pN2 [IIIC2]: Regional lymph node metastasis to para-aortic lymph nodes, with or without positive pelvic lymph nodes
Cervix-Specimen-Target site-Ovary (qualifier : right, left)
Ovary (qualifier : right, left)
Ovary-Specimen-Specimen collection procedure-Oophorectomy
Oophorectomy
Ovary-Specimen-Specimen collection procedure-Salpingo-oophorectomy
Salpingo-oophorectomy
Generic-Lesion-Lesion site
Lesion site
Generic-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin
Distance of lesion from closest uninvolved margin
Ovary-Specimen-Specimen collection procedure-Omentectomy
Omentectomy
Ovary-Infiltrating malignant neoplasm-Histologic type-Serous, borderline tumor
Serous, borderline tumor
Ovary-Infiltrating malignant neoplasm-Histologic type-Serous, carcinoma
Serous, carcinoma
Ovary-Infiltrating malignant neoplasm-Histologic type-Mucinous carcinoma
Mucinous carcinoma
Ovary-Infiltrating malignant neoplasm-Histologic type-Endometrioid borderline tumor
Endometrioid borderline tumor
Ovary-Infiltrating malignant neoplasm-Histologic type-Endometrioid carcinoma
Endometrioid carcinoma
Ovary-Infiltrating malignant neoplasm-Histologic type-Clear cell borderline tumor
Clear cell borderline tumor
Ovary-Infiltrating malignant neoplasm-Histologic type-Clear cell carcinoma
Clear cell carcinoma
Generic-In situ neoplasm-Distance of lesion from closest uninvolved margin
Distance of lesion from closest uninvolved margin
Ovary-Infiltrating malignant neoplasm-Histologic type-Transitional cell borderline tumor
Transitional cell borderline tumor
Ovary-Infiltrating malignant neoplasm-Histologic type-Transitional cell carcinoma
Transitional cell carcinoma
Ovary-Infiltrating malignant neoplasm-Histologic type-Other sex cord-stromal tumor (specify type)
Other sex cord-stromal tumor (specify type)
Ovary-Infiltrating malignant neoplasm-Histologic type-Malignant germ cell tumor (specify types and percentages)
Malignant germ cell tumor (specify types and percentages)
Generic-Infiltrating malignant neoplasm-Lymph-vascular invasion
Lymph-vascular invasion
Generic-Infiltrating malignant neoplasm-Histologic grade (Two-Tier Grading System)-High grade
High grade
Generic-Infiltrating malignant neoplasm-Histologic grade (Two-Tier Grading System)-Low grade
Low grade
Generic-Infiltrating malignant neoplasm-Perineural invasion
Perineural invasion
Ovary-Infiltrating malignant neoplasm-pT-pT0 [--]: No evidence of primary tumor
pT0 [--]: No evidence of primary tumor
Ovary-Infiltrating malignant neoplasm-pT-pT1a [IA]: Tumor limited to one ovary; capsule intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings
pT1a [IA]: Tumor limited to one ovary; capsule intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings
Ovary-Infiltrating malignant neoplasm-pT-pT1b [IB]: Tumor limited to both ovaries; capsule intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings
pT1b [IB]: Tumor limited to both ovaries; capsule intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings
Ovary-Infiltrating malignant neoplasm-pT-pT1c [IC]: Tumor limited to one or both ovaries with any of the following: capsule ruptured, tumor on ovarian surface, malignant cells in ascites or peritoneal washings
pT1c [IC]: Tumor limited to one or both ovaries with any of the following: capsule ruptured, tumor on ovarian surface, malignant cells in ascites or peritoneal washings
Ovary-Infiltrating malignant neoplasm-pT-pT2a [IIA]: Extension and/or implants on uterus and/or tube(s). No malignant cells in ascites or peritoneal washings
pT2a [IIA]: Extension and/or implants on uterus and/or tube(s). No malignant cells in ascites or peritoneal washings
Ovary-Infiltrating malignant neoplasm-pT-pT2b [IIB]: Extension to other pelvic tissues. No malignant cells in ascites or peritoneal washings
pT2b [IIB]: Extension to other pelvic tissues. No malignant cells in ascites or peritoneal washings
Ovary-Infiltrating malignant neoplasm-pT-pT2c [IIC]: Pelvic extension and/or implants (T2a or T2b / IIa or IIb) with malignant cells in ascites or peritoneal washings
pT2c [IIC]: Pelvic extension and/or implants (T2a or T2b / IIa or IIb) with malignant cells in ascites or peritoneal washings
Ovary-Infiltrating malignant neoplasm-pT-pT3a [IIIA]: Microscopic peritoneal metastasis beyond pelvis (no macroscopic tumor)
pT3a [IIIA]: Microscopic peritoneal metastasis beyond pelvis (no macroscopic tumor)
Ovary-Infiltrating malignant neoplasm-pT-pT3b [IIIB]: Macroscopic peritoneal metastasis beyond pelvis ≤ 2 cm in greatest dimension
pT3b [IIIB]: Macroscopic peritoneal metastasis beyond pelvis ≤ 2 cm in greatest dimension
Ovary-Infiltrating malignant neoplasm-pT-pT3c [IIIC]: Peritoneal metastasis beyond pelvis > 2 cm in greatest dimension and/or regional lymph node metastasis
pT3c [IIIC]: Peritoneal metastasis beyond pelvis > 2 cm in greatest dimension and/or regional lymph node metastasis
Generic-Infiltrating malignant neoplasm-pT
pT
Ovary-Infiltrating malignant neoplasm-pN-pN0: No regional lymph node metastasis
pN0: No regional lymph node metastasis
Ovary-Infiltrating malignant neoplasm-pN-pN1 [IIIC]: Regional lymph node metastasis
pN1 [IIIC]: Regional lymph node metastasis
Breast-Specimen-Target site-Total breast (including nipple and skin)
Total breast (including nipple and skin)
Generic-Infiltrating malignant neoplasm-pN
pN
Breast-Specimen-Specimen collection procedure-Total mastectomy (including nipple and skin)
Total mastectomy (including nipple and skin)
Breast-Infiltrating malignant neoplasm-Lesion site-Upper outer quadrant
Upper outer quadrant
Breast-Infiltrating malignant neoplasm-Lesion site-Lower outer quadrant
Lower outer quadrant
Breast-Infiltrating malignant neoplasm-Lesion site-Upper inner quadrant
Upper inner quadrant
Breast-Infiltrating malignant neoplasm-Lesion site-Lower inner quadrant
Lower inner quadrant
Generic-Infiltrating malignant neoplasm-pM
pM
Breast-Infiltrating malignant neoplasm-Lesion site-Nipple
Nipple
Breast-Infiltrating malignant neoplasm-Lesion site-Central
Central
Generic-Infiltrating malignant neoplasm-Treatment effect
Treatment effect
Breast-Infiltrating malignant neoplasm-Histologic type-Invasive ductal carcinoma (no special type or not otherwise specified)
Invasive ductal carcinoma (no special type or not otherwise specified)
Breast-Infiltrating malignant neoplasm-Histologic type-Invasive lobular carcinoma
Invasive lobular carcinoma
Generic-In situ neoplasm-Margins involvement
Margins involvement
Breast-Infiltrating malignant neoplasm-Histologic type-Invasive Carcinoma, type cannot be determinedd
Invasive Carcinoma, type cannot be determinedd
Generic-Infiltrating malignant neoplasm-Lesion site
Lesion site
Breast-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin
Distance of lesion from closest uninvolved margin
Breast-Infiltrating malignant neoplasm-Margin site-Superior
Superior
Breast-Infiltrating malignant neoplasm-Margin site-Inferior
Inferior
Breast-Infiltrating malignant neoplasm-Margin site-Medial
Medial
Breast-Infiltrating malignant neoplasm-Margin site-Lateral
Lateral
Breast-Infiltrating malignant neoplasm-Margin site-Anterior
Anterior
Breast-Infiltrating malignant neoplasm-Margin site-Posterior
Posterior
Breast-Infiltrating malignant neoplasm-Lymph node site-Intramammary lymph nodes)
Intramammary lymph nodes)
Breast-Infiltrating malignant neoplasm-Lymph node site-Sentinel lymph node(s)
Sentinel lymph node(s)
Breast-Infiltrating malignant neoplasm-pT-pT0: No evidence of primary tumor
pT0: No evidence of primary tumor
Breast-Infiltrating malignant neoplasm-pT-pTis (DCIS): Ductal carcinoma in situ
pTis (DCIS): Ductal carcinoma in situ
Breast-Infiltrating malignant neoplasm-pT-pTis (LCIS): Lobular carcinoma in situ
pTis (LCIS): Lobular carcinoma in situ
Breast-Infiltrating malignant neoplasm-pT-pTis (Paget): Paget disease of the nipple not associated with invasive carcinoma and/or carcinoma in situ (DCIS and/or LCIS) in the underlying breast parenchyma
pTis (Paget): Paget disease of the nipple not associated with invasive carcinoma and/or carcinoma in situ (DCIS and/or LCIS) in the underlying breast parenchyma
Breast-Infiltrating malignant neoplasm-pT-pT1: Tumor < =20 mm in greatest dimension
pT1: Tumor < =20 mm in greatest dimension
Breast-Infiltrating malignant neoplasm-pT-pT1mi: Tumor < =1 mm in greatest dimension (microinvasion)
pT1mi: Tumor < =1 mm in greatest dimension (microinvasion)
Breast-Infiltrating malignant neoplasm-pT-pT1a: Tumor >1 mm but < = 5 mm in greatest dimension
pT1a: Tumor >1 mm but < = 5 mm in greatest dimension
Breast-Infiltrating malignant neoplasm-pT-pT1b: Tumor >5 mm but < = 10 mm in greatest dimension
pT1b: Tumor >5 mm but < = 10 mm in greatest dimension
Breast-Infiltrating malignant neoplasm-pT-pT1c: Tumor >10 mm but < = 20 mm in greatest dimension
pT1c: Tumor >10 mm but < = 20 mm in greatest dimension
Breast-Infiltrating malignant neoplasm-pT-pT2: Tumor >20 mm but < = 50 mm in greatest dimension
pT2: Tumor >20 mm but < = 50 mm in greatest dimension
Breast-Infiltrating malignant neoplasm-pT-pT3: Tumor >50 mm in greatest dimension
pT3: Tumor >50 mm in greatest dimension
Skin (melanoma)-Infiltrating malignant neoplasm-Histologic grade (Clark)
Histologic grade (Clark)
Breast-Infiltrating malignant neoplasm-pT-pT4: Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or skin nodules). Note: Invasion of the dermis alone does not qualify as pT4.
pT4: Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or skin nodules). Note: Invasion of the dermis alone does not qualify as pT4.
Breast-Infiltrating malignant neoplasm-pT-pT4a: Extension to chest wall, not including only pectoralis muscle adherence/invasion
pT4a: Extension to chest wall, not including only pectoralis muscle adherence/invasion
Breast-Infiltrating malignant neoplasm-pT-pT4b: Ulceration and/or ipsilateral satellite nodules and/or edema (including peau d’orange) of the skin which do not meet the criteria for inflammatory carcinoma
pT4b: Ulceration and/or ipsilateral satellite nodules and/or edema (including peau d’orange) of the skin which do not meet the criteria for inflammatory carcinoma
Breast-Infiltrating malignant neoplasm-pT-pT4c: Both T4a and T4b
pT4c: Both T4a and T4b
Breast-Infiltrating malignant neoplasm-pT-pT4d: Inflammatory carcinoma
pT4d: Inflammatory carcinoma
Breast-Infiltrating malignant neoplasm-pN-pN0: No regional lymph node metastasis identified histologically Note: Isolated tumor cell (ITC) clusters are defined as small clusters of cells not greater than 0.2 mm or single tumor cells, or a cluster of fewer than 200 cells in a single histologic cross-section. ITCs may be detected by routine histology or by immunohistochemical (IHC) methods. Nodes containing only ITCs are excluded from the total positive node count for purposes of N classification but should be included in the total number of nodes evaluated.
pN0: No regional lymph node metastasis identified histologically Note: Isolated tumor cell (ITC) clusters are defined as small clusters of cells not greater than 0.2 mm or single tumor cells, or a cluster of fewer than 200 cells in a single histologic cross-section. ITCs may be detected by routine histology or by immunohistochemical (IHC) methods. Nodes containing only ITCs are excluded from the total positive node count for purposes of N classification but should be included in the total number of nodes evaluated.
Breast-Infiltrating malignant neoplasm-pN-pN0 (i-): No regional lymph node metastases histologically, negative IHC
pN0 (i-): No regional lymph node metastases histologically, negative IHC
Breast-Infiltrating malignant neoplasm-pN-pN0 (i+): Malignant cells in regional lymph node(s) no greater than 0.2 mm and no more than 200 cells (detected by H&E or IHC including ITC)
pN0 (i+): Malignant cells in regional lymph node(s) no greater than 0.2 mm and no more than 200 cells (detected by H&E or IHC including ITC)
Breast-Infiltrating malignant neoplasm-pN-pN0 (mol-): No regional lymph node metastases histologically, negative molecular findings (reverse transcriptase polymerase chain reaction [RT-PCR])
pN0 (mol-): No regional lymph node metastases histologically, negative molecular findings (reverse transcriptase polymerase chain reaction [RT-PCR])
Breast-Infiltrating malignant neoplasm-pN-pN0 (mol+): Positive molecular findings (RT-PCR), but no regional lymph node metastases detected by histology or IHC
pN0 (mol+): Positive molecular findings (RT-PCR), but no regional lymph node metastases detected by histology or IHC
Cervix-Infiltrating malignant neoplasm-Histologic grade (FIGO)
Histologic grade (FIGO)
Breast-Infiltrating malignant neoplasm-pN-pN1mi: Micrometastases (greater than 0.2 mm and/or more than 200 cells, but none greater than 2.0 mm).
pN1mi: Micrometastases (greater than 0.2 mm and/or more than 200 cells, but none greater than 2.0 mm).
Breast-Infiltrating malignant neoplasm-pN-pN1a: Metastases in 1 to 3 axillary lymph nodes, at least 1 metastasis greater than 2.0 mm
pN1a: Metastases in 1 to 3 axillary lymph nodes, at least 1 metastasis greater than 2.0 mm
Breast-Infiltrating malignant neoplasm-pN-pN2a: Metastases in 4 to 9 axillary lymph nodes (at least 1 tumor deposit greater than 2.0 mm)
pN2a: Metastases in 4 to 9 axillary lymph nodes (at least 1 tumor deposit greater than 2.0 mm)
Breast-Infiltrating malignant neoplasm-pN-pN3a: Metastases in 10 or more axillary lymph nodes (at least 1 tumor deposit greater than 2.0 mm)
pN3a: Metastases in 10 or more axillary lymph nodes (at least 1 tumor deposit greater than 2.0 mm)
Generic-Infiltrating malignant neoplasm-Treatment effect-No residual tumor (complete response, grade 0)
No residual tumor (complete response, grade 0)
Generic-Infiltrating malignant neoplasm-Treatment effect-Moderate response (grade 2)
Moderate response (grade 2)
Generic-Infiltrating malignant neoplasm-Treatment effect-No definite response identified (grade 3, poor or no response)
No definite response identified (grade 3, poor or no response)
Breast-Infiltrating malignant neoplasm-Progesterone receptor-No immunoreactive tumor cells present
No immunoreactive tumor cells present
Breast-Infiltrating malignant neoplasm-HER2/neu (FISH method)-Amplified (HER2 gene copy >6.0 or ratio >2.2)
Amplified (HER2 gene copy >6.0 or ratio >2.2)
Breast-Infiltrating malignant neoplasm-HER2/neu (FISH method)-Not amplified (HER2 gene copy <4.0 or ratio <1.8)
Not amplified (HER2 gene copy <4.0 or ratio <1.8)
Breast-In situ neoplasm-Histologic grade of ductal carcinoma in situ (DCIS)-Grade I (low)
Grade I (low)
Breast-In situ neoplasm-Histologic grade of ductal carcinoma in situ (DCIS)-Grade II (intermediate)
Grade II (intermediate)
Breast-In situ neoplasm-Histologic grade of ductal carcinoma in situ (DCIS)-Grade III (high)
Grade III (high)
Breast-Infiltrating malignant neoplasm-Histologic grade (Nottingham Histologic Score-Glandular (Acinar)/Tubular Differentiation)-Score 1: >75% of tumor area forming glandular/tubular structures
Score 1: >75% of tumor area forming glandular/tubular structures
Breast-Infiltrating malignant neoplasm-Histologic grade (Nottingham Histologic Score-Glandular (Acinar)/Tubular Differentiation)-Score 2: 10% to 75% of tumor area forming glandular/tubular structures
Score 2: 10% to 75% of tumor area forming glandular/tubular structures
Breast-Infiltrating malignant neoplasm-Histologic grade (Nottingham Histologic Score-Glandular (Acinar)/Tubular Differentiation)-Score 3: <10% of tumor area forming glandular/tubular structures
Score 3: <10% of tumor area forming glandular/tubular structures
Breast-Infiltrating malignant neoplasm-Histologic grade (Nottingham Histologic Score-Nuclear Pleomorphism)-Score 1: Nuclei small with little increase in size in comparison with normal breast
Score 1: Nuclei small with little increase in size in comparison with normal breast
Breast-Infiltrating malignant neoplasm-Histologic grade (Nottingham Histologic Score-Nuclear Pleomorphism)-epithelial cells, regular outlines, uniform nuclear chromatin, little variation in size
epithelial cells, regular outlines, uniform nuclear chromatin, little variation in size
Breast-Infiltrating malignant neoplasm-Histologic grade (Nottingham Histologic Score-Nuclear Pleomorphism)-Score 2: Cells larger than normal with open vesicular nuclei, visible nucleoli, and
Score 2: Cells larger than normal with open vesicular nuclei, visible nucleoli, and
Breast-Infiltrating malignant neoplasm-Histologic grade (Nottingham Histologic Score-Mitotic Count)-Score 1
Score 1
Breast-Infiltrating malignant neoplasm-Histologic grade (Nottingham Histologic Score-Mitotic Count)-Score 2
Score 2
Breast-Infiltrating malignant neoplasm-Histologic grade (Nottingham Histologic Score-Mitotic Count)-Score 3
Score 3
Breast-Infiltrating malignant neoplasm-Histologic grade (Nottingham)-moderate variability in both size and shape
moderate variability in both size and shape
Breast-Infiltrating malignant neoplasm-Histologic grade (Nottingham)-Score 3: Vesicular nuclei, often with prominent nucleoli, exhibiting marked variation
Score 3: Vesicular nuclei, often with prominent nucleoli, exhibiting marked variation
Breast-Infiltrating malignant neoplasm-Histologic grade (Nottingham)-in size and shape, occasionally with very large and bizarre forms
in size and shape, occasionally with very large and bizarre forms
Esophagus-Specimen-Target site-Esophagus
Esophagus
Esophagus-Infiltrating malignant neoplasm-Lesion site-Cervical (proximal) esophagus
Cervical (proximal) esophagus
Esophagus-Infiltrating malignant neoplasm-Lesion site-Esophagogastric junction (EGJ)
Esophagogastric junction (EGJ)
Esophagus-Infiltrating malignant neoplasm-Histologic type-Squamous cell carcinoma
Squamous cell carcinoma
Esophagus-Infiltrating malignant neoplasm-Histologic type-Adenocarcinoma
Adenocarcinoma
Esophagus-Infiltrating malignant neoplasm-Histologic type-Adenosquamous carcinoma
Adenosquamous carcinoma
Esophagus-Infiltrating malignant neoplasm-Margin site-Proximal Margin
Proximal Margin
Esophagus-Infiltrating malignant neoplasm-Margin site-Distal Margin
Distal Margin
Esophagus-Infiltrating malignant neoplasm-pT-pT0: No evidence of primary tumor
pT0: No evidence of primary tumor
Esophagus-Infiltrating malignant neoplasm-pT-pTis: High-grade dysplasia
pTis: High-grade dysplasia
Esophagus-Infiltrating malignant neoplasm-pT-pT1: Tumor invades lamina propria, muscularis mucosae, or submucosa
pT1: Tumor invades lamina propria, muscularis mucosae, or submucosa
Esophagus-Infiltrating malignant neoplasm-pT-pT1a: Tumor invades lamina propria or muscularis mucosae
pT1a: Tumor invades lamina propria or muscularis mucosae
Esophagus-Infiltrating malignant neoplasm-pT-pT1b: Tumor invades submucosa
pT1b: Tumor invades submucosa
Esophagus-Infiltrating malignant neoplasm-pT-pT2: Tumor invades muscularis propria
pT2: Tumor invades muscularis propria
Esophagus-Infiltrating malignant neoplasm-pT-pT3: Tumor invades adventitia
pT3: Tumor invades adventitia
Esophagus-Infiltrating malignant neoplasm-pT-pT4: Tumor invades adjacent structures (specify)
pT4: Tumor invades adjacent structures (specify)
Esophagus-Infiltrating malignant neoplasm-pT-pT4a: Resectable tumor invading pleura, pericardium, or diaphragm
pT4a: Resectable tumor invading pleura, pericardium, or diaphragm
Esophagus-Infiltrating malignant neoplasm-pT-pT4b: Unresectable tumor invading other adjacent structures, such as aorta, vertebral body, trachea, etc
pT4b: Unresectable tumor invading other adjacent structures, such as aorta, vertebral body, trachea, etc
Esophagus-Infiltrating malignant neoplasm-pN-pN0: No regional lymph node metastasis
pN0: No regional lymph node metastasis
Esophagus-Infiltrating malignant neoplasm-pN-pN1: Regional lymph node metastasis involving 1 to 2 nodes
pN1: Regional lymph node metastasis involving 1 to 2 nodes
Esophagus-Infiltrating malignant neoplasm-pN-pN2: 3 to 6 nodes involved
pN2: 3 to 6 nodes involved
Esophagus-Infiltrating malignant neoplasm-pN-pN3: 7 or more nodes involved
pN3: 7 or more nodes involved
Generic-Specimen-Specimen integrity -Intact specimen(s) (Unopened, Capsule intact, Single intact specimen, Multiple intact, designated specimens (margins can be evaluated))
Intact specimen(s) (Unopened, Capsule intact, Single intact specimen, Multiple intact, designated specimens (margins can be evaluated))
Generic-Specimen-Specimen integrity -Non intact specimen (Open, Capsule ruptured specimen, Multiple non designated specimens (Fragmented, Morcellated)(margins cannot be evaluated with certainty)
Non intact specimen (Open, Capsule ruptured specimen, Multiple non designated specimens (Fragmented, Morcellated)(margins cannot be evaluated with certainty)
Generic-Lesion-Lesion focality-Single focus (Solitary - Unifocal)
Single focus (Solitary - Unifocal)
Generic-Lesion-Lesion focality
Lesion focality
Generic-Lesion-Lesion focality-Multiple foci (Multifocal - (Ipsilateral – Bilateral))(specify location)
Multiple foci (Multifocal - (Ipsilateral – Bilateral))(specify location)
Generic-Infiltrating malignant neoplasm-Lesion focality-Single focus (Solitary - Unifocal)
Single focus (Solitary - Unifocal)
Generic-Infiltrating malignant neoplasm-Lesion focality-Multiple foci (Multifocal - (Ipsilateral – Bilateral))(specify location)
Multiple foci (Multifocal - (Ipsilateral – Bilateral))(specify location)
Pancreas-Specimen-Target site-Stomach
Stomach
Stomach-Specimen-Specimen collection procedure-Total gastrectomy
Total gastrectomy
Stomach-Specimen-Specimen collection procedure-Partial gastrectomy, proximal
Partial gastrectomy, proximal
Stomach-Specimen-Specimen collection procedure-Partial gastrectomy, distal
Partial gastrectomy, distal
Stomach-Specimen-Specimen collection procedure-Endoscopic resection
Endoscopic resection
Larynx-Infiltrating malignant neoplasm-pN mucosal malignant melanoma
pN mucosal malignant melanoma
Stomach-Infiltrating malignant neoplasm-Histologic type-Tubular adenocarcinoma
Tubular adenocarcinoma
Stomach-Infiltrating malignant neoplasm-Histologic type-Papillary adenocarcinoma
Papillary adenocarcinoma
Stomach-Infiltrating malignant neoplasm-Histologic type-Mucinous adenocarcinoma (greater than 50% mucinous)
Mucinous adenocarcinoma (greater than 50% mucinous)
Larynx-Infiltrating malignant neoplasm-pN carcinoma
pN carcinoma
Stomach-Infiltrating malignant neoplasm-Histologic type-Carcinoma, not otherwise specified
Carcinoma, not otherwise specified
Stomach-Infiltrating malignant neoplasm-Margin site-Proximal Margin
Proximal Margin
Stomach-Infiltrating malignant neoplasm-Margin site-Distal Margin
Distal Margin
Stomach-Infiltrating malignant neoplasm-pT-pT0: No evidence of primary tumor
pT0: No evidence of primary tumor
Stomach-Infiltrating malignant neoplasm-pT-pTis: Carcinoma in situ
pTis: Carcinoma in situ
Stomach-Infiltrating malignant neoplasm-pT-pT1: Tumor invades lamina propria, muscularis mucosae, or submucosa
pT1: Tumor invades lamina propria, muscularis mucosae, or submucosa
Stomach-Infiltrating malignant neoplasm-pT-pT1a: Tumor invades lamina propria or muscularis mucosae
pT1a: Tumor invades lamina propria or muscularis mucosae
Stomach-Infiltrating malignant neoplasm-pT-pT1b: Tumor invades submucosa
pT1b: Tumor invades submucosa
Stomach-Infiltrating malignant neoplasm-pT-pT2: Tumor invades muscularis propria
pT2: Tumor invades muscularis propria
Stomach-Infiltrating malignant neoplasm-pT-pT3: Tumor invades subserosal connective tissue, without involvement of visceral peritoneum or adjacent structures
pT3: Tumor invades subserosal connective tissue, without involvement of visceral peritoneum or adjacent structures
Stomach-Infiltrating malignant neoplasm-pT-pT4: Tumor involves serosa (visceral peritoneum) or adjacent structures
pT4: Tumor involves serosa (visceral peritoneum) or adjacent structures
Stomach-Infiltrating malignant neoplasm-pT-pT4a: Tumor invades serosa (visceral peritoneum)
pT4a: Tumor invades serosa (visceral peritoneum)
Stomach-Infiltrating malignant neoplasm-pT-pT4b: Tumor invades adjacent structures
pT4b: Tumor invades adjacent structures
Stomach-Infiltrating malignant neoplasm-pN-pN0: No regional lymph node metastasis
pN0: No regional lymph node metastasis
Stomach-Infiltrating malignant neoplasm-pN-pN1: Metastasis in 1 to 2 perigastric lymph nodes
pN1: Metastasis in 1 to 2 perigastric lymph nodes
Stomach-Infiltrating malignant neoplasm-pN-pN2: Metastasis in 3 to 6 perigastric lymph nodes
pN2: Metastasis in 3 to 6 perigastric lymph nodes
Stomach-Infiltrating malignant neoplasm-pN-pN3: Metastasis in 7 or more perigastric lymph nodes
pN3: Metastasis in 7 or more perigastric lymph nodes
Stomach-Infiltrating malignant neoplasm-pN-pN3a: Metastasis in 7 to 15 perigastric lymph nodes
pN3a: Metastasis in 7 to 15 perigastric lymph nodes
Stomach-Infiltrating malignant neoplasm-pN-pN3b: Metastassis in 16 or more perigastric lymph nodes
pN3b: Metastassis in 16 or more perigastric lymph nodes
Lip, oral cavity-Infiltrating malignant neoplasm-pT carcinoma
pT carcinoma
Colon-Infiltrating malignant neoplasm-Lesion site-Right (ascending) colon
Right (ascending) colon
Colon-Infiltrating malignant neoplasm-Lesion site-Hepatic flexure
Hepatic flexure
Colon-Infiltrating malignant neoplasm-Lesion site-Transverse colon
Transverse colon
Colon-Infiltrating malignant neoplasm-Lesion site-Splenic flexure
Splenic flexure
Colon-Infiltrating malignant neoplasm-Lesion site-Left (descending) colon
Left (descending) colon
Colon-Infiltrating malignant neoplasm-Lesion site-Sigmoid colon
Sigmoid colon
Cervix-Specimen-Target site-Rectum
Rectum
Colon-Infiltrating malignant neoplasm-Histologic type-Adenocarcinoma
Adenocarcinoma
Colon-Infiltrating malignant neoplasm-Histologic type-Mucinous adenocarcinoma
Mucinous adenocarcinoma
Larynx-Infiltrating malignant neoplasm-pT glottis carcinoma
pT glottis carcinoma
Colon-Infiltrating malignant neoplasm-Histologic type-Signet-ring cell carcinoma
Signet-ring cell carcinoma
Colon-Infiltrating malignant neoplasm-Histologic type-Medullary carcinoma
Medullary carcinoma
Colon-Infiltrating malignant neoplasm-Histologic type-Undifferentiated carcinoma
Undifferentiated carcinoma
Colon-Infiltrating malignant neoplasm-Margin site-Proximal Margin
Proximal Margin
Colon-Infiltrating malignant neoplasm-Margin site-Distal Margin
Distal Margin
Colon-Infiltrating malignant neoplasm-pT-pT0: No evidence of primary tumor
pT0: No evidence of primary tumor
Colon-Infiltrating malignant neoplasm-pT-pTis: Carcinoma in situ, intraepithelial (no invasion)
pTis: Carcinoma in situ, intraepithelial (no invasion)
Colon-Infiltrating malignant neoplasm-pT-pTis: Carcinoma in situ, invasion of lamina propria
pTis: Carcinoma in situ, invasion of lamina propria
Larynx-Infiltrating malignant neoplasm-pT supra glottis carcinoma
pT supra glottis carcinoma
Colon-Infiltrating malignant neoplasm-pT-pT1: Tumor invades submucosa
pT1: Tumor invades submucosa
Colon-Infiltrating malignant neoplasm-pT-pT2: Tumor invades muscularis propria
pT2: Tumor invades muscularis propria
Colon-Infiltrating malignant neoplasm-pT-pT3: Tumor invades through the muscularis propria into pericolorectal tissues
pT3: Tumor invades through the muscularis propria into pericolorectal tissues
Colon-Infiltrating malignant neoplasm-pT-pT4a: Tumor penetrates the visceral peritoneum
pT4a: Tumor penetrates the visceral peritoneum
Colon-Infiltrating malignant neoplasm-pT-pT4b: Tumor directly invades or is adherent to other organs or structures
pT4b: Tumor directly invades or is adherent to other organs or structures
Colon-Infiltrating malignant neoplasm-pN-pN0: No regional lymph node metastasis
pN0: No regional lymph node metastasis
Colon-Infiltrating malignant neoplasm-pN-pN1a: Metastasis in 1 regional lymph node
pN1a: Metastasis in 1 regional lymph node
Colon-Infiltrating malignant neoplasm-pN-pN1b: Metastasis in 2 to 3 regional lymph nodes
pN1b: Metastasis in 2 to 3 regional lymph nodes
Colon-Infiltrating malignant neoplasm-pN-pN1c: Tumor deposit(s) in the subserosa, or non-peritonealized pericolic or perirectal tissues without regional lymph node metastasis
pN1c: Tumor deposit(s) in the subserosa, or non-peritonealized pericolic or perirectal tissues without regional lymph node metastasis
Colon-Infiltrating malignant neoplasm-pN-pN2a: Metastasis in 4 to 6 regional lymph nodes
pN2a: Metastasis in 4 to 6 regional lymph nodes
Larynx-Infiltrating malignant neoplasm-pT sub glottis carcinoma
pT sub glottis carcinoma
Colon-Infiltrating malignant neoplasm-pN-pN2b: Metastasis in 7 or more regional lymph nodes
pN2b: Metastasis in 7 or more regional lymph nodes
Liver-Infiltrating malignant neoplasm-Lesion site-Liver
Liver
Liver-Specimen-Specimen collection procedure-Total hepatectomy
Total hepatectomy
Liver-Infiltrating malignant neoplasm-Histologic type-Hepatocellular carcinoma
Hepatocellular carcinoma
Generic-Infiltrating malignant neoplasm-Lesion focality
Lesion focality
Liver-Infiltrating malignant neoplasm-pT-pT0: No evidence of primary tumor
pT0: No evidence of primary tumor
Liver-Infiltrating malignant neoplasm-pT-pT1: Solitary tumor without vascular invasion
pT1: Solitary tumor without vascular invasion
Liver-Infiltrating malignant neoplasm-pT-pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm
pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm
Liver-Infiltrating malignant neoplasm-pT-pT3a: Multiple tumors more than 5 cm
pT3a: Multiple tumors more than 5 cm
Larynx-Infiltrating malignant neoplasm-pT mucosal malignant melanoma
pT mucosal malignant melanoma
Liver-Infiltrating malignant neoplasm-pT-pT3b: Single tumor or multiple tumors of any size involving a major branch of the portal vein or hepatic veins
pT3b: Single tumor or multiple tumors of any size involving a major branch of the portal vein or hepatic veins
Liver-Infiltrating malignant neoplasm-pT-pT4: Tumor(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum
pT4: Tumor(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum
Liver-Infiltrating malignant neoplasm-pN-pN0: No regional lymph node metastasis
pN0: No regional lymph node metastasis
Liver-Infiltrating malignant neoplasm-pN-pN1: Regional lymph node metastasis
pN1: Regional lymph node metastasis
Pancreas-Specimen-Specimen collection procedure-Partial pancreatectomy, pancreatic tail
Partial pancreatectomy, pancreatic tail
Pancreas-Specimen-Specimen collection procedure-Pancreaticoduodenectomy (Whipple resection), total pancreatectomy
Pancreaticoduodenectomy (Whipple resection), total pancreatectomy
Pancreas-Specimen-Specimen collection procedure-Partial pancreatectomy, pancreatic body
Partial pancreatectomy, pancreatic body
Pancreas-Infiltrating malignant neoplasm-Lesion site-Pancreatic head
Pancreatic head
Pancreas-Infiltrating malignant neoplasm-Lesion site-Uncinate process
Uncinate process
Pancreas-Infiltrating malignant neoplasm-Lesion site-Pancreatic body
Pancreatic body
Pancreas-Infiltrating malignant neoplasm-Lesion site-Pancreatic tail
Pancreatic tail
Pancreas-Infiltrating malignant neoplasm-Histologic type-Ductal adenocarcinoma
Ductal adenocarcinoma
Pancreas-Infiltrating malignant neoplasm-Histologic type-Mucinous noncystic carcinoma
Mucinous noncystic carcinoma
Pancreas-Infiltrating malignant neoplasm-Histologic type-Signet-ring cell carcinoma
Signet-ring cell carcinoma
Pancreas-Infiltrating malignant neoplasm-Histologic type-Acinar cell carcinoma
Acinar cell carcinoma
Pancreas-Infiltrating malignant neoplasm-Histologic type-Serous cystadenocarcinoma
Serous cystadenocarcinoma
Pancreas-Infiltrating malignant neoplasm-Histologic type-Invasive mucinous cystic neoplasm
Invasive mucinous cystic neoplasm
Pancreas-Infiltrating malignant neoplasm-Histologic type-Acinar cell cystadenocarcinoma
Acinar cell cystadenocarcinoma
Pancreas-Infiltrating malignant neoplasm-Histologic type-Adenosquamous carcinoma
Adenosquamous carcinoma
Pancreas-Infiltrating malignant neoplasm-Histologic type-Invasive intraductal papillary-mucinous carcinoma
Invasive intraductal papillary-mucinous carcinoma
Pancreas-Infiltrating malignant neoplasm-Margin site-Proximal pancreatic margin
Proximal pancreatic margin
Pancreas-Infiltrating malignant neoplasm-Margin site-Common bile duct margin
Common bile duct margin
Pancreas-Infiltrating malignant neoplasm-Margin site-Distal pancreatic margin
Distal pancreatic margin
Pancreas-Infiltrating malignant neoplasm-Margin site-Posterior retroperitoneal surface of pancreas (Uncinate process (retroperitoneal) margin (nonperitonealized surface of the uncinate process)
Posterior retroperitoneal surface of pancreas (Uncinate process (retroperitoneal) margin (nonperitonealized surface of the uncinate process)
Pancreas-Infiltrating malignant neoplasm-pT-pT0: No evidence of primary tumor
pT0: No evidence of primary tumor
Pancreas-Infiltrating malignant neoplasm-pT-pTis: Carcinoma in situ
pTis: Carcinoma in situ
Lesion size, largest dimension
Breast-Infiltrating malignant neoplasm-Lesion size, largest dimension
Breast-Lesion size, largest dimension
Pancreas-Infiltrating malignant neoplasm-pT-pT1: Tumor limited to the pancreas, 2 cm or less in greatest dimension
pT1: Tumor limited to the pancreas, 2 cm or less in greatest dimension
Pancreas-Infiltrating malignant neoplasm-pT-pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension
pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension
Pancreas-Infiltrating malignant neoplasm-pT-pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery
pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery
Pancreas-Infiltrating malignant neoplasm-pT-pT4: Tumor involves the celiac axis or the superior mesenteric artery
pT4: Tumor involves the celiac axis or the superior mesenteric artery
Lung-Infiltrating malignant neoplasm-Lesion site-Lung
Lung
Lung-Specimen-Specimen collection procedure-Pneumonectomy
Pneumonectomy
Lung-Specimen-Specimen collection procedure-Lobectomy
Lobectomy
Lung-Specimen-Specimen collection procedure-Bilobectomy
Bilobectomy
Lung-Specimen-Specimen collection procedure-Segmentectomy
Segmentectomy
Lung-Infiltrating malignant neoplasm-Margin site-Parenchymal Margin
Parenchymal Margin
Lung-Infiltrating malignant neoplasm-Histologic type-Adenocarcinoma
Adenocarcinoma
Lung-Infiltrating malignant neoplasm-Histologic type-Large cell carcinoma
Large cell carcinoma
Lung-Infiltrating malignant neoplasm-Histologic type-Small cell carcinoma
Small cell carcinoma
Lung-Infiltrating malignant neoplasm-Histologic type-Adenosquamous carcinoma
Adenosquamous carcinoma
Endometrium-Infiltrating malignant neoplasm-Lesion ulceration
Lesion ulceration
Lung-Infiltrating malignant neoplasm-Histologic type-Sarcomatoid carcinoma
Sarcomatoid carcinoma
Lung-Infiltrating malignant neoplasm-Histologic type-Typical carcinoid tumor
Typical carcinoid tumor
Lung-Infiltrating malignant neoplasm-Margin site-Bronchial Margin
Bronchial Margin
Lung-Infiltrating malignant neoplasm-Margin site-Vascular Margin
Vascular Margin
Breast-Infiltrating malignant neoplasm-Microinvasion (DCIS)
Microinvasion (DCIS)
Lung-Infiltrating malignant neoplasm-pT-pT0: No evidence of primary tumor
pT0: No evidence of primary tumor
Lung-Infiltrating malignant neoplasm-pT-pTis: Carcinoma in situ
pTis: Carcinoma in situ
Lung-Infiltrating malignant neoplasm-pT-pT1a: Tumor 2 cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus (ie, not in the main bronchus); or Superficial spreading tumor of any size with its invasive component limited to the bronchial wall, which may extend proximally to the main bronchus
pT1a: Tumor 2 cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus (ie, not in the main bronchus); or Superficial spreading tumor of any size with its invasive component limited to the bronchial wall, which may extend proximally to the main bronchus
Lung-Infiltrating malignant neoplasm-pT-pT1b: Tumor greater than 2 cm, but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus (ie, not in the main bronchus)
pT1b: Tumor greater than 2 cm, but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus (ie, not in the main bronchus)
Lung-Infiltrating malignant neoplasm-pT-pT2a: Tumor greater than 3 cm, but 5 cm or less in greatest dimension surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus (ie, not in the main bronchus); or Tumor 5 cm or less in greatest dimension with any of the following features of extent: involves main bronchus, 2 cm or more distal to the carina; invades the visceral pleura; associated with atelectasi or obstructive pneumonitis that extends to the hilar region but does not involve the entire lung
pT2a: Tumor greater than 3 cm, but 5 cm or less in greatest dimension surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus (ie, not in the main bronchus); or Tumor 5 cm or less in greatest dimension with any of the following features of extent: involves main bronchus, 2 cm or more distal to the carina; invades the visceral pleura; associated with atelectasi or obstructive pneumonitis that extends to the hilar region but does not involve the entire lung
Lung-Infiltrating malignant neoplasm-pT-pT2b: Tumor greater than 5 cm, but 7 cm or less in greatest dimension
pT2b: Tumor greater than 5 cm, but 7 cm or less in greatest dimension
Lung-Infiltrating malignant neoplasm-pT-pT3: Tumor greater than 7 cm in greatest dimension; or Tumor of any size that directly invades any of the following: chest wall (including superior sulcus tumors), diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium; or Tumor of any size in the main bronchus less than 2 cm distal to the carina but without involvement of the carina; or Tumor of any size associated with atelectasis or obstructive pneumonitis of the entire lung; or Tumors of any size with separate tumor nodule(s) in same lobe
pT3: Tumor greater than 7 cm in greatest dimension; or Tumor of any size that directly invades any of the following: chest wall (including superior sulcus tumors), diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium; or Tumor of any size in the main bronchus less than 2 cm distal to the carina but without involvement of the carina; or Tumor of any size associated with atelectasis or obstructive pneumonitis of the entire lung; or Tumors of any size with separate tumor nodule(s) in same lobe
Lung-Infiltrating malignant neoplasm-pT-pT4: Tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina; or Tumor of any size with separate tumor nodule(s) in a different lobe of ipsilateral lung
pT4: Tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina; or Tumor of any size with separate tumor nodule(s) in a different lobe of ipsilateral lung
Lung-Infiltrating malignant neoplasm-pN-pN0: No regional lymph node metastasis
pN0: No regional lymph node metastasis
Lung-Infiltrating malignant neoplasm-pN-pN1: Metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes, and intrapulmonary nodes, including involvement by direct extension
pN1: Metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes, and intrapulmonary nodes, including involvement by direct extension
Lung-Infiltrating malignant neoplasm-pN-pN2: Metastasis in ipsilateral mediastinal and/or subcarinal lymph node(s)
pN2: Metastasis in ipsilateral mediastinal and/or subcarinal lymph node(s)
Lung-Infiltrating malignant neoplasm-pN-pN3: Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph node(s)
pN3: Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph node(s)
Prostate-Specimen-Target site-Prostate
Prostate
Prostate-Specimen-Specimen collection procedure-Needle Biopsy
Needle Biopsy
Prostate-Specimen-Specimen collection procedure-Radical prostatectomy
Radical prostatectomy
Not classified
owl:Thing
Christel Daniel
David Ouagne
PATHLEX